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Abstract 
Nucleosomes often sit at precisely defined positions on eukaryotic gene 
promoters, influencing the regulation of target genes. Expression of milk 
proteins including 3-lactoglobulin is controlled by prolactin activation of the 
transcription factor Stat5 via the Janus kinase I Signal transducer and 
activator of transcription (Jak/Stat) pathway. Stat5 has previously been 
shown to tetramerise where binding sites are tandemly linked and the 
proximity of these binding sites appears to be important for these 
interactions. This work and previous large scale mapping of the 3-
lactoglobulin promoter shows that the dyad of a strongly positioned 
nucleosome lies at —184 bp from the transcription start on the promoter of the 
f3-lactoglobulin gene. This brings together two binding sites for Stat5, at the 
points of entry and exit of DNA from the nucleosome that would otherwise be 
spaced 185 bp apart, an arrangement that could potentially bring bound 
Stat5 dinners close enough to facilitate tetra merisation. The chromatin 
structure over the active and inactive gene promoter is different; there are 
two alternative nucleosome positions in the active and only one in the 
inactive promoter. One of these positioning sites would not allow the 
tetramerisation interaction to take place. In order to understand better the 
mechanisms by which the expression of 3-lactogIobuIin is regulated by Stat5 
we set out to investigate the role of these positioned nucleosomes in Stat5 
binding in vitro. Stat5A and B binding patterns on both naked DNA and on 
reconstituted chromatin probes are shown by a series of bandshift 
experiments using purified recombinant Stat5 produced in a baculovirus 
expression system. Characterisation of Stat5 reveals the protein to be 
phosphorylated and able to bind DNA. A mutation, W37A, which removes 
the ability of Stat5 to form dimer-dimer interactions was employed to further 
investigate a potential role of tetramerisation influencing Stat5 binding in a 
chromatin context. This architectural feature could act to control the temporal 
and tissue specific expression of 3—lactoglobuIin. 
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INTRODUCTION 
Differentiated cells throughout the body are controlled by the precisely 
regulated expression of genes. During development and all cell functions 
genes are switched on and off at precisely regulated time points, so that 
although every cell contains the same DNA sequences, only the correct genes 
are active at any time. Whether a particular gene will be on or not at a given 
time in a specific tissue is controlled by a complex interaction of transcription 
factors with DNA and its associated structural elements. Transcription 
factors can act in a variety of ways: by modifying the DNA, by altering 
chromatin structure or by recruiting or removing other factors including the 
RNA polymerase complex. They may be regulated by external signals, or by 
gene products or chromatin structures already present inside the cell. 
But how are all these genes regulated in so specific a manner? Each gene has 
regulatory regions associated with it that can bind different combinations of 
transcription factors. Some of these may be common to many genes, such as 
general transcription factor sites like the TATA box. Others are more 
specialised, involved in the regulation of perhaps only a set of related genes. 
1.1 Chromatin. 
Most studies of transcription factors have historically involved binding to 
naked DNA, but in a eukaryotic cell this is not the native state of DNA. Here 
DNA is organised into a series of higher order structures called chromatin. 
The role of chromatin is to maintain DNA in a highly ordered compact 
structure, and it is to this substrate that transcription factors must bind in 
order to affect expression of a gene. Only recently have techniques such as 
chromatin immunoprecipitation (ChIP) and nucleosome mapping at high 
resolution been developed for the study of transcription factors in vivo 
The evolution of the nucleus, and the organisation of DNA into chromatin, 
marks a major difference between prokaryotes and eukaryotes, as does the 
presence of repetitive elements in eukaryotic genomes requiring a higher 
degree of organisation of the DNA (Hickey, 1992; Bowen and Jordan, 2002). 
Some theories state that it is the organisation of DNA into nucleosomes or 
nucleosome-like structures that marks the real phylogenetic branch between 
prokaryotic and eukaryotic organisms (Bendich and Drlica, 2000) but this is 
by no means certain. Archaeabacteria, which are classified somewhere 
between eukaryotes and prokaryotes contain structures very similar to the 
eukaryotic nucleosome, but have not evolved the nuclear membrane (Woese 
and Fox, 1977; Shioda et al., 1989; Pereira et al., 1997). Whatever the barrier 
the increased level of regulation available, brought in when transcription and 
translation were physically separated and DNA was packaged in this 
ordered manner, allowed for the development of much larger genomes 
which then could give rise to more complex organisms. Most importantly 
cells could differentiate and take on a specific role within a multicellular 
organism. This required the development of mechanisms to overcome the 
inherent repressive nature of the organisation of DNA into chromatin. 
Mechanisms also evolved to take advantage of the nucleosomal structure of 
DNA in the specific regulation of genes (Struhl, 1999). 
1.1.1 Euchromatjn and Heterochromatjn 
Chromatin can be divided into two basic states, which were first described 
based on the uptake of dye in different areas of the nucleus (Heitz, 1928). 
These are heterochromatin, a highly condensed form of DNA, and 
2 
euchromatin, which is more loosely packed. In general, a gene situated in a 
region of heterochromatin will be repressed in comparison to genes in 
euchromatic regions (Grewal and Elgin, 2002; Vermaak et al., 2003). This is 
demonstrated in the phenomenon of position effect variegation (PEV), where 
an identical transgene may show different expression levels depending on 
the site of integration (Dobie et al., 1997). This can be partly explained for by 
the enhanced access of transcription factors to the more open chromatin 
structure if the transgene integrates into a euchromatic region rather than a 
region of heterochromatin. Inclusion of barrier elements in transgenes can 
overcome PEV (Sun and Elgin, 1999; Festenstein and Kioussis, 2000). Such 
barriers stop the spread of heterochromatin structure into a transgene. 
Heterochromatin is characterized by a closed chromatin structure that is 
resistant to cleavage by nucleases, by the presence of heterochromatin 
protein 1 (HP1), and by characteristic histone modifications such as 
methylation of histone H3 lysine 9 (H3-K9) and hypoacetylation of histone 
tails (Struhi, 1998; Lusser, 2002; Grewal and Elgin, 2002). Recently the 
discovery was made that RNA plays an important role in the maintenance of 
the heterochromath-i state (Volpe et al., 2002). 
1.1.2 Nucleosomes. 
The fundamental repeating unit of chromatin, the core particle, is 146 base 
pairs of DNA wrapped in 1.7 helical turns wound round a core histone 
octamer containing one copy each of an H3 and an H4 dimer and 2 copies of 
an H2A:H2B dimer. The structure of the nucleosome core particle is known 
in detail (Luger et al., 1997; Richmond and Davey, 2003). A linker histone 
such as Hi joins the complex to form a functional chromatosome, increasing 
the DNA protected against nucleases to 160bp (Simpson, 1978). A schematic 
3 
diagram of nucleosomes and a representation of how higher order chromatin 
structures might form is shown in Figure 1.1. 
The next stage in chromatin organisation is the 30nm fibre, formed from 
higher order interactions within the lOnm fibre in a process that is probably 
stablilised by linker histone interactions (Carruthers et al., 1998). The 30nm 
fibre then folds to form further higher order structures, culminating in the 
formation of chromosomes. The DNA is eventually compacted by a factor of 
50 000, fitting over a metre of DNA into the nucleus of a cell less than 10tm 
across. An overview of the basic forms of chromatin structure is shown in 
Figure 1.1. Little is known about the structures formed in the 30nm fibre and 
further higher order structures. 
1.1.3 Nucleosome Modifications. 
The amino-terminal tails of the core histones can be covalently modified. 
Lysine residues can be mono-, di- or tri-methylated in what appears to be a 
relatively static mark, and acetylated or phosphorylated in a dynamic 
process that may encode transcriptional information. Arginine residues can 
be methylated and serine residues phosphorylated. These modifications may 
be recognised by regulatory factors as a histone code signal as part of 
transcription regulation (Jenuwein and Allis, 2001; Lusser, 2002). For 
example the chromodomain of (HP1) specifically recognises the methylated 
form of H3-K9 in the repressed chicken f3-globin locus resulting in a 
heterochromatin structure. In the active locus F13-K4 is methylated and H3 
and H4 are acetylated (Kim and Dean, 2004). Histone acetyl transferases 
(HATs) such as CREB binding protein (CBP)/p300 acetylate histone tails. 




Figure 1.1. Chromatin Structure from Nucleosomes to Chromosomes 
Schematic diagram showing how A. DNA (black) is organised into a left 
handed helice round nucleosomes (grey) in the lOnm fibre, and B. how this 
may fold up to give the 30nm fibre and other higher order chromatin 
structures. 
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resulting in a more closed chromatin structure (Struhl, 1998; Woiffe, 2001; 
Lusser, 2002). As well as acting as a mark on chromatin, the addition of 
acetyl groups neutralises the positive charge of the lysine residues resulting 
in less tight interactions of the histone tails with the DNA and therefore a 
more open chromatin structure. The presence of these mechanisms serves to 
emphasise the important role nucleosomes have in gene regulation. 
1.1.4 Nucleosome Movement. 
ATP-dependent nucleosome remodelling complexes such as SWI/SNF use 
energy from the hydrolysis of ATP to move nucleosomes on DNA (Becker 
and Horz, 2002). These and other non-specific factors are recruited by 
binding to sequence specific factors, and can be involved in both activation 
and repression of transcription. It is likely that part of the activity of these 
complexes is to remove one or both of the H2A/H2B dimers (Workman and 
Kingston, 1998; Bruno et al., 2003). Nucleosomes also exhibit a tendency to 
redistribute on a DNA fragment in a temperature dependent manner that 
does not require ATP (Pennings et al., 1991; Meersseman et al., 1992). 
1.2 Nucleosome Positioning. 
Nucleosomes have been shown to sit at precisel y  regulated positions on 
DNA (Buckle et al., 1991; Simpson, 1991; Thoma, 1992). They are probably 
located there by sequence signals in the DNA, but other factors such as 
proteins bound to DNA may have additional influences. Nucleosome 
positions have been mapped to base pair accuracy in vitro in several 
eukaryotic genes, including the chicken f3-globin gene (Buckle et al., 1991; 
Kef alas et al., 1988) and the ovine J3-lactoglobulin (BLG) gene and promoter 
(Boa, 1999; Gencheva and Allan, 2005), using various techniques including 
the monomer extension technique, Exonuclease III and restriction'mapping 
of core particle DNA (Yenidunya et al., 1994; Meersseman et al., 1991; Kefalas 
et al., 1988). 
1.2.1 Nucleosomes and Gene Regulation 
Generally, the presence of nucleosomes on DNA is regarded as having an 
inhibitory effect on gene expression, as interactions of DNA with histones 
restricts access for transcription factors, many of which cannot bind to sites 
on a nucleosome. Although nucleosomes are dynamic structures and DNA 
sequences throughout much of the core can become transiently dissociated 
from histones, only a limited number of base pairs are available at any one 
time. The curve of DNA organised in a nucleosome is such that many factors 
do not recognise their binding sites, the rotational setting of DNA on a 
nucleosome can also affect whether a factor will bind (Martinez-Campa et al., 
2004). As such, the presence of nucleosomes on regulatory regions can have 
a fundamental role in regulation of transcription, although the precise effect 
varies between genes. Nucleosomes on regulatory regions may be either 
displaced or remodelled on gene activation. Once formed the RNA 
polymerase II complex can transcribe through bound nucleosomes 
(Felsenfeld et al., 1996). 
Nucleosomes do not necessarily have a negative impact on transcription. 
There are examples of the opposite occurring where the winding of DNA 
round a positioned nucleosome brings sequences together to allow 
interactions between two bound transcription factors, effectively removing 
the sequence between the sites (Jackson and Benyajati, 1993; Schild et al., 
1993; Zhu and Thiele, 1996; Stünkel et al., 1997). Another model is based on 
the formation of a "supergroove" where sites separated by 80bp and 
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organised in a nucleosome are brought together (Edayathumangalam et al., 
2004). 
1.2.2 Interaction of Transcription Factors with Nucleosomal DNA. 
Transcription factors may or may not be able to bind within chromatin. 
Partly this relies on the location of binding sites either within linker DNA or 
within DNA associated with a nucleosome (Figure 1.2). Certain transcription 
factors do not appear to bind at all to a chromatin template, unless it has 
been remodelled (Spangenberg et al., 1998). Other transcription factors can 
bind to DNA associated with a nucleosome, e.g. HNF3 binds to DNA at the 
periphery of a nucleosome on the vitellogenin promoter (Robyr et al., 2000). 
The DNA sequences at nucleosome boundaries bind the histone octamer less 
tightly and are therefore more accessible than more central sequences 
(Weischet et al., 1978). Restriction enzyme access to nucleosomes is 1000 
times less in the central lOObp and 50 times less in end sequences compared 
to naked DNA (Linxweiler and Horz, 1984; Anderson et al., 2002). 
The MMIV promoter has been extensively studied with regard to 
nucleosome positions and transcription factor access therein, notably of the 
glucocorticoid receptor (GR) and nuclear factor 1 (NF-1) (Richard-Foy and 
Hager, 1987; Perlmann and Wrange, 1988; Cordingley et al., 1987; Piña et al., 
1990; Eisfeld et al., 1997; Ostland Farrants et al., 1997; Spangenberg et al., 
1998). GR will bind to DNA associated with the periphery of a positioned 
nucleosome, but not to sites closer to the dyad. CR binding results in 
nucleosome remodelling which allows NF-1 to bind; NF-1 will not bind to 
DNA associated with a nucleosome, but it will bind to a nucleosome lacking 
H2A/H2B. Modification of nucleosomes in this way has been suggested to 
be one of the actions Of chromatin remodelling complexes such as SWI/SNF 
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Figure 1.2 Nucleosome Structure: Transcription Factor Access. 
A. Binding of transcription factors to sites on DNA can be affected by their 
interactions with nucleosomes. Sites in the linker DNA (green) are generally 
accessible for binding but sites in a nucleosome may or may not be 
accessible. Sites close to the nucleosome boundary (amber) are more likely 
to be accessible than those more centrally placed (red). B. The rotational 
setting of the DNA can also affect transcription factor binding. Factors may 
be able to access binding sites facing away from the nucleosome core 
(amber) but not those facing towards it (red), for example this is how the 
1 Obp periodicity of DNasel digestion on a positioned nucleosome comes 
about. 
(Section 1.1.4). At another promoter, the rat tyrosine aminotransferase, CR 
binding results in removal of the nucleosome rather than remodelling (Flavin 
et al., 2004) indicating that the behaviour of nucleosomes is by no means 
general. 
The organisation of DNA into nucleosomes can have a positive effect on 
transcription. The Xenopus vitellogenin Bi promoter, the Candida. glabrata 
metal responsive promoter, the Drosophila alcohol dehydrogenase (adh) 
promoter and the human U6 gene are examples of the wrapping of DNA 
round a nucleosome bringing together regulatory elements resulting in 
enhanced gene expression (Jackson and Benyajati, 1993; Schild et al., 1993; 
Thu and Thiele, 1996; Stünkel et al., 1997). The mechanism of this action in 
the adh promoter and in the vitellogenin promoter are illustrated in Figure 
1.3. 
1.2.3 Positioning Signals. 
Precisely what makes nucleosomes sit at defined positions on DNA is still a 
matter for debate. Reconstitutions onto naked DNA in vitro can result in 
precisely positioned nucleosomes, which may sit at similar positions to in 
vivo mapped nucleosome positions (Jackson and Benyajati, 1993; Boa, 1999; 
Hansen and van Holde, 1991; Linxweiler and Horz, 1985). The (H3H4)2 
tetramer is responsible for positioning nucleosomes (Prunell, 1983). The 
inherent bendability of the DNA sequence seems to be an important factor 
(Jackson and Benyajati, 1993) as the DNA wound round the nucleosome is 
heavily bent/twisted and contains several kinks (Hogan et al., 1987). CpG 
methylation of DNA may provide an additional factor to consider in 
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Figure 1.3 Models of Positioned Nucleosomes Enhancing Transcription 
Factor Interactions. 
A. A schematic representation of the Drosophila alcohol dehydrogenase 
promoter, adapted from (Jackson and Benyajati, 1993). In the absence of a 
positioned nucleosome, the enhancer can interact with either the proximal or 
the distal promoter. A tissue-specific positioned nucleosome ensures the 
enhancer is much more likely to interact with the distal promoter in fat body 
tissue. B. A schematic representation of the Xenopus vitellogenin Bi 
promoter. The positioned nucleosome brings together an estrogen 
responsive element (ERE), with the proximal promoter thus facilitating 
enhanced transcription (top). Deleting the nucleosome sequence (bottom) 
has the same effect. This diagram is adapted from (Schild et al., 1993). 
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1.2.4 Nucleosome Reconstitution. 
Nucleosomes can be reconstituted onto naked DNA sequences in vitro by the 
transfer of histones from donor chromatin or from purified core histones by 
salt gradient dialysis to give a structure indistinguishable from native 
nucleosomes (Tatchell and van Holde, 1977; Riley and Weintraub, 1978; 
Luger et al., 1997). At high salt concentrations the histone core is dissociated 
from DNA, but exists as an octamer (Thomas and Kornberg, 1975). As the 
salt is removed histones bind to DNA. In the absence of DNA the octamer 
will also become unstable and dissociate into (H3H4)2 and H2A-H2B 
tetramers (Tatchell and van Holde, 1977). Statistically a stretch of DNA more 
favourable to being organised into a nucleosome will have nucleosomes 
associated with it more often. This is referred to as the strength of a 
nucleosome position. As [NaC1] is brought down to -1M, a histone tetramer 
(H3H4)2 forms and binds (Wilhelm et al., 1978). The position of the tetramer 
defines the eventual location of the nucleosome. The core histone octamer is 
partially formed at 800mM NaCl, and at 600mM NaCl assembly of 
nucleosomes is complete, although not conformationally stable until in a low 
ionic strength buffer (Tatcheil and van Holde, 1977; Hansen and van Holde, 
1991; Dong and van Holde, 1991). 
1.3 Mapping Nucleosome Positions. 
Many positioned nucleosomes exhibit a group of rotationally positioned 
nucleosomes, spaced lObp apart (Dong et al., 1990; Meersseman et al., 1991; 
Pennings et al., 1991). The rotational position of a nucleosome can be 
determined by accessibility to nucleases or chemical cleavage reagents to the 
side of the DNA helix that faces into or away from the nucleosome (Figure 
1.2b). DNaseI, which attacks DNA in the minor groove, produces a 
characteristic lObp pattern in digests of a rotationally positioned nucleosome 
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as the minor groove is alternatively facing towards and away from the 
histone core. The presence of a group of nucleosomes with a spacing other 
than lObp will not show up in a DNaseI digest, as the cutting patterns cancel 
each other out, resulting in a digest pattern similar to that of naked DNA. 
The translational position of a nucleosome is defined as the position of a 
nucleosome on the DNA from a set point and can be mapped by the 
protection of DNA covered by the nucleosome from attack by nucleases. The 
monomer extension technique (Yenidunya et al., 1994) makes use of core 
DNA protected from MNase digestion by nucleosomes reconstituted onto 
the sequence of interest. Isolated core DNA is annealed back to a single 
stranded version of the template, and extended to a known restriction site. 
Extension products are resolved on a sequencing gel and from their size 
nucleosome boundaries can be mapped with base pair accuracy. Another in 
vitro nucleosome mapping technique makes use of the stepwise digestion of 
the 3' strand by Exolli. Exoill digestion will pause at a nucleosome 
boundary, although eventually it will also digest internally to the 
nucleosome pausing at lObp intervals as DNA / histone interactions occur 
(Riley and Weintraub, 1978; Prunell, 1983; Kefalas et al., 1988). Digestion 
pause sites and thus nucleosome boundaries can be mapped in relation to a 
DNA end by digestion of 5' end labelled DNA. 
In vivo, sequence effects will still drive the formation of nucleosomes at 
certain sequences, but higher order chromatin structure and the presence of 
other DNA binding proteins can also affect nucleosomal location. 
Nucleosomes can be mapped with nucleotide resolution in vivo using 
techniques such as ligation-mediated PCR (LM-PCR). LM-PCR works by 
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ligation of a linker sequence to the end of core DNA (e.g. from a MNase 
digest) and the amplification of core DNA by nested primers within the 
sequence and a primer corresponding to the linker DNA thus allowing the 
high resolution mapping of nucleosome boundaries. 
However problems can arise in viva as there will also be other DNA binding 
proteins present that may restrict access to DNA, potentially resulting in 
detection of false nucleosome boundaries. DNA at nucleosome boundaries 
does not interact as strongly with a nucleosome as DNA more centrally 
positioned on the nucleosome does (Weischet et al., 1978). DNA at the centre 
of a nucleosome binds the (H3H4)2 tetramer whereas sequences at the 
nucleosome boundary bind H2A/H2B (Luger et al., 1997). If a nuclease is not 
fully halted at a nucleosome boundary nucleosome positions calculated may 
be weak or incorrect. Use of a combination of DNA cutting methods such as 
DNaseI and MNase can help overcome these problems, and will also even 
out any DNA sequence preferences of the different nucleases. 
1.3.1 Nucleosome Structure Over the Ovine f3-Lactoglobulin Gene. 
The nucleosome structure over 10kb of the Ovine -Lactoglobulin (BLG) 
gene and promoter has been mapped both in viva and in vitro (Boa, 1999; 
Gencheva and Allan, 2005). The in vivo map compared the nucleosome 
structure in lactating mammary gland, the tissue BLG is expressed in, to the 
structure in liver; a non-expressing tissue. Many aspects of the two maps 
were similar, but they displayed some important differences. In liver, a 
regular nucleosome array is present throughout the gene and its promoter. 
In mammary tissue the array is retained up to the promoter, but the 
nucleosome structure becomes disrupted over the gene and few positioned 
nucleosomes are detected (illustrated in Figures 1.4 and Figure 3.1). The 
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terminal 3' nucleosome in the mammary promoter array is actually a pair of 
two positioned nucleosomes. As only one nucleosome can actually sit over 
this DNA region in any cell, the fact that two alternatives are present in the 
active gene but not the inactive may point to a nucleosome structure-
facilitated switch in the promoter. 
The technique used to map the in vivo nucleosome positions does not map at 
high resolution. In order to be able to interpret the functional significance of 
the observed change in chromatin structure in the BLG promoter, 
information regarding the precise position of nucleosomes with respect to 
the DNA sequence would be invaluable. 
An in vitro nucleosome positioning map of the BLG promoter and gene was 
produced using monomer extension (Boa, 1999; Gencheva and Allan, 2005). 
The region corresponding to the nucleosome pair mapped in vivo at the 
proximal promoter displayed a strong nucleosome positioning sequence, 
placing a nucleosome dyad at —183bp with respect to the transcription start 
site and a second strong overlapping site with a dyad at —224bp. The 
position at —183 is given the name nucleosome A and is represented in 
yellow in all figures in this thesis. The position at —224bp, is named 
nucleosome B, and likewise is represented in brown (Figures 3.2 and Figure 
1.4). Nucleosome A sits almost exactly between two binding sites for the 
transcription factor Stat5, whereas nucleosome B lies over the upstream StatS 
binding site leaving only the downstream site external to the nucleosome. 
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Figure 1.4 The BLG Gene. 
The BLG gene contains 7 exons, marked by black boxes. DNasel 
hypersensitive sites are marked by arrows and roman numerals. HSIII 
coincides with three Stat5 binding sites (red circles) and the point where the 
in vivo mammary nucleosome array running through the promoter terminates 
(indicated below the gene). Part of the region covered by HSIII has been 
enlarged below the array. Two in vitro mapped nucleosome positions A 
(yellow) and B (brown) differentially cover the Stat5 binding sites. 
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1.4 Milk Proteins. 
Ever since nuclear proteins from lactating mammary gland were first 
observed binding to a milk promoter (Lubon and Hennighausen, 1987) the 
search has been on to define the factors responsible for the high level tissue 
specific and temporal regulation of milk proteins. Stat5 was first discovered 
as a mammary specific DNA binding protein, milk protein binding factor 
(MPBF) (Watson et al., 1991) or mammary gland factor (MGF) (Schmitt-Ney 
et al., 1991). Further characterisation revealed these to be members of the 
signal transducer and activator of transcription (Stat) family of transcription 
factors (Burdon et al., 1994a; Wakao et al., 1994) and the protein was 
renamed Stat5. Later it was realised there were two forms of Stat5, Stat5a 
and Stat5b (Liu et al., 1995). Stat5 regulates expression of milk proteins via 
prolactin induced activation of the Janus kinase (Jak) / Stat pathway (Heim, 
1999; Barahmand-Pour et al., 1998; Darnell et al., 1994; Brelje et al., 2002). 
1.4.1 The Proximal Promoters. 
A conserved binding site for Stat5 is found in the region around -90 to -100 
bp from the transcription start site in the promoters of many milk protein 
genes. This proximal site is responsible for the hormone responsiveness of 3- 
 casein (Wakao et al., 1994), BLG (Burdon et al., 1994a; Burdon et al., 1994b; 
Demmer et al., 1995) and asl-casein (Pierre et al., 1994). Introduction of such 
a site into the murine a-lactalbumin proximal promoter introduces this 
property (Soulier et al., 1999). There is often more than one Stat5 binding site 
in the proximal promoter region (Vilotte and Soulier, 1992; Jolivet et al., 
1992), in BLG these are located at -278, -210 and -93 bp from the 
transcription start site (Watson et al., 1991). In asl-casein and -casein these 
factors have been shown to act synergistically with a second set of Stat5 
binding sites at a site further from transcription start, the distal promoter. 
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1.4.2 The Distal Promoters. 
Many milk protein genes also contain a second set of Stat5 binding sites at a 
site further from transcription start (Millot et al., 2001; Pierre et al., 1994; Li 
and Rosen, 1995). These act cooperatively with the proximal Stat5 sites and 
other factors to produce maximal expression of the genes (Pierre et al., 1994). 
No functionally tested distal Stat5 binding sites have been reported in BLG, 
but there are Stat5 consensus binding sites at —2336 and —4014bp from the 
transcription start site. Half consensus sites or near-consensus Stat5 binding 
sites are spread throughout the promoter. Resection of the BLG promoter 
first to 3150bp and then to 400bp of 5' flanking sequence leads to two 
reductions in the BLG promoter activity in CHO-K3 cells suggesting there 
are other factors responsible for the BLG gene activity in these regions 
(Demmer et al., 1995). 
1.5 The BLG Gene. 
BLG is the major milk whey protein in ruminants. It is not found in humans 
or rodents, but a transgenic mouse model exhibits a nearly identical 
expression profile to sheep (Whitelaw et al., 1992). BLG, as with most milk 
proteins, is expressed at high levels and has been exploited to produce 
pharmaceutical drugs such as factor IX (Schnieke et al., 1997) and al-
antitrypsin (Archibald et al., 1990) in sheep milk using the BLG promoter to 
drive expression specifically in the mammary gland. BLG is a member of the 
lipocalin family, and binds fatty acids. It may have a role in the transport of 
these and retinol (vitamin A) (Kontopodis et al., 2002). 
1.5.1 DNase I Hypersensitive Sites in BLG. 
There are five DNaseI hypersensitive sites (HS) in the BLG promoter (Figure 
1.4); each has a distinctive temporal pattern and is only found in mammary 
tissue (Whitelaw and Webster, 1998; Whitelaw et al., 1992). HSI, located 
-1200 bp from the transcription start site, is detected from mid pregnancy, 
but is predominantly detected during lactation. The occurrence of HSII, 
located -800bp from transcription start, is erratic and weak. HSIII lies over 
the sequence from -300 to +lOObp relative to the transcription start site, this 
includes the region of DNA where the change in the in vivo nucleosome 
structure occurs (Figure 1.4 and Figure 3.1). This is also where the Stat5 
binding sites are located (Figure 1.4 and Figure 3.3). The extent of digestion 
at HSIII directly reflects the level of BLG expression. HSIII is detected 
weakly in virgin mammary gland, increasing in strength through late 
pregnancy to a peak during lactation before disappearing during involution. 
BLG is expressed at low levels in virgin mammary gland and expression 
increases from mid pregnancy through lactation until weaning and the 
subsequent involution of the mammary gland. HSIII is present in the correct 
pattern in mice transgenic for BLG, including those where the 5' flanking 
sequence has been reduced to 406bp. This 406bp proximal promoter is also 
able to direct correct tissue specific and temporally regulated expression of 
BLG in transgenic mice (Webster et al., 1995; Whitelaw et al., 1992). 
HSJV and V are present up to the first upregulation of milk protein gene 
expression at mid pregnancy, and may reflect a poised chromatin structure 
of the gene in mammary tissue. HSIV and V are 700bp and 1500bp 
downstream of HSIII respectively (Whitelaw et al., 1992; Whitelaw and 
Webster, 1998). 
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The HS sites over the sheep and goat BLG gene differ, HSIV is present 
during lactation in goat tissue but not in sheep. Sheep BLG is expressed at a 
higher level than goat but the promoter sequence is 96% similar, suggesting 
that the chromatin structure has a role in regulation of BLG. No HS sites are 
detected in liver (Pena et al., 1998). 
1.5.2 BLG Promoter Expression Studies. 
The role of the three Stat5 binding sites in the transcriptional activity of the 
proximal promoter has been studied in various promoter reporter studies. 
The proximal BLG promoter contains three binding sites for Stat5 only one of 
which (StM) fully obeys the recognised Stat5 consensus sequence (Figure 
1.5). Transient transfection studies in CHO-K3 cells containing the long form 
rabbit prolactin receptor revealed that only StM is responsible for BLG 
promoter activity (Demmer et al., 1995). However in studies of transgenic 
mice and in the mammary epithelial cell line HC11, all three Stat5 binding 
sites are required for maximum activity and appear to act cooperatively 
(Burdon et al., 1994a; Burdon et al., 1994b). The major difference between the 
CHO-K3 and the other two systems is the mammary gland developmental 
background; the gene may be primed for activation ready to respond to 
lactation stimulus. Such a state could take the form of a preset chromatin 
structure over the gene as suggested by the presence of HSIV and HSV 
before BLG expression is upregulated. In transient transfections such as 
those in CHO-K3 cells the gene is not organised into chromatin, but the 
promoter-reporter constructs will be organised into a chromatin structure in 
both the transgenic mice and the stably transfected HC11 cells, neither of 
which contain endogenous BLG. HC11 cells express transfected BLG at a 
much lower level than transgenic mammary gland, this may reflect that the 
transgene has gone through mammary gland development in mouse, but not 
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Figure 1.5 Stat5 Binding Sites. 
Consensus binding sites for Stat5, the Stat5 consensus is shown in bold. 
StM, Al and A3 are from the sheep BLG promoter, asl is the rabbit aSl 
casein proximal Stat5 binding site and Pcas is the rat 13-casein proximal site. 
The consensus sequence shown for tetramer binding is for a second site, 
separated by 6bp from a strong site. The tetramer consensus is less well 
defined, as a full consensus is not necessarily required for binding, the 
sequence represented here has been demonstrated to encourage binding as 
a tetramer (Soldaini et al., 2000). 
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in HC11 cells. Developmental specific variation in chromatin structure may 
explain the different activities seen between CHO, HC11 and mouse assays 
for the proximal Stat5 sites. 
High level expression and tissue and temporal specificity is conferred in 
transgenic mice by a minimum proximal promoter sequence of 406bp 
(Whitelaw et al., 1992; Webster et al., 1995). However in CHO-K3 cells 
expression from the 406bp promoter is much reduced compared to 
constructs containing an extended 5' sequence, up to 4.2kb (Demmer et al., 
1995). Removal of the StM site from these longer promoters also abolished 
prolactin induction but this is not reproducible in mammary epithelial cells 
(Burdon et al., 1994a; Burdon et al., 1994b). In the light of the properties of 
other milk protein promoters, it is possible that a cooperative interaction 
between distal sequences and the proximal promoter might play a role in 
generating the maximal BLG expression. No analysis of the longer 
promoters has been carried out either in the HC11 cell line or mice and no 
HS sites coincide with the distal Stat5 binding sites. 
1.6 Stat5. 
BLG, like other milk proteins is activated in response to prolactin stimulation 
of the Jak I Stat pathway. Stat proteins are a family of cytoplasmic 
transcription factors. They were discovered initially through studies of 
interferon signaling (Darnell et al., 1994), but are activated by a wide range of 
cytokines and growth factors, see (Ihle, 1996), and (Darnell, 1997) for 
reviews. Stat genes have been identified in Drosophila (Yan et al., 1996; Hou 
et al., 1996) and in Dictostelium, (Kawata et al., 1997) but not in yeast 
indicating an appearance early in the evolution of eukaryotes. 
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1.6.1 Complex Regulation of Stat Factors. 
Seven members of the Stat family have been identified so far in mammals, 
participating in many roles in the regulation of a whole host of cellular 
processes. These are numbered Stati to Stat6, including the two forms of 
Stat5, 5a and 5b. Stati is required for the interferon (IFN) pathway and Stati 
knockout mice have no innate immune response. Stat2 also is required for 
regulation of IFN-a (but not IFN-'y). Stat2 knockout mice are early embryonic 
lethal, as are Stat3 knockouts. Stat3 is activated by amongst other factors 
epidermal growth factor (EGF) and interleukin-6 (IL-6), and has a role in 
mammary gland involution. A large range of factors can activate Statsi, 3 
and 5, but their actions are specific to cell type. Stat4 knockout mice are 
deficient in T helper 1 cells, and Stat6 knockout mice are deficient in T helper 
2 cells. Stat4 is activated by IL-12 and IFN-a and Stat6 is activated by IL-4 
and IL-13 (Horvath and Darnell, 1997; Darnell, 1997; Philp et al., 1996). 
Stat proteins are found in pairs in mouse and human. Stat5 and Stat3 lie on 
mouse chromosome 11 and are 24% similar. Stats 1 and 4 lie on mouse 
chromosome 1 and are 50% similar and Stats 2 and 6 lie on chromosome 10 
and are 19% similar. The low similarity suggests that the duplication causing 
these pairs occurred early in evolution of the gene. Stat5a and 5b are 96% 
similar in their peptide sequences suggesting this was a more recent 
duplication (Copeland et al., 1995). 
1.6.2 Stat5a and Stat5b. 
The two forms of Stat5, 5a and 5b were originally discovered during the 
cloning of murine Stat5 (Liu et al., 1995). 
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Stats 5a and 5b have partially redundant roles. Stat5a-/- mice develop 
normally but have mammary gland morphology defects and fail to lactate, 
Stat5b does not appear to be able to substitute for Stat5a in this situation (Liu 
et al., 1997) leading to the conclusion that Stat5a is the major Stat involved in 
lactogenesis. Stat5b -I- mice also show defects in lactation indicating that 
Stat5b plays a separate role in lactogenesis. Stat5b mice also show defects in 
reproduction, fat deposition, hair growth and sexually dimorphic liver gene 
expression. These characteristics can mostly be attributed to a loss of 
responsiveness to growth hormone (GH) (Heim, 1999; Udy et al., 1997). Stat5 
binds to certain promoters in response to GH stimulation of the Jak/Stat 
pathway and the prolactin receptor has been shown to interact with the GH 
receptor (GHR) on ligand binding (Biener et al., 2003; Ooi et al., 1998; Woelfie 
et al., 2003). Stat5a/5b double mutants have a phenotype similar to GH or 
GHR null mice and are infertile (Teglund et al., 1998). 
Stat5a and Stat5b play different roles in the regulation of milk protein 
production; Stat5b-/- mice produce WT levels of whey acidic protein (WAP) 
after 36 hours post partum (pp) but Stat5a-/- mice do not (Teglund et al., 
1998). At 12 hours pp WAP expression is reduced by the same proportion in 
both knockouts compared to the WT. However neither appears to affect the 
sustained expression of f-casein individually suggesting that 5a and 5b act 
redundantly in regulation of this gene. In HC11 mammary epithelial cells, 
despite the presence of similar levels of Stat5a and Stat5b protein, Stat5a 
homodimers are the predominant DNA binding species (Cella et al., 1998; 
Teglund et al., 1998). The expression pattern of BLG in transgenic mice is 
more similar to 3-casein than to WAP. The major upregulation of WAP 
expression occurs later in gestation than that of BLG or -casein. BLG 
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expression is leaky in the mouse mammary gland and upregulation occurs 
earlier than J3-casein upregulation (Harris et al., 1991). This leaky expression 
may reflect a tighter regulation of endogenous BLG in sheep, where the gene 
is located in the correct position within the genome. 
1.6.3 Stat5 Mammary and Haematopoetic Roles. 
Stat5 has also been shown to be activated by other signals including GH, IL-
2, IL-3, IL-5, granulocyte-macrophage colony stimulating factor (GM-CSF), 
erythropoietin (EPO), thrombopoietin (TPO), and EGF (Ihle, 1996; Hoey and 
Schindler, 1998; Darnell, 1997; Sadowski et al., 1993). Thus Stat5 is also 
activated in cell types other than mammary, is involved in the regulation of 
other genes and is not mammary specific as was originally thought. Stat5 
activity has been extensively studied in respect of its roles in erythropoiesis 
and thrombopoiesis; a double knockout of Stat5a and Stat5b shows non-fatal 
defects in these processes (Socolovsky et al., 2001; Teglund et al., 1998). IL-2 
activates Stat5 as part of the regulation of the IL-2 receptor (Meyer et al., 
1997; Rusterholz et al., 1999). 
These facts would suggest that it is another factor, and not Stat5, that is 
involved in directing mammary specific expression of BLG. BLG is also 
expressed, albeit at low levels, in transgenic mouse mammary tissue where 
all three Stat5 binding sites have been mutated so that Stat5 is not able to 
bind (Burdon et al., 1994b). Nevertheless, mutations of the Stat5 binding 
sites have demonstrated an essential role for this transcription factor in the 
high expression level of BLG but not in tissue specificity (Burdon et al., 
1994b; Demmer et al., 1995; Burdon et al., 1994a). Other factors may yet be 
shown to relevant in the proximal promoter, the sequence of which is 
sufficient to target BLG expression to the mammary gland. The mammary 
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specific signal does not necessarily have to be a transcription factor that can 
be detected binding to the DNA during lactation, it is possible that it may be 
encoded in a specific chromatin structure formed at an earlier developmental 
timepoint or by a combination of factors recruited by protein-protein 
interaction rather than by sequence specific DNA binding. 
1.6.4 Mammary Gland Development. 
It has long been known that insulin, hydrocortisone and prolactin act 
synergistically to produce milk proteins in the lactating mammary gland 
(Juergens et al., 1965). Both prolactin and Stat5 have been shown to be 
essential for mammary gland development. Stat5 is required for the 
formation of secretory alveoli, although prolactin null mice still form these 
structures, suggesting Stat5 does not always act through prolactin 
stimulation. Both prolactin receptors and Stat5 are required for milk protein 
gene expression (Miyoshi et al., 2001; Kelly et al., 2002). Over expression of 
Stat5 in mice leads to increased -casein levels and a delay in apoptosis, this 
is enhanced if a constitutively active form of Stat5 is used. Such a protein 
also leads to increased tumour formation (Iavnilovitch et al., 2002). 
Misregulation of Stat5 may be a factor in breast cancers, Stat5a is active and 
nuclear localised in 76% of human breast cancers (Corlata et al., 2004). 
BRCA1 and BRCA2 have a role in the downregulation of StatS, germline 
mutations of these genes increase susceptibility to breast cancer (Taniuchi et 
al., 1967). Another factor involved in mammary gland differentiation is 
MRG, a member of the FABP family. Mutation of this and the related MRGI 
have also been linked to breast cancer progression (Wang et al., 2003). 
During normal regulation of the mammary gland a second Stat family 
member, Stat3, is involved in mammary involution at weaning. 
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Upregulation of Stat3 and downregulation of Stat5 negatively regulates 
mammary gland growth (Philp et al., 1996; Chapman et al., 1999). 
1.7 Stat5 Action. 
1.7.1 Stat Activation. 
Several conserved domains exist between Stat proteins; these are described 
below and in Figure 1.6. The N-terminal domain is involved in protein-
protein interactions, including those with nuclear cofactors such as CBP/p300 
and between Stat dimers. It also has a role in negative regulation, as does the 
coiled coil domain (Strehiow and Schindler, 1998). The SH2 domain makes 
specific contacts with phospho-tyrosine of a second Stat, mediating 
dimerisation which allows the DNA binding domain to bind DNA 
(Barahmand-Pour et al., 1998; Shuai et al., 1994). The C-terminus contains 
the transactivation domain; phosphorylation of a serine in this area affects 
the transcription activity of Stat target genes, an effect which appears to be 
dependent on the target promoter (Beuvink et al., 2000; Park et al., 2001). 
C-terminal truncated isoforms have been associated with the negative 
regulation of Stat5. These naturally occurring dominant negative forms of 
Stat5 dimerise and bind to DNA with a longer half life than full length Stat5, 
but they do not activate transcription as they lack the transactivation domain 
and thus their presence blocks binding sites for active Stat5 dimers (Wang et 
al., 1996; Moriggl et al., 1996). For reviews of Stat structure see (IhIe, 1996; 
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Figure 1.6. Domains and DNA Binding of Stat Proteins. 
A. In this schematic representation of a Stat protein each conserved domain 
is represented by a coloured box. From the amino terminal (N) a black box 
marks the domain responsible for protein-protein interactions, the green box 
marks a coiled coil domain and the red box the DNA binding domain. The 
blue box marks the SH2 domain and the orange box the transcription 
activation (TA) domain at the carboxy terminal (C) of the protein. The 
conserved tyrosine which is phosphorylated on activation of Stat is marked 
by Y. B. Schematic representation of Stat as a dimer bound to DNA. Mutual 
interactions between the SH2 and the phosphorylated tyrosine (pY) cause 
two Stats to dimerise, DNA is bound between the two DNA binding domains. 
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Many groups are currently working on aspects of Stat-mediated signal 
transduction, as Stat proteins have roles in regulating many important 
cellular processes. Figure 1.7 presents a schematic representation of the 
general activation pathway for Stat proteins. Actual pathways are much 
more complex, as any one Stat can be activated and modified by many 
different factors and lead to regulation of numerous genes. The pathway, in 
the detail shown in Figure 1.7 and described below, is relevant to all Stat 
proteins. 
Activation of the Jak/Stat pathway is initiated when an activator molecule, 
usually a cytokine or a hormone, binds to its receptor on the cell surface. A 
ligand-induced change in the receptor leads to auto-phosphorylation of Jak 
kinases associated with the intracellular domain of the receptor. These in 
turn phosphorylate a tyrosine residue on the receptor, which is recognized 
and bound by the Src homology 2 (SH2) domain of a latent Stat molecule in 
the cytoplasm. Latent Stat proteins were originally thought to exist as 
monomers, but recent evidence shows that latent Stats are also present as 
dimers in a conformation that is not translocated to the nucleus and is unable 
to bind DNA (Schroeder et al., 2004; Soler-Lopez et al., 2004). Stats recruited 
to activated receptors are themselves tyrosine phosphorylated by Jak and 
dissociate from the receptor as dimers, joined by mutual interactions 
between their SH2 domains and the conserved phospho-tyrosine residue 
(Y694 in Stat5a and Y699 in Stat5b) of their partner. 
Stats form homo-dimers (e.g. 5a/5a or 5b/5b) and some can form hetero-
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Figure 1.7. Jak I Stat Activation Pathway. 
A schematic representation of the general Jak I Stat activation pathway. A 
cytokine or hormone binds to receptors in the cell surface resulting in 
receptor phosphorylation by Jak kinases associated with the receptor. A 
latent Stat protein is recruited to the receptor by interactions of the SH2 
domain (marked as a black band on Stat proteins) with the phosphorylated 
tyrosine and the Stat is itself phosphorylated resulting in dimerisation. This 
Stat dimer is recruited to the nucleus where it binds DNA. 
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to the nucleus by an unknown mechanism, where they bind DNA and 
contribute to the activation of target genes. Stat proteins can interact with 
and be modified by other proteins at any stage in this process and such 
interactions are only beginning to be understood. Of course Stat5 binding to 
DNA is not just a matter of binding to Stat5 sites, as eukaryotic DNA is 
organised into chromatin and this may render Stat5 binding sites 
inaccessible. There are currently no reports in the literature describing how 
Stat5 binds within a chromatin context. 
1.8 Stat5 Regulation: Interactions with Proteins. 
Stat proteins show an activity specific to cell type and stimulus. As the 
preferred DNA binding sites are more or less identical for the majority of Stat 
proteins, it is unlikely that specificity is conferred via DNA binding. 
Specificity must therefore be conferred by other mechanisms. 
1.8.1 Receptors and Jaks. 
Stat specificity can be conferred by specific interactions with receptors. For 
example IFN activation of Stat5 has been shown to lead to the tyrosine 
phosphorylation and activation of different Stat5 isoforms in different cell 
types (Meinke et al., 1996). Latent forms of many Stat proteins are present in 
mammary gland, but only Stat5 is activated in response to prolactin. Two 
tyrosine residues in the C-terminal of the long form prolactin receptor have 
been identified that when phosphorylated will induce binding and activation 
of only Stat5a and Stat5b. The remaining Stats that cannot associate with the 
receptor retain their latent conformation (Mayr et al., 1998). A group of 
feedback inhibitors, the suppressors of cytokine signalling (SOCS) proteins, 
inhibit Stat proteins by binding to Jaks thus preventing the binding and 
activation of Stat proteins. SOCS are upregulated in response to prolactin 
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receptor activation in non mammary tissues during lactation, and in 
mammary gland after forced weaning (Tam et al., 2001). The selective 
activation of different Stat proteins and inhibition by SOCS proteins 
represent two mechanisms by which interactions with receptors could 
influence the mammary specificity of Stat5. More roles are likely to emerge 
as receptors could influence which Stat dimers are formed and modify 
residues other than the conserved tyrosine (Y694/Y699) that is required for 
Stat activation. 
1.8.2 Non Jak-Mediated Stat5 Activation. 
Stat5 can be activated through pathways other than the Jak/Stat pathway. 
Flt3 has been shown to activate Stat5a without activating any Jaks as has Src 
which activates both forms of Stat5, but with alternative phosphorylation at 
the C-terminal resulting in nuclear translocation of Stat5b but not Stat5a 
(Zhang et al., 2000; Kazansky et al., 1999; Kabotyanski and Rosen, 2003). 
ERBB family kinases have been shown to mediate Stat5 activity in mammary 
gland differentiation, and to phosphorylate Stat5 on tyrosine residues other 
than the conserved Y694/Y699 (Long et al., 2003). The functional role of these 
differentially phosphorylated Stat5s is still unknown. 
1.8.3 HAT Activity. 
Stat5 recruits transcription coactivators such as CBP/p300 to the promoter, 
thus stimulating transcription (Pfitzner et al., 1998). CBP/p300 are part of a 
family of transcription activators that contain HAT activity and are involved 
in the coactivation of many genes. CBP/p300 interacts with another family of 
coactivators, the p160/SRC/NcoA family. Stat5a binds a member of this 
family, NCoA-1, by an interaction involving a motif of three amino acids in 
the Stat5 transactivation domain, these same amino acids are essential for the 
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transcriptional activity of Stat5 (Litterst et al., 2003). In the 13-casein promoter 
this interaction requires the GR (Wyszomierski and Rosen, 2001) and 
glycosylation of threonine 92 in the N-terminus of Stat5a (Gewinner et al., 
2004). 
Stat5 also interacts with HDACs, the function of this interaction is not to 
deacetylate histone tails, but to deacetylate CBP/p300. Acetylation of 
CBP/p300 results in its inactivation (Rascie et al., 2003; Xu et al., 2003). Stat5 
has also been implicated in the negative regulation of genes in a mechanism 
that does not require Stat5 binding to DNA (Luo and Yu-Lee, 2003). 
1.8.4 NF-1. 
Another factor that plays a major role in the regulation of milk proteins is 
NF-1; there are binding sites for NF-1 in the promoters of milk protein genes, 
often situated close to those for Stat5 (Watson et al., 1991; Li and Rosen, 
1995). NF-1B but not NF-1A acts synergistically with Stat5 and CR to 
activate transcription of WAP (Mukhopadhyay et al., 2001). Maximal 
induction of milk protein promoters in cell culture requires the addition of a 
combination of dexamethasone, insulin and prolactin. Dexamethasone binds 
and activates CR, and GR has been shown to interact with Stat5 in vivo (Cella 
et al., 1998). In the MMTV CR binding causes a change in nucleosome 
structure that allows NFl binding. Maximal induction of milk protein 
expression probably requires the binding of StatS, NFl and CR to promoters. 
1.8.5 SP-1. 
Another general transcription factor, SP-1, has been demonstrated to interact 
with Stat5. NF-1, SP-1 and CBP/p300 have been shown to interact with 
specific transcription factors in a synergistic fashion in other promoters 
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(Aigueperse et al., 2001; Martino et al., 2001). SP-1 has been shown to be able 
to bind DNA organised into a nucleosome, the binding affinity appears to be 
related to the position of an SP-1 binding site on the nucleosome (Li et al., 
1994). SF1 has not been shown to be essential for high-level expression of a 
milk protein gene, but could play a role in the establishment of an active 
transcription complex. 
1.8.6 Transcription Factor Binding Sites in the Proximal BLG Promoter. 
There are transcription factor binding sites for a number of factors in the 
proximal promoter of BLG. These include NF-1, SP-1 and GR, which have all 
been shown to interactact with Stat5 as well as YY1 and other sites such as 
NF-kappaB and C/EBP alpha (Figure 1.8). 
1.8.7 Stat5 and Chromatin. 
Stat5 has been shown to recruit CBPIp300 HAT activity and HDAC activity, 
but that these do not modify histones (Pfitzner et al., 1998; Xu et al., 2003; 
Rascie et al., 2003). Recently, acetylation of histone H3 and H4 was shown to 
be decreased on Stat5 activation of a Stat5 responsive promoter at the region 
of Stat5 binding. The authors suggest this correlates with chromatin 
remodelling at this locus resulting in the movement of a nucleosome (Rascie 
and Lees, 2003). Stati has been shown to be able to mediate expression from 
a chromatin template, this requires L724 andphosphorylation of S727 in the 
transactivation domain (Zakharova et al., 2003). 
1.9 Stat5 DNA Binding. 
The DNA binding domain is found in the centre of a Stat protein. It has a 
structure similar to an immunoglobulin fold, although there is little sequence 
identity to other DNA binding molecules containing this motif, such as 
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-321 GGCTCTGACC ITGTCCTTGC TAAGAGGCTG ACCCCG 
****** *********** 	 ********* ******* 
—281 TGTTCCTGGC ACTGGCAGCC AGCCTGGACC CAGAGTCCAG 
* * *** *** * 
—241 ACACCCACcIT_GTGCCCCGC 	•TGGGGTC TACCAGGAAC 
**** 	 ** 
—201 CGTCTAGGCC CAGAGGGGGA C. CTGCTT GGCCTTGGAT 
************* **** 
—161 G 	GGC CTCCTATTfGT_CCTCGITAGAG 	GCCACCC 
*** ** * * * *** ******* * ******* 	****************** 
—121 QGGGGCCTGA GGATGAGCCA AGTGGGA 	GGGAACCGC 
—81 GTGGCTGGG 
Figure 1.8 Transcription Factor Binding Sites on the BLG Promoter. 
A search for transcription factor binding sites on the sequence nAB used in 
bandshifts was carried out using Transcription Element Search Engine on the 
WWW (TESS) of the Transfac database (http:Ilwww.cbil.upenn.edultess) 














NF -KB. Stats can only bind to DNA as an active dimer; interactions between 
the SH2 and DNA-binding domains mediate this (Chen et al., 1998). Stats 
bind at a palindromic motif, called the gamma activating sequence (GAS) 
consensus sequence after its original discovery in the IFNy promoter, 
TTC(N)3GAA. Variations in N may contribute further to the specificity of 
Stat/DNA interactions (Seidel et al., 1995; Schindler et al., 1995). Stat5a 
homodimers prefer to bind to (A/g)(T/c)TTC(C/T)N(G/a)GAA(A/tc)(T/c) and 
Stat5b homodimers to (A/tg)(T/A)TTC(C/T)(T/cag)(G/a)GAA(T/A)(T/ca) (the 
GAS sequence is underlined), but can bind as either homo- or hetero-dimers 
of the two forms of Stat5. These two sequences are very similar so it is 
unlikely that there is a difference in DNA binding site selection for the two 
Stat5 isoforms (Soldaini et al., 2000). 
1.9.1 Structure of Stat Dimer Bound to DNA. 
When Stat proteins bind to form dimers, they form a shape like pliers as 
suggested in Figure 1.6. Mutual interactions between the SH2 domains and 
the phosphorylated tyrosine form a hinge, allowing DNA to sit between the 
DNA binding domains. DNA is bent by 40° away from the dimer interface 
and is almost completely enclosed by Stat binding, this would suggest Stat 
binding is not compatible with nucleosome binding. The N-terminal 
domains, forming the handles of the pliers, are placed far apart from each 
other (Figure 1.6). The image in Figure 1.6 is a schematic representation of 
how a Stat dimer bound to DNA would look, based on the crystal structures 
of Stati and Stat3 dimers bound to DNA solved by (Chen et al., 1998) and 
(Becker et al., 1998) respectively. These structures do not resolve the N-
terminal domains. 
0. 
1.9.2 Stat Tetra merisation. 
Stats-1, -3, -4 and-5 have been shown to tetramerise on tandemly linked 
binding motifs (Vinkemeier et al., 1996; John et al., 1999; Meyer et al., 1997; 
Zhang and Darnell, 2001; Yamamoto et al., 2002). It has been suggested that 
Stat5 may be able to bind to non-consensus sites as a tetramer of two dimers. 
For example, a change of T1'C to TAC in the GAS consensus will lower Stat 
binding as a dimer, but allows tetramer binding, resulting in formation of 
only tetramer complexes on a probe containing this sequence (Verdier et al., 
1998; Soldaini et al., 2000). The extra stability conferred by the 
tetramerisation interaction allows binding at these non-consensus sites. The 
Al and A3 Stat5 binding sites in the BLG promoter are non-consensus sites 
which contain either a TAC or the compliment of this, GTA (Figure 1.5). 
Stat5a makes tetramerisation interactions much more efficiently than Stat5b 
does (Verdier et al., 1998; John et al., 1999). This may represent another 
mechanism for the different actions of Stat5a and Stat5b. 
The N-terminal domain, which mediates tetramerisation of Stat4, has been 
crystallised separately. The structure revealed a conserved tryptophan 
residue (37 in Stat5) in a flexible 'hook' which probably makes contacts with 
glutamic acid 66 (in Stat4) to form a tetramer (Vinkemeier et al., 1998; John et 
al., 1999). This structure was used to develop mutation studies, where 
removal of the conserved tryptophan blocks Stat tetramer formation, 
indicating that this area is responsible for tetramerisation. Mutation of this 
tryptophan to an alanine (W37A) also abolished tetramerisation interactions 
(John et al., 1999). DNA binding site and Stat tetramerisation deficient 
mutants have been used to show the functional importance of: Stat3 
tetramerisation in activation of the a2 macroglobulin gene (Zhang and 
Darnell, 2001): Stat4 tetramerisation in IL-12 induction of the perforin gene 
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promoter (Yamamoto et al., 2002) and of Stat5 tetramerisation in the 
induction of the hepatic serine protease inhibitor 2.1 and in IL-2 activation of 
the IL-2 receptor a (IL-Ma) chain (Bergad et al., 1995; John et al., 1996). The 
Stat5 tetramerisation mutant, W37A, can only activate the IL-2Ra promoter if 
the Stat5 binding sites are mutated from a non-consensus and a consensus 
pair to two consensus sites allowing two Stat5s to bind as dimers (John et al., 
1999) this suggests that it is the binding of multiple Stat5 dimers which 
activates this promoter. 
1.10 Stat5 Tetramerisation on the BLG Promoter? 
To allow tetramer formation, Stat5 binding sites must usually be situated 
close together on the DNA. The optimum spacing for Stat5 appears to be 
6bp; sites spaced further apart will also allow the interaction but sites spaced 
closer than Sbp do not. Binding sites must also be arranged in a tandem 
repeat (Vinkemeier et al., 1996; Soldaini et al., 2000). The N-terminus 
appears to contain a degree of flexibility, and is able to make interactions 
from a range of DNA binding site spacing. It may be possible that bringing 
the sites together by means other than by their adjacent location on a DNA 
sequence in cis will have the same effect. Winding of DNA round a 
nucleosome has been shown to bring together regulatory elements in a 
manner that enhances gene activation, Section 1.2.2. 
It is possible that the strongly positioned nucleosome at —183bp on the 
proximal promoter acts to bring together the StM and Al Stat5 binding sites 
in such a way as to facilitate a tetramerisation interaction enhancing BLG 
promoter activity (Figure 1.9). The major form of Stat5 that is involved in 
lactogenesis, Stat5a, is able to form tetramers much more efficiently than 
Stat5b can. This suggests a role for tetramerisation in facilitating Stat5a 
Figure 1.9. The Tetramerisation Model. 
A schematic representation of the location of Stat5 binding sites on 
nucleosome positions A and B. The structures in parts A and C represent 
nucleosome A and those in parts B and D represent nucleosome B. Parts A 
and B represent the Stat5 binding positions on DNA and parts C and D 
represent how Stat5 might bind to DNA. The wide end of the wedge that 
represents a bound Stat5 dimer is the N-terminus, where dimer-dimer 
interactions take place. 
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specific mammary Stat5 action. Furthermore, the Al binding site in BLG is 
non consensus, containing GCA instead of GGA. Such sequences have been 
show to encourage binding of Stat5 as a tetramer (Soldaini et al., 2000). The 
availability and relative location of each Stat5 binding site will be 
dramatically different between the two alternative nucleosome positions at 
—183 (Figure 1.9 A and C) or —224 bp (Figure 1.9 B and D) from the 
transcription start site. It is not known whether Stat5 is able to bind DNA in 
or near to a nucleosome. Either nucleosome A at —183bp or nucleosome B at 
—224bp could position the Stat5 binding sites in a favourable manner for BLG 
gene activation. Nucleosome B places the consensus StM binding site further 
from the nucleosome (Figure 1.9 B), which may allow preferential Stat5 
binding to this site. On the other hand nucleosome A contains two Stat5 
binding sites external to the core DNA (Figure 1.9 A) an arrangement that 
would potentially allow a tetramerisation interaction between the two bound 
Stat5s if the orientation is correct. Alternatively such an orientation could 
have the reverse effect and the binding of Stat5 to one site could block 
binding to the other. 
It is clear that the regulation of BLG is affected by both the binding of Stat5 
and the chromatin structure, indeed the chromatin structure may influence 
Stat5 binding and vice versa. In this study the positions of nucleosomes 
reconstituted onto a fragment of the BLG promoter, nAB, are defined. The 
ability of Stat5 to bind to sites close to and within these nucleosome is 
studied and a potential role of tetramerisation in stabilising this interaction is 
investigated. 
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2 MATERIALS AND METHODS. 
2.1 Reagents, Stock Solutions and Buffers. 
All chemicals are supplied by BDH and stored at room temperature unless 
otherwise stated. Solutions are in dI-120 unless otherwise indicated. All 
autoclaved reagents were sterilised by autoclaving at 15 pounds per square 
inch for 15 minutes at 121°C. 
A/NT/L: Solutions A, NT and L at ratio of 2:3:5. Antiprotease and 
antiphosphatase solutions added prior to use. Those added were: 
Dithiothreitol (DTF) to 0.4mM, —Mercaptoethanol (BME) to 5.6mM, 1% 
antiprotease mix from Sigma and 1% antiphosphatase mix from Sigma. 
A/NT: Solutions A and NT at 1:1 ratio containing antiprotease and 
antiphosphatase as above. 
Acrylamide: 40% solution at acrylamide:bis ratios of 19:1 or 37.5:1 from 
National Diagnostics. 
Ammonium Persulfate: Catalyst for acrylamide polymerisation. 25% 
aqueous solution stored at +4°C. Fresh stock made weekly. 
Ampicillin: (Sigma) stock at 4mg/ml. Final concentration 50i.ig/ml. 
Beta-mercaptoethanol (BME): (Sigma) stock at 143M. 
Buffer C: 20mM Hepes pH7.9, 25% glycerol, 0.42M NaCl, 1.5mM MgCFz, 
0.2mM EDTA. Inhibitors PMSF to 0.5mM and BME to 0.5mM. 
Coomassje Gel Stain: 50% methanol, 10% acetic acid, 0.1% Coomassje. 
Destain (Coomassie stained gels): 10% acetic acid, 10% isopropanol. 
DNA Size Markers: 1kb markers and massrujer markers from Fermentas. 
lObp markers from Invitrogen. 
DMSO: Dimethyl suiphoxide (Sigma). 
DTT: (Melford labs) 100mM stock stored at —20°C. 
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EDTA: (Ethylene diaminetetra-acetic acid disodium salt) stock at 0.5M, 
adjusted to pH8 with NaOH. 
1 X Exolil Buffer: 10mM Tris.HC1 pH8, 10mM NaCl, 0.75mM MgCb, 1mM 
BME. Stored at —20°C as 10 X stock solution. 
5 X Ficoll Loading Buffer: 5 X TBE, 17.5% (w/v) Ficoll 400 (Amersham) with 
bromophenol blue and xylene cyanol. 
Formamide gel loading buffer: 95% formamide, 20mM EDTA, Bromophenol 
blue and xyiene cyanol. 
Gentamycin: Stock at 10mg/mi, final concentration 7.ig/ml. 
2 X GRB 1.6% (w/v) Ficoll 400, 2mM Hepes (Sigma) pH7.9, 1mM EDTA 
pH8.0. Solution is dissolved at 37°C and DTT added to 0.1mM. Store at - 
20°C. 
IPTG: (Melford labs) Isopropyl-l-thio-P-D-galactoside, stock at 100mM. 
Kanamycin: (Melford labs) Stock at 10mg/mi final concentration 50tg/ml. 
KC1: Stock solution at 1M. 
LB plates: 7g agar in 500m1 LB medium. Agar is dissolved and sterilised by 
autoclaving. X-gal, IPTG and antibiotics are added just prior to pouring 
lOmi cooled agar to sterile petri dishes. 
LB medium: lOmg/L Bacto Tryptone, 5mg/L Yeast extract, lOmgfL NaCl. 
Autoclave to sterilise. 
NaAc: Sodium acetate, 3M stock solution pH 5.0 with acetic acid. 
NaCl: Stock solution at 5M. 
PBS 10 X Phosphate buffered saline. Stock solution was made up by 
addition of 10 tablets (from Oxoid) per lOOml and autoclaving to sterilise. 
PMSF: Phenylmethanesuiphonyl fluoride (Sigma). Stock of 250mM, 
dissolved in isopropanol and stored at 37°C. 
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10 X PNK buffer: 500mM Tris.HC1 pH7.6, 10mM MgC12, 10mM BME. 
Poly(dI.dC).Poly(dI.dC): (Poly(deoxyinosithc-deoxy-cytidylic) acid) (Sigma) 
non-specific competitor DNA routinely used in bandshifts. 
Ponceau S: 0.1% in 5% acetic acid. 
Phosphate buffer: 0.02M sodium phosphate, 0.5M NaCl. 
Protein size markers: Either Precision Protein Standards from BIORAD or 
Benchmark His Tagged protein standards from Invitrogen. 
Radioactive nucleotides: [a 32P] dCTP (3000ci/mmol) and [y32P] ATP 
(3000ci/mmol) from Amersham. 
SDS: Sodium dodecyl sulphate, 10% stock solution. 
SOC medium: From Invitrogen. 0.5% yeast extract, 2% tryptone, 10mM 
NaCl, 2.5mM KC1, 10mM MgC12, 10mM MgSO4, 20mM glucose. 
Solution A: 0.6M Sucrose, 120mM KC1, 15mM NaCl, 0.3mM spermidine, 
2mM. spermine, 28mM BME, 4mM EDTA, 2mM EGTA, 2mM DU, 0.2% 
triton X-100, 10mM Tris.HCIL pH 7.9. 
Solution L: 15mM NaCl, 10mM Tris.HC1 pH 7.9. 
Solution NT: 10mM NaCl, 0.1% NP40, 10mM Tris.HC1 pH 7.9. 
Solution I: 15mM Tris-HC1 pH8, 10mM EDTA, 100tg/ml RNase A (for 
minipreps). 
Solution II: 0.2M NaOH, 1% SDS (for minipreps). 
Solution III: 3M potassium acetate (for minipreps). 
TAE 1 X working solution: 40mM Tris acetate, 2mM EDTA. Stock at 50 X. 
20 X TBE: 1M Tris 1M boric acid, 20mM EDTA for native polyacrylamide 
gels, use at 0.25 to 1 X. 
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10 X TBE: 0.5M Tris pH8, 0.5M Boric acid, 10mM EDTA. Use at 1 X for 
denaturing polyacrylamide gels. 
10 X TBS: 1.5M NaCl 250mM Tris.pH 7.5. Autoclave to sterilise. 
TBST: 1 X TBS containing 0.05% Tween 20. 
20 X TE: 2mM EDTA and 200mM Tris pH8 use at 1 X. 
TEMED: (N,N,N',N'-Tetramethyi-ethyienediamine) Cross linking reagent 
for polyacrylamide gels. 
TEl?: 1 X TE containing PMSF at 10mM. 
IEl?soo: 1 X TEP containing 0.8M NaCl. 
TEPio: 1 X TEP containing 10mM NaCl. 
Tetracycline: Stock solution 12mg/mi in 70% ethanol, final concentration 
12j.tg/ml. 
1M Tris Buffer: Tris (hydroxyimethyl) methylamine. Stock at 1M aqueous 
solution. pH 7.5 - 8 with 1-IC!. Autoclave to sterilise. 
Triton X-100: (Iso -Octylphenoxypolyethoxyethanol) from Sigma. 
Tween 20: (polyoxyethyiene(20)-sorbitan monolaurate) from Sigma. 
Xgai: (5-bromo-4-ch1oro-3indoyi+Dgalactoside). Stock 20mg/mi in 
dimethyl formamide, stored at -20°C protected from light. 
2.2 Preparation of DNA. 
2.2.1 Transforming Competent Cells. 
Plasmids were introduced into either ultracompetent (XL-10 Gold), or 
supercompetent (XL-1 Blue) cells (both from Stratagene) by chemical 
transformation. Approximately lOng of a ligation reaction, or <ing plasmid 
DNA was added to aliquots of thawed competent cells and incubated on ice 
for 10-30 minutes. Cells were heat shocked at 42°C for 30 seconds then 
allowed to recover on ice for at least two minutes. After addition of 500 pi 
prewarmed SOC medium, cells were incubated at 37°C with shaking at 
200rpm for one hour. In order to isolate individual clones, transformation 
reactions were plated onto LB-agar plates containing a selective antibiotic, 
resistance for which is encoded in the plasmid DNA, usually this was 
ampicillin. lOOp.g/ml X-gal and 40tg/ml IPTG were added if blue white 
screening (section 2.3.2) was to be used to select colonies. For 
straightforward plasmid transformations 5jtl transformation mix was diluted 
in 200 j.il SOC and for ligation reactions half of the total mix was plated. 
Antibiotic concentrations routinely used are 100 j.ig/ml ampicillin, or 7.tg/ml 
gentamicin. 
2.2.2 Small Scale Preparation of DNA 
Around lOp.g DNA was routinely produced from a 4ml culture using the 
following miniprep protocols. Individual colonies were picked from plates 
using a sterile pipette tip, inoculated into 4ml LB containing selective 
antibiotics and incubated at 37°C with rotation at 200rpm overnight until 
they had reached stationary phase (approximately 16 hours). Cells were 
pelleted then resuspended in 300tl Solution I. 300pJ Solution II was added to 
lyse cells, then the genomic DNA and protein was precipitated by dropwise 
addition of 3001.d Solution III and centrifugation at 16,100g for ten minutes. 
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Supernatant containing the plasmid DNA was transferred to a tube 
containing 0.8m1 ice-cold isopropanol to precipitate the plasmid DNA. 
Precipitated DNA was pelleted by centrifugation at 16,100g for 15 minutes, 
and washed twice with 0.5m1 70% EtOH. Air-dried plasmid DNA was 
resuspended in dH2O or TE. Alternatively minipreps were carried out using 
Promega Wizard Plus SV Miniprep kit that makes use of spin columns to 
speed up the process. 
2.2.3 Large Scale Preparation of DNA. 
A larger culture volume (100-400ml) can be utilised to produce greater 
amounts of DNA. Routinely -250tg DNA was produced using the QIAGEN 
midi prep kit. 
2.3 DNA Purification. 
Many applications require the purification of DNA. This was carried out by 
a number of protocols. 
2.3.1 Gel Purification. 
Specific DNA fragments were isolated from a reaction, for example a 
restriction digest product, by separation on an agarose gel. 10 X loading 
buffer (60% glycerol, 0.25% Orange G, 10 X TAE) was added to the sample 
before loading onto an agarose gel (between 0.8 and 2% (w/v) depending on 
fragment size), in 1 X TAE. Ethidium bromide in the buffer (at 250j.tgfL) 
intercalates with the DNA and fluoresces under long range UV light 
(304nm). Appropriate bands were identified by comparison of migration 
against 1kb DNA ladder (Fermentas), and excised from the gel using a clean 
scalpel. DNA was easily removed from the gel slice by use of the Qiaexll or 
Qiaquick gel extraction kits (both from Qiagen). The gel slice was dissolved 
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in buffer QG at 50°C. This buffer contains chaotropic salts, which disrupt the 
gel structure. DNA from dissolved gel slices was bound to silica particles 
and agarose and residual salts were washed out using an ethanol buffer. The 
DNA was eluted into 30jtl TE. 
2.3.2 Phenol / Chloroform Extraction. 
Nucleic acids were isolated from protein, for example after nuclease 
digestion, by phenol / chloroform extraction. Hydrophobic protein groups 
are soluble in phenol, whereas hydrophilic DNA is soluble in aqueous 
solution. Chloroform assists the process by denaturing proteins and 
therefore aiding dissociation from DNA (Current Protocols in Molecular 
Biology). The protein precipitates in the layer between the aqueous and 
phenol phases. This method is useful when total DNA is to be recovered. 
DNA/protein mixtures are mixed by vortexing (fragments less than 1kb only) 
at a ratio of 1:1 with phenol (that has been equilibrated to pH7.6 by repeat 
extraction with Tris buffer). Microcentrifugation at 12,000g for 5 minutes 
separates the phases. The top aqueous phase was removed to a fresh tube 
and the phenol extraction repeated once. An equal volume of 
chloroform:isoamyl alcohol (24:1) was added to remove residual traces of 
phenol and the aqueous phase removed as described for phenol extraction. 
DNA was precipitated using ethanol (section 2.3.3). 
2.3.3 Ethanol Precipitation. 
DNA in a large volume of aqueous solution was precipitated to a pellet then 
resuspended into a smaller volume at higher concentration. DNA in solution 
is made to 300mM NaAc by addition of 3M NaAc, pH5. At least 2 X volume 
prechilled 100% ethanol is added to this. Incubation at either —70°C for one 
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hour or —20°C overnight precipitated the DNA out of solution. Samples were 
spun for 15 minutes at 12,000g. The supernatant was discarded and washed 
with prechilled 70% ethanol, this step removes excess salt, the ethanol 
concentration is sufficient to prevent DNA coming back into solution. After 
a further spin for 5 minutes, the 70% ethanol was removed as completely as 
possible. The pellet was then washed in an ether/ethanol mix (50:50) and 
either air dried or vacuum desiccated to remove ethanol before resuspension 
in dH20 or TE. All residual ethanol was removed as this can affect 
downstream reactions. Over drying of pellets also adversely affected their 
ability to go back into solution, particularly with larger DNA fragments. 
2.3.4 Calculating DNA Concentration. 
The concentration of DNA in solution was calculated from absorbance at 
260nm. For a solution containing double stranded DNA in a 1cm cell, one 
0D260 unit indicates a DNA concentration of 50.ig/ml. Often the amount of 
DNA available was not sufficient to calculate the concentration in this way. 
In this case a known volume of the sample was run on an agarose gel 
alongside a known quantity of DNA and an estimate taken from the relative 
intensity of fluorescence of the known and unknown bands. 
2.4 Manipulation of DNA. 
2.4.1 Restriction Enzyme Digestion. 
DNA was digested by various restriction enzymes as per the manufacturers 
instructions (Roche or New England Biolabs). Digestion was verified by 
agarose gel electrophoresis. Restriction maps were generated using 
NEBCutter V2.0 (http://tools.neb.comlNEBcutter2/index.12hp) (Vincze et al., 
2003). 
2.4.2 Cloning. 
Sequences were cloned into plasmid vectors by ligation of DNA ends from 
complementary restriction sites on the vector and insert. Where this was not 
possible, ends were blunted with either T4 polymerase or the Klenow 
fragment of DNA polymerase following manufacturers instructions (NEB). 
Ligation reactions were carried out with the Rapid DNA ligation kit (Roche). 
If a fragment is to be cloned using a single enzyme, the vector DNA ends 
were first dephosphorylated with calf intestinal alkaline phosphatase (ClAP, 
(NEB)) to prevent religation of the vector. Phosphate groups on the insert 
DNA allow the backbone to be joined. Ligated DNA was transformed into E. 
coli to select for correct insertions. Many commercial cloning vectors, such as 
pBluescript, use disruption of a lacZ gene to screen for insertions. Colonies 
with a vector containing the insert remain white and religated vector colonies 
appear blue and on agar plates contain X-gal and IPTG. This is called blue 
white screening. Restriction enzyme digestion and sequencing was used to 
verify the orientation and correct size of the insert. Ligated circular DNA 
does not transform into E.coli as well as supercoiled plasmid DNA so more 
must be added to a transformation reaction. It is important to note however 
that too much DNA will have an adverse affect on the cells. 
Recombinant baculovirus DNA (Bacmid DNA) was produced by 
transposition of the Stat5 gene, cloned into a pFastbac expression vector, into 
the baculovirus genome in DHlObac cells which contain a helper plasmid 
encoding a transposase. Transfected cells are grown with tetracycline 
(10tg/m11) gentamycin (7jig/ml) and kanamycin (50 jig/mi) to select for 
colonies containing recombinant viral DNA. Insertion of the Stat5 gene 
destroys the lacZ gene so individual recombinant colonies can be recognised 
and picked for small-scale DNA preparation. High molecular weight DNA 
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(>100kb) is purified using the protocol described in (2.2.2) and transfected 
into insect cells (2.6.3). pFastbac vectors and DH10Bac cells are part of the 
bac-to-bac baculovirus expression system from Invitrogen. For more details 
on cloning into pFast vectors refer to Chapter 4.3.2. 
2.4.3 Polymerase Chain Reaction. 
Polymerase Chain Reactions (PCR) amplify the region of DNA between two 
oligonucleotide primers. The primers were cyclically denatured, allowed to 
anneal to the template sequence, and the primer extended along the length of 
the template by polymerase. Multiple cycles of this amplify a specific region 
of DNA. The sequence synthesised in the first round can act as a template in 
the second and so on, doubling the product with each round of amplification. 
PCR reactions were carried out generally as follows: Primers were chosen 
from the flanking regions of DNA and synthesised by MWG Biotech. The 
melting temperature (Tm) of primers was calculated using the formula: 
Tm = 2 x (A+T) + 4 x (C+G). 
A value 4°C lower than this was used as the annealing temperature. PCR 
reactions were catalysed using Taq polymerase and buffers from Roche, 
except for reactions where products were expected to be greater than 1kb, in 
which case the Expand High Fidelity PCR system (Roche) was used. This 
system includes Tgo polymerase as well as Taq polymerase. Tgo polymerase 
has proofreading properties resulting in a more accurate PCR product. 
dNTPs were added at a final volume of 2mM and template at lng4il. 
Reactions were carried out in a volume of 50tl in a geneAmp PCR system 
9700 (Applied Biosystems). After an initial denaturing step of 95°C for 5 
minutes, 35 cycles of: 
95°C for 20 seconds denaturing step 
54°C for 30 seconds annealing step 
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72°C for 30 seconds elongation step 
Followed by further elongation at 72°C for 5 minutes to ensure all products 
are full length. Primers were removed by the Qiagen PCR cleanup kit. The 
product was further purified by gel extraction (section 2.3.1). 
2.4.4 Site Directed Mutagenesis. 
Point mutations can be carried out using a modified PCR. Complementary 
primers to both strands of the DNA containing at most a couple of base pair 
changes from the template were designed. Changed bases were located in 
the middle of the primer, and certainly not near the 3' end, as this must 
anneal tightly to the template in order for elongation to occur. Five cycles 
were carried out at a lower annealing temperature calculated by 2°C less 
than the normal primer annealling temperature for every mismatched A or T 
and 4°C less for every mismatched C or G. The remaining cycles were 
carried at the normal annealing temperature as there should be sufficient 
product containing the mutation to use as a template. PCR reactions were 
either carried out as normal, or to create mutations in a plasmid vector, were 
carried out using pfu turbo polymerase (Stratagene) on a supercoiled 
plasmid, this polymerase catalyses extention of the whole plasmid. A single 
sequence was used as the primer, but as two complimentary oligonucleotides 
containing the mutation resulting in two strands of the plasmid containing 
the mutation. Methylated DNA from the original template plasmid sequence 
is digested by DpnI, this enzyme will not digest the PCR product. The 
resulting DNA was transformed into competent cells and mutation verified 
by sequencing. This method was adapted from the Quikchange kit, 
developed by Stratagene. 
2.4.5 Sequencing. 
All DNA sequencing was performed by The Sequencing Service (School of 
Life Sciences, University of Dundee, Scotland http://www.dnaseg.co.uk ) 
using Applied Biosystems Big-Dye Ver 3.1 chemistry on an Applied 
Biosystems model 3730 automated capillary DNA sequencer. 
2.5 Radioactive Labelling of DNA. 
All radioactive work and disposal was carried out as per local and national 
guidelines on the use of radioactive isotopes. Radioactive nucleotides were 
from Amersham. 
2.5.1 5' End Labelling. 
PCR products or oligonucleotides were 5' endlabelled using T4 
Polynucleotide kinase (PNK) (Amersham). T4 PNK catalyses the transfer of 
a phosphate group from the y position of ATP to the 5' hydroxyl terminus of 
polynucleotides. In this method the probe is labelled at both ends of double 
stranded DNA. Reactions were carried out essentially as detailed below. 
50ng DNA in 1 X PNK buffer and 30 units of T4 PNK were incubated with 
0.74 MBq [y32P] ATP for one hour at 37°C, then heat inactivated for 10-20 
minutes at 68°C. it was found that addition of DTT to 10mM increased the 
efficiency of the reaction. Unincorporated [7 32P] ATP was removed by 
passing the reaction through a ProbeQuant G50 (for larger DNA products) or 
G25 Micro Column (labelled oligonucleotides) (both from Amersham). 
DNA ladders were labelled by a similar reaction. Where DNA ends are 
already phosporylated, phosphate groups are first removed using 20U ClAP 
in supplied buffer for 30 minutes at 37°C. The ClAP was heat inactivated at 
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75°C for 15 minutes before the end labelling reaction was carried out, there 
was no need to purify DNA between reactions. 
2.5.2 a32P Labelling. 
For uniform labelling throughout the probe 0.74 - 1.11 MBq [a32P] dCTP was 
included in an otherwise normal PCR reaction. Following the PCR, 
unincorporated & 2P was removed by passing the reaction through a G50 
microcolumn. The reaction was gel extracted from a 2% agarose gel to purify 
the correct sized fragment and to remove primers. 
2.6 Production of Stat5. 
2.6.1 Baculovirus Expression System. 
Recombinant StatS was produced using a baculovirus expression vector 
system (BEVS). This system was chosen as Stat5 produced in this way has 
been used previously in bandshift experiments (Soldaini et al., 2000; John et 
al., 1999). The advantages of using the BEVS are that proteins produced in 
insect cells are modified in a similar manner to mammalian cells (Smith et al., 
1983), and are expressed at relatively high levels, which can be greater than 
50% of the total cell protein (Maeda et al., 1985; Miyamoto et al., 1985). Insect 
cells also adapt well to growth in suspension culture allowing cultures to be 
easily scaled up. Spodopterafrugiperda (SF9) cells were used and infected with 
recombinant Autographa calfornica Multiple Nuclear Polyhedrosis Virus 
(AcMNPV). Recombinant Stat5 expression was driven by the polyhedrin 
promoter, which in the wild type virus makes up the virus coat particles 
observed as occlusion bodies in SF9 cells infected with the wild type virus. 
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2.6.2 SF9 Cells. 
SF9 cells were typically maintained at 27°C in suspension culture using a 
spinner system at densities between 3x10 5 and 2x106 cells/ml in serum free 
medium (SF90011 from Invitrogen) containing penicillin at 100U/ml and 
streptomycin at 100tg/ml. Over time, cultures maintained in spinner culture 
and serum free medium lost viability, growth rates slowed and eventually 
cells began to die. Fresh cultures were seeded regularly and discarded after 
approximately 30 passages. A fresh culture was used for each protein 
expression experiment. 
Resuscitated cells were seeded at 1x10 7 cells per T75 flask, and the medium 
was replaced when cells were attached, typically after 1-2 hours. After 4-5 
days cells were split into five T75 flasks. By this time cells are >100% 
confluent but remain viable. SF9 cells are not tolerant to trypsinisation and 
when grown in serum free medium attach firmly to the flask. At such high 
density cells begin to detach and are easily harvested. Sufficient cells were 
harvested from 3-5 over-confluent T75 flasks to start a lOOml spinner culture 
at 1x106  cells/ml. Cells took approximately two weeks, or three passages, to 
become adapted to spinner culture conditions during which time the stirring 
speed was gradually increased from 50 to 80 rpm. When cells were fully 
adapted growth rates increase so that cultures were split two or three times 
in a week and cells no longer formed aggregates. 
Samples were counted daily using a haematocytometer to follow growth 
rates (Figure 2.1). Only cells from the logarithmic phase were used. Regular 
growth curves were produced to show logarithmic growth, an example is 
shown in Figure 2.1. The number of cells in one of the nine major squares 
were counted over at least four squares, more squares if the cell count is 
54 
lower than 1x10 6 cells per ml. Cells overlapping the bottom or left edge of 
minor squares are not counted to avoid counting cells twice. The volume in 
each of the major squares is 0.1mm 3, or lx104 ml therefore the average 
number of cells in each major square x10 4 gives the number of cells per ml. 
Exclusion of trypan blue was used to show cell viability where required. 
Damaged cells have been shown to take up the blue stain but viable cells 
exclude it. 
Mid log phase cells were frozen at lxl0 7cells/ml in a 50:50 mix of fresh and 
conditioned medium containing 7.5% DMSO. Cells were wrapped in tissue 
to insulate them from sudden temperature changes and kept at —20°C for 5 
hours; —80°C for 24 hours then stored long term at —150°C. Aliquots were 
taken after transfer to —150°C and resuscitated to check cell viability. 
2.6.3 Transfecting SF9 Cells. 
9x105  mid log phase cells were seeded per well of a six well plate and allowed 
to attach for one hour. During this time ljtg bacmid DNA was mixed with 
100tl Grace's medium (Invitrogen) and in a separate tube 6p1 Cellfectin 
reagent (Invitrogen) also was mixed with lOOgl Grace's medium. These were 
combined and left for 45 minutes at room temperature to allow formation of 
DNA-lipid complexes. Cells were washed with 2ml Grace's medium, 0.8m1 
Grace's medium was added to the lipid/DNA complex and added to the 
cells. Non transfected wells were included as a control. The plate was 
incubated at 27°C for five hours after which time the transfectjon mix was 
removed and replaced with SF90011 containing antibiotics. Transfected cells 
were incubated in a bag containing moist towels (a humidified incubator). 
After 72 hours, infected cells began to lyse and show late signs of infection. 
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Figure 2.1 SF9 Growth. 
SF9 cells were counted at various time points using a haematocytometer (A). 
At least four samples per time point were counted, in the major squares 
marked in grey. Only cells lying completely within the square (white circles) 
or over the upper or right hand boundary were counted, cells lying over the 
other boundaries were not counted (red circles). (B) The best-fit line when 
plotted as a log graph is linear, indicating exponential growth. 
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When cells reached late stages of infection, medium was removed and 
clarified by centrifugation at 500g to remove cell debris. This P1 viral stock 
was then amplified by infection of 2x 10 6  cells in a 6 well plate at an 
estimated multiple of infection (MOl) of 0.1. Medium was collected and 
clarified after 48 hours to give the P2 viral stock. A further amplification step 
in a T75 flask was carried out to give a higher volume virus stock (P3). 
2.6.4 Virus Titre. 
The Viral titre in the P2 or P3 stock was calculated using the BacPAK 
baculovirus Rapid Titer Kit from BD Biosciences. 6 x10 4 SF9 cells per well in 
96 well plates were infected in quadruplicate with 50j.il viral stock at 
dilutions between 10 and 10 5. After incubation in a humidified incubator 
for 43 hours cells were fixed and wells blocked with 3.5% goat serum in PBS 
containing 0.05% Tween 20 (PBST). The cells were then incubated with a 
mouse antibody against an AcMNPV envelope glycoprotein, gp64, at a 
dilution of 1:200 in goat serum in PBST. This antibody will detect and bind 
to infected cells. A secondary goat anti-mouse-IgG antibody containing a 
HRP conjugated enzyme was used at 1:250. Foci of infected cells were 
visualised as blue stained cells by addition of blue peroxidase substrate. The 
average number of foci was counted over the three dilutions and the virus 
titer calculated by the following equation: 
Virus titre (pfu/ml) = average number of foci per well X dilution factor X40 X2 
Multiplication by 40 normalises for inoculum volume to give titer in focus 
forming units (ffu) per ml. Multiplication by 2 is a conversion factor 
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empirically calculated by BD Biosciences to give the titre in pfu/ml. All 
reagents were supplied by BD Biosciences 
2.6.5 Virus Infection. 
For large scale production of rStat5, 7.5 x10 6  mid log phase SF9 cells were 
seeded in a T75 flask and infected at an MOl of 10. These were incubated in 
a humidified incubator at 27°C for 72 hours before harvesting. 
2.6.6 Harvesting Recombinant Stat5. 
Medium was collected from SF9 cells before cells were harvested after viral 
infection. Cells were washed twice with phosphate buffer to remove traces 
of medium. A lysis buffer is added which consists of phosphate buffer 
containing antiprotease and antiphosphatase mixes from Sigma plus 0.05 
times volume Insect Popculture reagent (Novagen). This contains a 
detergent that breaks up the cell membranes during a 15 minute incubation 
at 4°C. Lysed cells were frozen at —20°C then spun at 3 1200g in an Eppendorf 
benchtop centrifuge to remove cell debris and DNA from the lysate before 
loading onto a column for purification of the recombinant protein. Over 
expression of rStat5 can easily be seen when whole cell extract is analysed by 
SDS PAGE (Figure 4.8). 
2.6.7 Purification of 6-His Tagged Stat5. 
Recombinant Stat5 produced in the baculovirus expression system was 
purified using Ni2  chelating affinity for a 6-His tag engineered into the N 
terminus of the protein. lml columns packed with chelating sepharose 
(Amersham) were charged with a solution of Ni 2 . Histidine residues form 
complexes with the metal ions and proteins with these groups available are 
retained in the column (Porath et al., 1975). A group of 6 histidine residues 
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positioned together has a high affinity for the column. The presence of 
imidazole in the binding and elution buffers competes the histidine 
association with the nickel ions. 
Various imidazole concentrations for the binding and elution buffers were 
tested, 30mM imidazole for the binding buffer and 300mM imidazole for the 
elution buffer was found to be best for optimum purification of the 6-His 
tagged Stat5. Columns were equilibrated with the binding buffer before a 
cell extract in binding buffer was loaded onto the column, the flow through 
was collected for analysis of protein binding. The column was washed with 
lOml binding buffer to minimise binding of other proteins and aliquots 
collected for analysis. After addition of 5m1 elution buffer the eluate was 
collected in 0.5ml fractions. The 6-His tagged Stat5 normally eluted from the 
column in the second and third fractions. A sample was run on SDS 
polyacrylamide gel electrophoresis (PAGE) to verify purification and the 
condition of rStat5 produced (Figure 4.8). Yield was between 3 and 6.3j.tg 
rStat5 per 106  cells. 
The 6-His tag of the Stat5W37A was designed to be removed by cleavage 
with AcTEV protease (Invitrogen). Digests were carried out at room 
temperature in buffer supplied with the enzyme. After digestion samples 
were stored at —20°C before analysis on protein gels. 
2.6.8 Preparation of Nuclear Extracts. 
Nuclear extracts were prepared from lactating mammary gland, a tissue in 
which the BLG gene is active, and from liver as a negative control. Tissue 
from lactating sheep was used, as sequences used in these studies are from 
the ovine BLG gene. Mid-lactation (11 days post partum) mouse tissue was 
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also used, as this was readily available. Extracts were prepared by a method 
based on (Dignam et al., 1983). Tissue was ground to a fine powder using a 
pestle and mortar in liquid nitrogen and cells were resuspended at 100m1 per 
20mg tissue in A/NT/L (at a ratio of 2:3:5). Cells were lysed by several 
strokes of a dounce homogeniser, filtered through four layers of Miracloth 
(Calbiochem) to remove any connective tissue debris and washed once in 
lOmi A/NT/L, and once in A/NT. The washed pellet was collected by 
centrifugation at 1,200g for ten minutes and resuspended in buffer C 
containing inhibitors at 3ml per 10 9 cells. Nuclei were lysed by gentle 
agitation with a magnetic stirrer for 30 minutes at +4°C. The extract was 
cleared by centrifugation at 25,000g for 30 minutes. Protein concentrations 
measured by the BCA assay kit (section 2.7.3) were between 2 and 4 mg/mi. 
2.7 Protein Analysis. 
2.7.1 SDS PAGE. 
Protein samples were analysed by SDS PAGE. Prepoured gels and buffers 
were bought from Invitrogen and gels run according to manufacturers 
protocols. NuPAGE 12% Bis Iris and Tris acetate gel systems were used. 
Total proteins were visualised by staining with Coomassie gel stain for one 
hour, then destaining with destain solution. Bands were visible after two 
hours destaining and further destaining in fresh solution overnight resulted 
in a clear background. 6-His tagged proteins were visualised by staining 
with Invitrogen's InVisionTM His-tag in gel stain. Gels were fixed for one 
hour in a solution containing 40% ethanol and 10% acetic acid, then rinsed 
twice in dH20 for 10 minutes. The gel was stained with the InVisionTM 
solution for at least one hour, but preferably overnight before washing twice 
with phosphate buffer for ten minutes. An image was taken after this initial 
wash and after any subsequently required further washes. Gels were loaded 
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with BenchmarkTM His-tagged protein standard (Invitrogen) which also 
served as a positive control for the stain. The maximum excitation 
wavelength for the InVisionTM stain is 560nm and the maximum emission is 
590nm. Images were taken using a fluor fx multi-imager from BIORAD, 
using the closest settings to these maxima (excitation at 532nm and a long 
pass filter of 555nm). 
2.7.2 Western Blotting. 
Samples were separated by SDS PAGE and transferred to Protran BA83 
nitrocellulose membrane (from Schleicher and Schuell) using the NuPAGE 
system from Invitrogen following manufacturers instructions. Transfer of 
protein was verified by Ponceau S staining. Membranes were blocked 
overnight in a solution of TBS containing either 3% BSA, or 5% non-fat dried 
milk (Marvel). Incubations with primary antibodies and secondary (HRP-
conjugated) antibodies were at dilutions recommended by suppliers in 
blocking buffer, plus 0.05% Tween 20 to minimise non-specific interactions. 
Bands were visualised by a chemiluminescence reaction using the PIERCE 
SuperSignal West Pico system and images captured onto Kodak film. 
Densitometry analysis was carried out using Quantity One software 
(Molecular Dynamics), after films were converted into a digital format using 
the densitometry / x-ray film function of a Fluor S multi-imager (imager and 
software from BioRad). The signal from each band was measured over a 
duplicated area and normalised to background. The percentage of the signal 
over the total selected area was calculated for each band. Data was exported 
to Microsoft Excel and normalised to the lane loading using data from a 
Western blot with the loading control anti-SF9 cell line antibody. 
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2.7.3 Measuring Protein Concentration. 
Protein concentration was measured using the BCA assay kit from PIERCE. 
25tl unknown samples and BSA standards diluted in the same buffer as the 
samples, were incubated in a 96 well plate in triplicate with 20011 of the 
supplied working solution at 37°C for 30 minutes. Reduction of Cu 2 to Cu 
by protein in an alkaline solution is detected by bicinchoninic acid, and the 
resulting colour change to purple was measured at A56o after subtraction of a 
blank which was the dilution buffer in working reagent. Data were exported 
to Microsoft Excel and a BSA standard curve generated from which the 
protein concentration of the samples was calculated. 
2.8 Bandshift Analysis. 
Bandshift or Electrophoretic Mobility Shift Assays (EMSAs) are a sensitive 
and reliable tool used to detect DNA protein binding complexes, They have 
the ability to detect femtomolar quantities of protein binding to DNA 
(Current Protocols in Molecular Biology, volume 2). Protein and labelled 
probe were incubated together in the presence of a non-specific competitor 
DNA (Poly(dI.dC).Poly(dI.dC)), to minimise non-specific interactions. 
Complexes were separated by migration through non-denaturing PAGE in 
TBE. Naked DNA migrates at a much faster rate than DNA associated with 
protein. DNA-protein stability is maintained by the 'cage effect' whereby the 
polyacrylamide gel physically keeps DNA and protein in close proximity so 
that if they were to dissociate the likelihood of their re-association is 
increased. 
2.8.1 Non Denaturing Polyacrylamide Gels. 
Bandshift reactions were separated by non-denaturing PAGE. Depending on 
the application these gels contain 4-6%(v/v) 37.5:1 polyacrylamide, in 0.25 to 
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lx TBE. Acrylamide/TBE mixtures are mixed with the crosslink reagent 
TEMED (1 .25 j.tl/ml) and the polymerisation catalyst APS (313 j.tg/ml), the gel 
mix was poured into a the space between two glass plates thoroughly 
cleaned with 70% ethanol and dH20 that were separated by 1mm plastic 
spacers. Gels were prerun for one hour. Wells were flushed with running 
buffer immediately before loading to remove any traces of non-polymerised 
acrylamide. Samples were either loaded in Ficoll loading buffer or for Stat5 
bandshifts the reaction was loaded without loading buffer as the bandshift 
buffer contains sufficient Ficoll. After the gel had finished running, the 
plates were separated and the gel was vacuum dried at 80°C for one hour to 
Whatman DE81 anion exchange chromatography paper. 
2.8.2 Preparation of Oligonucleotide Probes. 
Oligonucleotide probes for bandshift reactions were created by annealing 
two complimentary oligonucleotides (synthesised by MWG biotech) 
corresponding to Stat5 binding sites on the BLG promoter. 50pmol of the 
sense strand was 5' end-labelled as described above. A 6 fold excess of the 
unlabelled antisense oligonucleotide was added and the mixture brought to 
>95°C for 5 minutes then allowed to cool slowly to room temperature. 5X 
Ficoll loading buffer was added and the mixture loaded onto the minimal 
number of wells on a 10% polyacrylamide gel in 1X TBE. This was run at 
200V constant until the bromophenol blue dye was approximately half way 
down the gel. 
The glass plates were split open and loading buffer mixed with some 32 
labelled DNA spotted onto pieces of filter paper arranged strategically round 
the edges of the gel. The glass plate plus gel and spots was sealed into a 
plastic bag and exposed to a phosphor screen. After one hour the screen was 
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scanned using a fluor fx multi-imager (BioRad). A real size image was 
produced, and a printout of this was used to orientate the blue dots on the 
gel with the dots on the phosphorimage. The phosphorimage also revealed 
the location of the nucleosome position isomers thus allowing the 
appropriate bands to be isolated. 
The double stranded oligonucleotide band was cut out and eluted in 200[d 
TE containing 50mM KC12 resulting in a final double stranded probe 
concentration of 250 fmol/p.l. 
2.8.3 Stat5 Bandshift Analysis. 
Stat5 bandshifts were carried out using either 20-40 jig of a mammary nuclear 
extract or 1-2 jig purified recombinant Stat5 (rStat5) produced in the 
baculovirus expression system. This equates to between 11 and 22 pmoles of 
rStat5. Stat5 was incubated with ijig Poly(dI-dC).Poly(dI-dC) (a non specific 
competitor) in buffer GRB. This mix was incubated on ice in a total volume 
of 20jil for 15 minutes before the addition of lj.tl radiolabelled probe (0.25 
pmol, which normally contained between 50 and 100 cps) and any 
competitor DNA. This equates to a molar ratio of rStat5 to probe DNA of 
between 44:1 and 88:1. 
Unlabelled competitor DNA competes with the labelled probe for Stat5 
binding, and when added at a known molar excess was a useful tool for 
comparing the affinity of Stat5 for various DNA sequences. Reaction mixes 
were incubated for a further 15 minutes at room temperature (21 1C). 
Samples were loaded straight onto a 5% non-denaturing polyacrylamide gel 
in lx TBE, with 0.25X TBE running buffer. Gels were run at 200V constant 
for three hours. An empty lane was loaded with GRB containing 
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bromophenol blue and xylene cyanol to follow migration. In a 5% gel the 
fragment nAB migrates just ahead of the xylene cyanol. 
2.8.4 Nucleosome Reconstitution by Salt Gradient Dialysis. 
Nucleosomes were formed on a fragment of the BLG promoter, nAB, by the 
salt gradient dialysis method. Initial reconstitutions were carried out at 
ratios of 20, 30, 40, and 50:1 donor chromatin to DNA. These looked similar 
when run on a gel so subsequently only 20:1 was used, as even at this ratio, 
the majority of the probe is associated with protein. Donor chromatin used 
was chicken erythrocyte monomers, stripped of linker histones and other 
proteins. Only the four core histones are present. 
TEP buffers were prechilled to +4°C and PMSF was added to 2.5mM to 
inhibit proteases. A dialysis sheet with 6000/8000Da exclusion limits was 
prepared by soaking in dH20 treated with PMSF. For reconstitution at a 
ratio of 20:1, 4.95 jig chicken erythrocyte donor chromatin (at 825ng/pl from 
Dr J. Allan) and 250ng probe were incubated in TEP containing 1.2M NaCl 
for 30 minutes at 37°C. This was applied to the membrane of a microdialyser 
(Invitrogen) previously equilibrated with prechilled TEP containing 0.8M 
NaCl (TEP800) and dialysed against SOOml TEP800 at 2m1/minute for 4 hours. 
The salt concentration was brought down further to 10mM NaC1 by 
overnight dialysis against 1 litre of TEPio. 
2.8.5 Isolating Positioned Nucleosomes. 
Nucleosomes positioned at different sites on a DNA fragment can be 
separated by their migration through a non-denaturing polyacrylamide gel. 
A nucleosome at the centre of the fragment is more retarded in its migration 
through the gel than a nucleosome sitting at the end of the same DNA 
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fragment (Pennings, 1997). I have made use of this behaviour to separate the 
different positioning isomers formed on nAB. 
Reconstituted nucleosomes were separated on a 5% non-denaturing 
polyacrylamide gel in 1X TBE. Gels were prerun for at least one hour at +4°C 
and run at 60V constant overnight. Nucleosome positioning isomers were 
maintained at a low temperature to minimise nucleosome movement. 
Individual nucleosome positioning isomers were separated simply by cutting 
each band out of the gel as described for isolating the annealed 
oligonucleotide probes (section 2.8.2). Cut out bands were eluted into 200t1 
TEPia containing carrier chromatin at 60ng/.d. Samples of the cut out bands 
are run alongside the original reconstitution mix on a non-denaturing 
polyacrylamide gel to verify the correct isolation of the positioning isomers. 
2.9 Mapping Nucleosome Positions. 
DNA associated with nucleosomes is protected from the action of nucleases. 
Digestion of unprotected DNA to identify nucleosome boundaries enables 
calculation of the location nucleosomes position at on a given DNA 
fragment. In this study positions of nucleosome on reconstituted DNA 
probes were mapped by two different enzymatic approaches. The 
methodology employed with each approach is quite different, thus the 
combination of data from the two approaches provides a better indication of 
where on the DNA nucleosomes are positioned. 
2.9.1 Exonuclease III Mapping. 
Fragment nAB of the BLG promoter, which includes the three StatS binding 
sites, was produced by PCR using primers designed to incorporate a PvuII 
restriction site at the upstream end and a RsaI restriction site at the 
downstream end. See Figure 2.2 for primer sequences. The fragment was 5' 
end labelled using T4 PNK and [y32P] ATP. The engineered restriction sites 
facilitated the removal of 8-9bp from the ends of the fragment resulting in a 
molecule labelled at only one end, and on only one strand. This fragment 
was reconstituted with nucleosomes from carrier chromatin as described 
previously (2.8.4). 
Exonuclease III (Exo III) cuts away at the 3' end of duplex DNA in a stepwise 
manner (Richardson et al., 1964). It shows some sequence specificity of 
C>A=T>G (Liaxweiler and Horz, 1982) and thus a partial digest of DNA will 
show a unique pattern of pause sites. The presence of a positioned 
nucleosome causes Exolli to pause at the nucleosome boundary. However, 
Exolli will eventually cut into the nucleosome producing a characteristic 
lObp periodicity in pause sites (Linxweiler and Horz, 1985; Riley and 
Weintraub, 1978; Kefalas et al., 1988). 
NaFPvuII 	 GGCTCTcAg*CTGTCCUGTcTAAG 
NbRRsaI 	 GGCTGGt*aCCCCAGCCACGCGGT 
Table. 2.1. Primers used to introduce PvuIl or Rsal restriction 
enzyme sites into nAB. 
Changed bases are shown in lower case. Restriction sites created are 
underlined and cleavage sites marked bv* . 
50ng DNA or 250ng isolated nucleosome isomers were incubated at 37°C for 
15 minutes with 25-3,000 U/ml Exolli (NEB) in 1X Exoill buffer. One U of 
Exolil is defined as the amount of enzyme required to produce inmol acid 
soluble nucleotide in 30 minutes at 37°C in a total reaction volume of 50pJ. 
Reactions were stopped by adding EDTA to 15mM and SDS to 0.2% and by 
heating to 70°C for 20 minutes. Samples were phenol/chloroform extracted, 
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ethanol precipitated and resuspended in formamide gel buffer and single 
stranded DNA products were resolved on a denaturing gel. 
Data were analysed using AIDA (Advanced Image Data Analysis) software. 
The gel was calibrated by the migration of known labelled DNA standards, 
which in this case was a lObp ladder from Invitrogen. The position of the 
label at the 5' end of the strand is known. From this each pause site for 
Exolli was accurately mapped to its position on the fragment. By using DNA 
labelled at first one 5' end then the other both boundaries of each nucleosome 
were mapped in this manner. 
2.9.2 Denaturing Polyacrylamide Gel Electrophoresis. 
Single stranded DNA lengths were determined by electrophoresis in a 
denaturing 8% polyacrylamide gel containing lx TBE and 8M Urea at 50W 
for about three hours.. Prior to loading on a gel, DNA was denatured by 
heating to 95°C for five minutes then put straight onto ice before loading 
onto a gel prerun to 55°C. The gel apparatus was disassembled, prior 
treatment of one plate with Repel silane ensured the gel only ever stuck to 
one plate. Gels were fixed in a solution of a 10% acetic acid, 12% methanol 
solution and rinsed with dH20. Fixed gels were transferred on to 17Chr 
Whatman chromatography paper and vacuum using a Bio-Rad 583 gel dryer. 
Gels were visualised after an initial overnight exposure using a 
phosphorimager, then exposures of up to one month for further analysis. 
2.9.3 Restriction Mapping. 
The second enzymatic approach to mapping nucleosome positions used a 
combination of micrococcal nuclease (MNase) digestion to produce core 
DNA, and subsequent restriction enzyme digestion. MNase pauses at 
nucleosome boundaries (Noll and Kornberg, 1977; Horz and Altenburger, 
1981). Nucleosomes were reconstituted onto nAB that had been labelled 
uniformly by addition of [ct32P] dCTP into the PCR reaction used to produce 
the fragment. (See labelling DNA 2.5.2). 
Core particle DNA was produced by digestion of unfractionated 
reconstitutes. 50tg/m1 reconstitute in TEPio containing 1mM CaCh was 
digested with MNase (10 units/ml) for 20 minutes on ice followed by further 
trimming to the nucleosome boundaries at 21°C, at times individually 
calculated by timepoint digests. Isolated core particle DNA was analysed by 
denaturing polyacrylamide gel electrophoresis to check the quality of the 
146bp band. 
Core protected DNA was digested by unique cutting restriction enzymes. 
Products of these digestions were separated on a denaturing gel alongside 
lObp ladder. An enzyme cleaving within the core DNA produces two 
products, the sizes of which add up to 146bp. The digest products from 
cleavage by two or more enzymes within a fragment facilitated mapping of 
nucleosome boundaries with respect to the known restriction sites. 
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3 CHARACTERISING NUCLEOSOMES POSITIONS ON nAB 
Several DNaseI hypersensitive sites detected throughout the BLG promoter 
and gene mark areas of interesting chromatin structure (Whitelaw and 
Webster, 1998). Hypersensitive site III is of particular interest as its 
appearance is linked to the activity of the BLG promoter. HSIII sits at the 
proximal promoter, immediately before the transcription start site. The 
appearance of DNaseI hypersensitive sites represents a change in the 
accessibility of DNA to nuclease attack. This can be due to transcription 
factor interactions, or to the displacement or movement of a nucleosome. 
The presence of HSIII suggests a link between the chromatin structure of the 
promoter and the regulation of BLG expression. For a more in-depth 
description of the DNaseI hypersensitive sites in BLG refer to section (1.5.1). 
3.1 Introduction: Nucleosome Positions on the BLG Promoter. 
In order to study a role for chromatin in the regulation of the BLG gene, 
positions of nucleosomes over the BLG promoter have been studied both in 
vivo and in vitro by our lab (Boa, 1999; Gencheva and Allan, 2005). From this 
data a clearer picture of the role positioned nucleosomes may play emerges. 
3.1.1 Nucleosome Positions In Vivo. 
In vivo nucleosome binding positions have been mapped throughout the BLG 
gene and promoter in tissues that either express, or do not express BLG. A 
partial cuprous phenanthrolene digest of chromatin, combined with 
digestion at a unique restriction site was utilised to map nucleosome 
positions by indirect-end-labelling (Wu, 1980). Extracted DNAs were 
separated by agarose gel electrophoresis, transferred to nitrocellulose and 
probed with a sequence adjacent to the restriction enzyme site. Part of the 
resulting nucleosome map derived from this analysis is shown in Figure 3.1. 
70 
A major reason for studying BLG is that its expression is limited to the 
lactating mammary gland. Differentiation of the mammary gland takes place 
in the adult; hence tissue at different developmental stages is readily 
accessible. Results of the in vivo mapping experiments show a regular 
nucleosome array is present throughout both the promoter and the gene in 
liver (Figure 3.1 lanes 4 and 5) where the BLG gene is in its inactive state. A 
different structure is detected in the active tissue, where the nucleosome 
array is seen at the 5' end of the promoter but not in the transcribed region 
(Figure 3.1 lanes 2 and 3). The last (most 3') nucleosome remaining from the 
array through the promoter is detected over the area of DNase HSIII, which 
includes binding sites for the transcription factor Stat5. The indirect labelling 
indicated that there are two weak nucleosome positions at this site (marked 
by the upper set of (stick) arrows to the left of the gel in Figure 3.1). The 
nucleosome position 5' to this is also a pair, but is much stronger (marked by 
the lower pair of (block) arrows in Figure 3.1). Importantly this data 
indicates that a nucleosome is located over the proximal promoter in the 
active state and constitutes an integral component of the HS itself. 
The technique used to map nucleosome positions in vivo is relatively low 
resolution and lacks the accuracy to precisely define where on the DNA 
individual nucleosomes lie. Importantly, it does tell that nucleosomes form 
an array over a particular area of DNA, and provides an indication of where 
the array is disrupted. However the significance of this arrangement is not 
yet clear. Active genes are often found to have a more open and accessible 
chromatin structure (Felsenfeld et al., 1996). However the fact that the array 
ends at a DNaseI hypersensitive site, where there are two alternative 
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Figure 3.1 In Vivo Chromatin Structure over the BLG Gene. 
A regular nucleosomal array is seen throughout both the promoter and 
transcribed region in liver, but in the active mammary gene this pattern is 
disrupted throughout the expressed region. The indirect end-labelling 
analysis is shown in A. Lanes 2 and 3 show the map of the in vivo 
nucleosome positions in sheep mammary gland. The two pairs of arrows on 
the left indicate the two pair of alternative nucleosome positions. Lanes 4 
and 5 show the nucleosome map in liver. This data is represented in 
schematic form in B, showing the alternative nucleosome positions. Green 
arrows represent the transcription start site and grey ovals represent 
nucleosome positions. Lane I is genomic DNA digested with RsaI plus 1 k 
ladder. The relative strength of the nucleosome positions is represented by 
the shade of grey. Both these images were adapted from Figure 52 of (Boa, 
1999). 
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mechanism for positioned nucleosomes in regulation of the BLG gene. 
3.1.2 Nucleosome Positions In Vitro. 
To complement the in vivo analysis, in vitro nucleosome binding positions, 
determined solely by the interactions of the histone core with the DNA 
sequence, were also mapped over the BLG gene and promoter using the 
monomer extension technique (Yenidunya et al., 1994; Boa, 1999; Gencheva 
and Allan, 2005). In this approach, nucleosomes are reconstituted onto the 
DNA of interest and digested with MNase to produce 146bp of core particle 
DNA protected by the nucleosome. The monomer DNA recovered from the 
core particles is then labelled and annealed to a single stranded version of the 
original template DNA and extended to a known restriction site. The sizes of 
the resulting products, measured on a denaturing polyacrylamide gel, 
identifies the boundary of the parent nucleosome. The band intensity also 
reflects the preference of nucleosomes to sit at certain points on the DNA. 
Using this technique, which enables accurate mapping of nucleosome 
binding sites over a long stretch of DNA, several strong individual 
nucleosome positions were detected throughout the gene (Figure 3.2). Of 
particular note was a strong nucleosome positioned with its centre, or dyad, 
at -183 base pairs (bp) relative to the transcription start site, referred to 
hereafter as nucleosome A (Figure 3.2). 
The BLG promoter harbours three binding sites for the transcription factor 




Figure 3.2. In Vitro Map of Nucleosome Positions over the BLG Gene. 
Nucleosome positions derived from the in vitro analysis are represented as 
ovals over the BLG promoter and gene (top). The green arrow marks the 
transcription start site and the green box exon one. Blue boxes indicate the 
locations of DNasel hypersensitive sites. A strongly positioned nucleosome, 
A highlighted in yellow, sits with its dyad at —183 bp. A second positioned 
nucleosome with a dyad at —224, nucleosome B, is highlighted in brown. 
Below the map is the signal intensity trace from the in vitro mapping 
experiment indicating the relative strength of each nucleosome position. This 
image was adapted from Figure 74 of (Boa, 1999). 
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bp from transcription start (Figure 3.3). This placement provides a 
separation of 185bp, which could accommodate a single nucleosome plus 
linker DNA. In fact this spacing corresponds closely to the genomic 
nucleosome repeat length found in mammary cells (Boa, 1999). The strong in 
vitro positioned site, nucleosome A, has a dyad estimated to be at —183bp, 
which would place it precisely between the —93 and the —278 Stat5 binding 
sites (yellow oval in Figure 3.3). 
-278 	21O 93 
C.0 :,~O-:AD 0, - 1111111=11111111MI 
• Stat5 Binding site 
Figure 3.3. Detail of the In Vitro Positioned Nucleosomes on the BLG 
Gene. 
Nucleosome position A is shown in yellow and the weaker position B in 
brown. Stat5 binding sites are represented by red circles. Nucleosome A is 
located between the Stat5 binding sites at —93 and —278 but covering the site 
at —210. Nucleosome B incorporates the —210 and the —278 Stat5 binding 
sites leaving only the —93 site accessible in linker DNA. 
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The in vitro map (Figure 3.2) also shows a second relatively strong 
nucleosome positioning site at —224, referred to hereafter as nucleosome B. 
This position overlaps nucleosome A and would lie over two of the Stat5 
binding sites, leaving only the —93 site exposed in the linker DNA (brown 
oval in Figure 3.3). Of course only one of these alternative nucleosome 
positioning sites could be occupied in a cell at any one time. 
The two alternative in vitro nucleosome positioning sequences nucleosome A 
and nucleosome B lie in the same region of DNA as, and may correspond to, 
the two alternative positions observed immediately before the transcription 
start site (marked by stick arrows in Figure 3.1) at the boundary between the 
regularly spaced array seen in the promoter of the active gene in vivo, and the 
disrupted nucleosome structure through the gene. These mapped 
nucleosomes also correspond to the region that is covered by HSIII, the 
presence of which correlates strongly with expression of BLG. 
The in vivo nucleosome map shows that there is a distinctive chromatin 
structure over the proximal promoter of the BLG gene. It is possible that the 
in vivo mapped nucleosome pair immediately proximal to the transcription 
start site corresponds to the two in vitro mapped nucleosome positions A and 
B, suggesting a mechanism whereby the nucleosome positions could 
influence Stat5 binding, or alternatively a mechanism by which Stat5 could 
influence the nucleosome positions. Stat5 plays a major role in the regulation 
of BLG (Burdon et al., 1994b) and in the regulation of other milk protein 
genes. Two of the Stat5 binding sites are accessible, i.e. in linker DNA 
external to nucleosome A but in nucleosome B only site one is external. 
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3.2 Reconstitution of a Nucleosome onto the -LactoglobuIin 
Promoter. 
In this chapter, chromatin structure over the proximal region of the BLG 
promoter will be recreated in an in vitro reconstitution system, in order to 
study Stat5 binding to the promoter within a nucleosomal context. The 
reconstitution system employed is explained and the positions nucleosomes 
locate on the DNA fragment are examined. 
3.2.1 Fragment Design and Rationale. 
A fragment of the BLG promoter was chosen that incorporates the three Stat5 
binding sites and the two prominent in vitro nucleosome positions (Figure 
3.4). The fragment is denoted nAB for the two nucleosome binding sites. 
nAB was produced by PCR using primers nAF and nBR. The product is 
240bp long and runs from -312 to -73 with respect to the transcription start 
site (Figure 3.4). As each core binds 146bp of DNA only one core histone 
octamer should normally interact with a DNA molecule of this size. The 
fragment was designed as the minimum that would incorporate both of the 
alternative nucleosome positions, plus the three Stat5 binding sites, while 
remaining small enough to minimise the binding of multiple nucleosomes 
which can occur on fragments 260bp and larger (Tatchell and van Holde, 
1978). 
3.2.2 Reconstitution. 
Core histones were reconstituted onto 5' end-labelled nAB by redistribution 
from chicken erythrocyte donor chromatin using dialysis from high to low 
salt (section 2.8.4). At high concentrations of NaCl (2M), core histones are 
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nAF 
-321 ggctctgacc tgtccttgtc 
-271 
-221 
-171 	 Ii! 	 I* ctcctattgt cctcgtagag gaagccaccc 
-121 cggggcctga ggatgagcca agtgggatt 	 acCgC gtggctgggg 
NBR 
Figure 3.4 Sequence of the Probe nAB. 
PCR primers nAF and nBR are indicated. The predicted nucleosome 
position A is marked by a yellow line above the sequence. Nucleosome 
position B is highlighted in brown. Stat5 binding sites are in red type. 
dissociated from DNA. By slowly reducing the ionic strength from 2M 
through 0.8M to 10mM, histones reassociate and bind DNA (Tatchell and 
van Holde, 1977). During this process nucleosomes form preferentially on 
certain sequences (Beato and Eisfeld, 1997; Dong et al., 1990; Dong and van 
Holde, 1991; Yenidunya et al., 1994; Richard-Foy and Hager, 1987) although 
the precise parameters determining this process are not yet fully understood. 
3.2.3 Positioning Isomers. 
Reconstituted nucleosomes were analysed on 5% native polyacrylamide gels 
in TBE. Individual binding positions resolve on these gels according to their 
proximity to the centre of the DNA fragment. A centrally positioned 
nucleosome will be most retarded in its electrophoretic migration whereas a 
nucleosome positioned towards the end of the fragment will not be hindered 
to the same extent and will migrate more rapidly (Pennings, 1997). Thus 
individual nucleosome positioning isomers can be separated and isolated 
from a reconstitution. The strength of each nucleosome binding site is 
reflected by the intensity of the band observed. 
3.2.4 Predicted Nucleosome Isomer Positions. 
In a typical reconstitution onto nAB, three nucleosome positioning isomers 
are detected, labelled Ni through N3 (Figure 3.5). The slowest migrating 
band, Ni, is also the most intense and therefore the most abundant. The 
slowest migrating nucleosome is predicted to be positioned most centrally on 
the DNA fragment. The strongest positioned nucleosome from the in vitro 
map, nucleosome A, is predicted to lie most centrally on nAB with DNA tails 
external to the nucleosome of 54 and 37bp (Figure 3.6C). Thus it is likely that 
Ni represents nucleosome A. 
Wt 
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Figure 3.5 Nucleosome Positioning Isomers Resolved on a Non-
Denaturing Polyacrylamide Gel. 
Nucleosomes reconstituted onto nAB were separated on a 5% native 
polyacrylamide gel. The unfractionated reconstitute (R) is shown in lane 4, 
and purified isolated nucleosome positioning isomers N1-N3 in lanes 3-1. 
Schematic representations of the possible nucleosome positions from their 
migration in a native polyacrylamide gel are shown on the right hand side, 
these are based on the proximity to the centre of the DNA. 
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The nucleosome positioning isomer N2 migrates slightly faster than Ni. N2 
is probably positioned more towards a DNA end than Ni is. N3 migrates 
most rapidly through the gel suggesting this nucleosome positions most 
closely to the end of nAB. Nucleosomes exhibit a tendency to position at end 
positions; a reconstitution onto any DNA fragment will often show a 
tendency to produce an end positioned nucleosome. N3 may represent such 
an end position, or alternatively it may represent the second in vitro mapped 
nucleosome (B), which is predicted to have DNA tails external to the 
nucleosome of 13 and 78bp (Figure 3.6C). From their migration through a 
non-denaturing polyacrylamide gel either N2 or N3 could represent 
nucleosome B. 
In this chapter I show that Ni, and also N2, represent the in vitro mapped 
position A. A closer look at nucleosome A in Figure 3.213 shows that there 
may be two nucleosome positions flanking the main band by -10 bp either 
side. N2 may be one or both of these shoulder positions. The third 
nucleosome positioning isomer, N3, is likely to be nucleosome position B 
whose positions predicts it lies close to the end of nAB. Nucleosome B, like 
nucleosome A contains flanking nucleosomes that show up in the in vitro 
map (Figure 3.213). 
3.2.5 Isolation of Nucleosome Positioning Isomers. 
Individual nucleosome positioning isomers were isolated after separation on 
a native polyacrylamide gel by excision of gel slices containing the individual 
bands and elution into TEPio. Samples of isolated positioning isomers run 
alongside the original reconstitution mixture show that in the low salt, low 
temperature conditions employed for elution the majority of nucleosomes 
remain at the same positions on the probe (Figure 3.5). Only a small fraction 
of the probe became free of protein and redistributed between positioning 
isomers was minimal. A small percentage of both Ni and N2 does move to 
N3, and some N2 moves to Ni. N3 is not observed to move. These 
"contaminating" bands may also reflect a failure to cleanly separate the 
positioning isomers, as Ni and N2 in particular migrate quite closely 
together in the gel. Nevertheless, the vast majority of the signal does remain 
in the correct bands. 
3.3 Mapping of Nucleosome Core Particles. 
In order to determine exactly where the Stat5 binding sites are in relation to 
each positioned nucleosome, the nucleosome binding positions on fragment 
nAB had to be mapped precisely. The positions of the two strong binding 
sites, Ni and N2, were mapped using two enzymatic approaches involving 
Exonucleaseill (Exolil) and micrococcal nuclease (MNase) with restriction 
digestion. The methodology behind each approach is distinct, thus the 
combined data from the two approaches should give a more reliable 
indication of the locations of nucleosome positions on nAB. 
3.4 Exonuclease III Mapping. 
Exonucleaselli (Exolli) removes nucleotides from the 3'OH end of double 
stranded DNA in a stepwise manner (Richardson et al., 1964; Richardson and 
Komberg, 1964). It displays a slight sequence specificity of C>A=T>G 
(Linxweiler and Horz, 1982), thus a partial digest of naked DNA shows a 
unique transient pattern of pause sites. The presence of a positioned 
nucleosome on a DNA fragment causes Exolli to exhibit a notable pause at 
the nucleosome-DNA boundary. Additional digestion within a nucleosome 
does occur with a distinct iObp pattern (Riley and Weintraub, 1978; Kef alas 
et al., 1988). 
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In order to harness Exolil to map nucleosome positions on DNA, fragments 
were produced that were labelled uniquely at one 5' end in order to map 
Exolil pause sites to each fragment end separately. Unique cutting 
restriction enzyme sites were incorporated into the ends of nAB in order to 
be able to selectively remove one labelled end. A PCR primer was designed 
with a PvuII site in the sequence of the upstream primer nAF to give the 
primer nApF (Figure 3.613). Similarly an RsaI site was incorporated into the 
downstream PCR primer nBR to give primer nBrR (Figure 3.6B). Digestion 
of the resulting PCR product with either RsaI or PvuII after 5' end labelling 
results in DNA uniquely labelled at only one end (Figure 3.6A (RsaI) and 
(PvuII)). These enzymes were chosen because they leave DNA with no 
overhangs after digestion; Exonucleaselil cannot digest single stranded 
DNA, so restriction enzymes that would leave a 3' overhang were avoided as 
these are very poor substrates for the enzyme. These fragments are subtly 
different from the fragment nAB (Figure 3.6A and Table 3.1) used for the 
original reconstitution, and as such may be expected to behave differently in 
a reconstitution. The ratio of DNA tails that are external to the nucleosome 
indicates how centrally on a given fragment a nucleosome sits; a nucleosome 
with a tail ratio of 1.0 is positioned right in the middle of a fragment. The 
higher the ratio, the closer to the end of the fragment a nucleosome positions. 
Digestion of 5' end labelled nApBr with PvuII results in a fragment, called 
(PvuII), labelled only once, at its downstream end. This can be used to map 
the upstream end of a positioned nucleosome by Exoill digestion. In 
contrast, RsaI digestion results in DNA labelled only at the upstream end and 
this fragment, (RsaI), is used to map downstream boundaries of 
nucleosomes. 
Figure 3.6. Comparison of Nucleosome Positions on nAB with nApBr. 
A schematic representation of fragments nAB and nApBr and their relative 
ends (A). Positions of primers are shown relative to nucleosome A and 
nucleosome B. Full length PCR products nAB and nApBr, as well as the 
products of restriction digest of nApBr are shown as labelled. More 
information on each fragment mentioned can be found in Table 3.1. Primer 
sequences used are displayed in B. The downstream primer sequence 
shown has been converted to how it would appear on the upper strand, DNA 
will actually be labelled on the lower strand. Restriction sites incorporated 
into the primers are underlined, and cleavage points indicated by stars (*) 
The lengths of DNA external to each nucleosome, A or B, are shown in C. 
Nucleosome A on fragment nAB has DNA tails of 54 and 37 bp: the ratio of 
these is 1.46. The ratio of the lengths of the DNA tails indicates how 
centrally a nucleosome is positioned on the fragment. This ratio was affected 
by the changes introduced into the fragment by use of the primers that 
introduce restriction enzyme sites. The lengths of tail DNA external to the 
nucleosome core is shown for each fragment, and the ratio of these is shown 
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Figure 3.6. Comparison of Nucleosome Positions on nAB with nApBr. 





Start End Primers Digest 
nAB 240 -312 -73 nAF : nBR - 
nApBr 261 -324 -64 nApF: nBrR - 
nApB 252 -324 -73 nApF: nBR - 
nABr 249 -312 -64 nAF: nBrR - 
(RsaI) 254 -324 -71 nApF : nBrR RsaI 
(PvuIl) 252 -315 -64 nApF: nBrR PvuIl 
nApB 243 -315 -73 nApF: nBR PvulI 
nABr 
242 -312 -71 nAF : nBrR Rsal 
A second set of digests was carried out to demonstrate complete cleavage of 
labelled ends. The size of the cleaved end fragment is too small in relation to 
the whole fragment to allow verification of its removal directly (Figure 3.7, 
compare lanes 4, 5 and 6). Removal of the ends was verified by double 
digestion with internally cutting enzymes AccI (Figure 3.7 lanes 1 —3) and 
Smal (Figure 3.7 lanes 7 - 9). AccI cleaves the full-length sequence into two 
fragments of 100 and 142bp (lane 3 and 37B), but in a double digest with 
either of PvuII (lane 2) or RsaI (lane 1) only one fragment is labelled and 
shows up on the gel. SrnaI cleaves the uncut sequence into 190 and 52bp 
(lane 9 and 3.7B). With a double digest only one product is seen indicating 
the ends have successfully been removed (Figure 3.7 lanes 7 and 8). Figure 
3.7 B shows the positions of the restriction digest sites, and the calculated 
fragment sizes. 
3.4.1 Characterising Reconstitutes to be used in Exolli Mapping. 
Nucleosomes were reconstituted onto the uniquely end-labelled fragments 
described above and individual positioning isomers were isolated (Figure 
3.8). The pattern of nucleosome migration on (RsaI) and (PvuII) show some 
subtle differences from each other (Figure 3.8). Reconstitutes prepared on 
(PvuII) have a similar pattern to that seen with reconstitutes prepared on the 
normal nAB probe, but two nucleosome positions are observed in respect of 
the fastest migrating band N3 (compare nAB in Figure 3.5 lane 4 to (PvuII) in 
Figure 3.8 lane 4). The reconstitute on (RsaI) also has two bands 
corresponding to N3, plus an extra band migrating closer to the central N2 
position (Figure 3.8 lane 5). In (RsaI), the isomer at the Ni position also 
appears to migrate slightly faster than it does in (PvuII). An attempt to 
isolate all four positions from the reconstitution onto (RsaI) was unsuccessful 
and resulted in nucleosome Ni isomers being split between two fractions. 
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Figure 3.7. Restriction Enzyme Digests to Verify Correct Removal of the 
Upstream or Downstream Labelled Ends of nApBr. 
A. Products from restriction digests of 5' end-labelled nApBr were separated 
on an 8% polyacrylamide gel. Labelled ends were removed by digestion 
either with Rsal (R) (lanes 1, 4 and 7) or Pvull (P) (Lanes 2, 5 and 8) DNA 
without either end removed (U) is also shown (lanes 3, 6 and 9). Subsequent 
digestion with a second enzyme that cleaves internally in the fragment 
verifies the removal of each end. A schematic diagram showing the cleavage 
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Figure 3.8 Reconstitution of Nucleosomes onto (RsaI) and (PvuII). 
Lane 4 is an unfractionated reconstitute (R) on (PvuII), and lanes 1-3 are the 
individual positioning isomers isolated from this material. Lane 5 is an 
unfractionated reconstitute on (Rsal), and lanes 6-9 are the individual 
positioning isomers isolated from this material. 
The Ni fraction from the (RsaI) reconstitute contains only the slowest 
migrating nucleosome Ni, but the N2 fraction contains bands corresponding 
to isomers Ni and N2. In the subsequent Exolil digests (Figure 3.12) the N2 
fraction will contain digest products of both the Ni isomer and the N2 
isomer, so only bands seen in the (RsaI) N2 fraction that are not present in the 
(RsaI) Ni fraction must belong to position (RsaI) N2. No attempt was made 
to separate the two fastest migrating nucleosomes (N3) in either of the nApBr 
reconstitutions. 
The differences in migration between the (PvuII) and the (RsaI) reconstitutes 
may be explained by the extra nucleotides present at the ends of the 
sequence resulting from the use of primers incorporating the PvuII and RsaI 
restriction sites (Figure 3.6). Using the previously mapped positions of 
nucleosomes A and B (Figure 3.2) as an example, nucleosome A. predicted to 
sit at —183, would have free DNA tails of 54 and 37bp on a reconstitute on 
nAB. The ratio of the free DNA tails gives an indication of how centrally on 
the fragment a nucleosome lies. The closer this ratio is to 1 the more 
centrally the nucleosome lies. The ratio of the free DNA ends for nucleosome 
A on fragment nAB is 1.46 (Figure 3.6C), indicating that it would be a fairly 
central position, and thus is likely to migrate relatively slowly through a 
polyacrylamide gel. The same nucleosome A reconstituted on (PvuII) would 
be positioned even closer to the centre of the fragment, having a DNA end 
ratio of 1.24. The reverse is true with a reconstitute on (RsaI) as the ratio rises 
to 1.67 (Figure 3.6C). Nucleosome A on (RsaI) would migrate slightly faster 
than on nAB, and on (PvuII) it would migrate slightly slower than on nAB. 
Thus the predicted migration rates for Nucleosome A on the (RsaI) and the 
(PvuII) fragments, shown in Figure 3.6, are consistent with the difference 
seen in migrations for the Ni isomer in Figure 3.8. 
The main N2 isomer band appears to migrate at the same level in 
reconstitutes on all three fragments. However in reconstitutes on (RsaI) the 
band reflecting the N2 isomer is of lower intensity than the N2 isomer bands 
in reconstitutes on either (PvuII) or nAB. A faster migrating band of similar 
intensity to the N2 isomer is also present in (RsaI), designated NX (Figure 
3.8). The total amount of signal in the (RsaI) N2 and NX nucleosome isomer 
bands approximately equals the amount of signal contained in the (PvuII) 
and nAB N2 isomer bands, suggesting NX may be a component of N2. This 
could indicate that the subtle differences in the sequence at the end of the 
fragment result in a proportion of the nucleosomes in N2 positioning at a 
different site. However these changes in the DNA sequence are at the very 
ends of the fragment and as such are predicted only to interact with an end-
positioned nucleosome. The migration of N2 through a polyacrylamide gel 
does not imply it is a nucleosome positioned at the end of a fragment, 
making it unlikely that interactions with the sequences at the end of the 
fragment could result in a completely new nucleosome position. 
Alternatively it could indicate the possibility that N2 actually harbours two 
separate nucleosome positions, which are not resolved in reconstitutes on 
nAB or (PvuII) but the subtle difference in free DNA tail length in (RsaI) 
allows the two isomers to resolve. 
N3, predicted to be nucleosome B, migrates as two bands in reconstitutes on 
both the (RsaI) and (PvuII) fragments but not in reconstitutes on nAB. The 
ratio of free DNA lengths for nucleosome B on (PvuII) and nAB are similar at 
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6.00 and 5.43 (Figure 3.6). However this is much reduced in (RsaI) with a 
ratio of 3.33. This difference may be able to account for the isomer NX 
migrating between N2 and N3 in (RsaI). However the fact that the two bands 
associated with N3 are present in reconstitutes on both (PvuII) and (RsaI) 
argues against this redistribution (Figure 3.8). 
It is unclear how these subtle differences in fragment length might affect the 
migration of N3. It is possible that differences are not resolved for 
nucleosomes positioned towards the end of a fragment. It is likely that N3 is 
composed of multiple positioned nucleosomes, some of which are directed 
by the DNA sequence and some by end effects. End positioned nucleosomes 
can lie at either end of the DNA fragment, this may explain the similar 
positions observed for both (PvuII) and (RsaI). 
The subtle differences in migration of the Ni isomer have been explained by 
changes in free DNA lengths. Analysis would be much more 
straightforward if nucleosome isomer patterns were identical for each 
fragment. Different combinations of primer pairs were employed to 
minimise the difference produced at the ends of the fragments. Primer nAF 
was paired with primer nBRr to produce the fragment nABr, which could be 
cleaved by RsaI. Similarly primer nAFp was paired with primer nBR to 
produce nApB, which could be cleaved by PvuII (Figure 3.6 and Table 3.1). 
These combinations only differ by two or three base pairs after digestion 
with the relevant enzyme. 
Reconstitution experiments on nApB and nABr (Figure 3.9) look essentially 
the same as a reconstitution on nAB (Figure 3.5) with the exception that the 
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nApB Ni isomer migrates as two bands. This is unlikely to represent a 
different nucleosome position caused by changes in the DNA sequence, as 
these changes are not within the region that is predicted to be covered by the 
nucleosome Ni. The mutations introduced to add the PvuII restriction site, 
even after digestion, result in addition of an extra three base pairs (CTG) to 
the upstream end of the fragment compared to the sequence of nAB. This 
may be enough to resolve different nucleosome positioning isomers within 
Ni, although why these were not resolved in reconstitutes on (PvuII) and 
(RsaI) is unclear. Verification of the removal of the labelled end was not 
carried out on nApB and nABr, so the band could be explained by 
incomplete digestion. Notably both nABr and nApB have only one 
nucleosome isomer at N2 indicating that the differences seen at this position 
in (PvuII) and (RsaI) reconstitutions were due to the extra lengths of DNA. 
Exonucleaseill experiments described below are on nucleosomes isolated 
from reconstitutions onto (PvuII) and (RsaI). 
3.4.2 Positioning Stability Under Exolli Conditions. 
To show that nucleosome positions are not affected by the conditions used in 
the Exolil digests, isolated positioning isomers were treated with Exolil and 
their separation on native polyacrylamide gels was compared to untreated 
nucleosomes. An unfractionated reconstitute treated under Exoill 
conditions, but in the absence of Exolil, looked identical to an untreated 
reconstitute (Figure 3.10 compare lanes 1 and 2). There was also no 
nucleosome movement detected under these conditions among isolated 
position isomers (data not shown). This demonstrated that the buffer and 
temperature change has no noticeable affect on nucleosome positioning. 
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Figure 3.9 Reconstitution onto nApB and nABr, cut Respectively with 
PvuI! or RsaI. 
Lane 4 is an unfractionated reconstitute (R) on nABr, and lanes 1-3 are the 
individual isolated positioning isomers from this material. Lane 8 is an 
unfractionated reconstitute on nApB and lanes 5-7 are the individual isolated 
positioning isomers from this material. 
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Isolated positioning isomers were also treated with either 200 or 800 units/ml 
Exolli and again separated on a polyacrylamide gel in TBE. Nucleosome 
positioning isomers treated with the lower concentration of Exolil migrate 
essentially the same as the untreated samples (Figure 3.10 compare lanes 3 
with 4, 6 with 7, and 9 with 10). Only the N2 nucleosome isomer displays 
redistribution, to a position closely resembling the NX nucleosome isomer 
observed in Figure 3.8. Digestion with Exolli at the higher concentration of 
800 u/mi causes nucleosomes to migrate in a different pattern (Figure 3.10 
compare lane 3 with 5, lane 6 with 8 and lane 9 with 11). As shown by the 
extent of digestion in Figures 3.11 and 3.12, at this concentration Exolli will 
have progressed well into the nucleosome, probably up to the dyad axis. 
This means the nucleosome structure is unlikely to be as stable as that of an 
intact nucleosome having only one turn of double stranded DNA to hold it 
together. On the whole nucleosomes appear to maintain their position, an 
observation supported by the presence of a lObp cutting pattern observed 
when the digest products are separated on a denaturing polyacrylamide gel 
(Figure 3.11 and 3.12). This strongly suggests a static, translationally 
positioned nucleosome. 
3.4.3 ExoIll Mapping of Upstream Nucleosome Boundaries. 
In order to map upstream nucleosome boundaries, isolated nucleosome 
isomer populations recovered from a reconstitute on fragment (PvuII) were 
digested with increasing amounts of Exolil. Samples of unreconstituted 
(naked) DNA were also digested, but with lower amounts of Exolil. 
Reactions were stopped after 15 minutes at 20°C and DNA products were 
separated on a 10% denaturing polyacrylamide gel. The length of each 
labelled DNA fragment corresponds to the distance in base pairs of each 
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Figure 3.10 Nucleosome Positioning Stability under ExollI Conditions. 
Nucleosome positions on uniformly labelled WT nAB were analysed under 
Exonuclease Ill conditions to demonstrate nucleosome positioning isomers 
are not affected by treatment with Exoill. Lane 1 shows an unfractionated 
reconstitute in TEP 10 , maintained at +4°C. Under these conditions 
nucleosome positions remain stable. Lane 2 is the same reconstitute 
incubated in Exolli buffer in TEP 1 0 at 20°C for 15 minutes. Lanes 3, 6 and 9 
are untreated nucleosome positions NI, N2 and N3 respectively in TEP 10 . 
Lanes 4, 7 and 10 have been digested with 200 units/ml and lanes 5, 8 and 
11 with 800 units/ml Exoill. 
Exolli pause site from the labelled end, which is located at —64bp from the 
transcription start site (Figure 3.13). 
The Exoill map of nucleosome positions derived from Ni, N2 and N3 from 
(PvuII) is shown in Figure 3.11. Analysis of the band sizes was carried out by 
reference to lObp markers (Invitrogen). 
The ExollI digest of Ni shows bands of 238, 227 and 220 nucleotides (nt), but 
these are also clearly present in the naked DNA digests and thus are likely to 
be DNA sequence specific pause sites. The next major Ni specific pause site 
produces a fragment of 208 nt. This band marks the beginning of a group of 
pause sites, spaced with a i0nt periodicity, at 208, 198, 188nt etc. This pattern 
is characteristic of Exoill cutting of DNA associated with a nucleosome (Riley 
and Weintraub, 1978; Kefalas et al., 1988), indicating that the 208nt band 
marks the boundary of the Ni position. The upstream boundary of the Ni 
position is therefore 208nt from the RsaI end of the fragment; i.e. at —272 bp 
from the transcription start site (Figure 3.13). The Ni upstream nucleosome 
boundary and pause sites, with respect to the transcription start site, are 
marked in red in Figure 3.11. The fourth band in the iOnt pattern appears to 
reflect a slightly stronger pause site, this may reflect a structural feature of 
this nucleosome. 
The Exolil digest pattern of N2 is not as straightforward as that of Ni (Figure 
3.11). The same DNA sequence specific pause sites are seen as in Ni, plus 
there are pause sites that give rise to prominent fragments of 200 and 190bp. 
These sites are present at only very low Exoill concentrations. The same 
pause sites are seen in the naked DNA digest but here they are not nearly as 
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Figure 3.11 (PvulI) Exonucleaselli Protection Mapping. 
Isolated nucleosome positioning isomers Ni, N2 and N3 on (PvuIl) were 
digested with 200, 800 and 3000 u/mI Exolil and the corresponding control 
DNA digested with 0, 50, 100 and 400 u/mI ExollI. Products were separated 
on 10% denaturing gels. Marker sizes in nt are marked in black. Features of 
the Ni nucleosome are marked in dark red; numbers refer to positions on the 
gene in base pairs from the transcription start site. An arrow on the left side 
marks the boundary of NI at -272, and dashed lines on the left show the 
1 Obp periodicity of digestion that is characteristic of a positioned nucleosome. 
Features of the N2 nucleosome are marked in dark blue on the right hand 
side of the gel. Again numbers refer to base pairs from the transcription start 
site. The arrow on the right marks the boundary of N2 at —242. The thick 
black line marks a strong nucleosome specific cut site, not associated with 
the N2 nucleosome boundary. Dashed lines on the right mark the internal 
lObp pattern. There is a potential N3 specific pause site at 228nt which 
corresponds to a position on the gene of —292, this is marked by a grey 
arrow. mis a lObp ladder. Figure 3.11 is on the following page. 
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Figure 3.11 (Pvull) Exonucleaselli Protection Mapping. 
strong. These DNA-specific Exolli pause sites may be strengthened by 
interactions of DNA external to the nucleosome core with the nucleosome 
surface. The first non sequence-specific pause site present at the higher 
enzyme concentrations produces a band of 177bp. This site again marks the 
beginning of a lObp pattern, which extends for 30bp into the nucleosome to a 
second strong pause site in a similar pattern to the Ni digest. The upstream 
boundary of N2 is therefore 177nt from the RsaI end of the fragment i.e. at 
.-242nt from start (Figure 3.13). The upstream nucleosome boundary and 
pause sites, referenced to the transcription start in N2 are marked in blue in 
Figure 3.11. 
A digest of N3 is also included in this gel, but no non-sequence-specific 
bands were observed in this analysis. The amount of signal in N3 is much 
less than that in Ni or N2, nevertheless an Exolil pause site at 228nt is 
detected (marked by a grey arrow in Figure 3.11). This band is also detected 
in naked DNA digests and in Ni and N2 digests, but in N3 is much stronger 
when compared to the total signal present. It is possible that this represents 
a N3 nucleosome boundary that happens to coincide with a DNA specific 
pause site thus placing the upstream boundary of N3 at -292bp from the 
transcription start site. 
3.4.4 ExoliP Mapping of Downstream Nucleosome Boundaries. 
The downstream ends of the nucleosome positions Ni and N2 were mapped 
on the upper strand from a reconstitution onto (RsaI) (Figure 3.12). Digests 
of NX and N4 were also carried out but no pause sites were detected (data 
not shown). 
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Figure 3.12 RsaI Exonucleaselli Protection Mapping. 
Isolated nucleosome positioning isomers NI and N3 were digested with 200, 
800 and 3000 u/mI Exoill and the corresponding control DNA digested with 
50, 100 and 400 u/mI Exolll. The lane beside the marker at the right hand 
side is undigested DNA. Products were separated on 10% denaturing 
polyacrylamide gels. Marker sizes in nt are marked in black. Features of the 
NI nucleosome are marked in dark red; numbers refer to position on the 
gene in base pairs from the transcription start site. An arrow on the left side 
marks the boundary of NI at —123, and dashed lines on the left show the 
lObp periodic digestion characteristic of a positioned nucleosome. Features 
of the N2 nucleosome are marked in dark blue on the right hand side of the 
gel. Again numbers refer to base pairs from the transcription start site. The 
dashed line on the right hand side marks the predicted boundary of N2 at 
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Figure 3.12 (RsaI) Exonucleaselil Protection Mapping. 
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The Exoill digest of Ni has strong nucleosome specific bands of 199, 189, 
179and 169nt. Again these follow a lObp pair periodicity from a strong 
pause site at 199nt; the boundary of nucleosome position Ni is therefore 
199nt from the upstream labelled end (-322) mapping the downstream 
boundary of Ni to -123bp from start (Figure 3.13). 
The Exoill digest of N2 displays a very similar pattern to that of Ni. A close 
look at the separation of the isolated positioning isomers from the 
reconstitute on (RsaI) (Figure 3.8) shows that the major band in both the Ni 
and N2 isolates migrates at the same rate and is probably the same band. 
There is a weaker band in the N2 analysis that migrates at the level predicted 
for, and probably is, the actual N2 position. Assuming a nucleosome 
protects the accepted 146bp of DNA, the predicted downstream boundary 
would be at -93 and should show up in Figure 3.12 as a band of 229nt. This 
point is marked in Figure 3.12 beside the N2 digest. There is a sequence 
specific pause site at this position which may conceal an N2 specific band. 
The signal in the N2 band is weak compared to the Ni band in the (RsaI) 
reconstitute (Figure 3.8 compare lanes 8 and 9). 
3.4.5 Exonuclease III Mapped Nucleosome Positions. 
The Ni nucleosome position isomer has been mapped at both the upstream 
and the downstream boundaries, resulting in a protected DNA length of 
149bp. Previous Exoill digests have shown between 143 and 147bp DNA 
protected by a nucleosome (Linxweiler and Horz, 1985; Kefalas et al., 1988). 
Although the figure of 149bp is slightly larger, it is still in agreement with 
these values. Interactions between non-nucleosomal DNA and the histone 
core, could account for the additional protected DNA. There is a run of 4 G 
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Figure 3.13 Nucleosome Positions Mapped by Exonucleaseill Digestion. 
Data from the ExolIl upstream and downstream mapping experiments are 
summarised. The fragment used is detailed in A with the ends marked with 
respect to the transcription start site of BLG. The fragment length detected in 
Figures 3.11 and 3.12 is marked in nt. The two ends of NI (in red) have 
been mapped resulting in a nucleosome position covering 149bp of DNA (B). 
Position N2 (in blue) has only been mapped at one end. However the dyad 
can still be calculated from this, assuming a nucleosome covers 146bp of 
DNA. This positions the dyad at —169bp (C). N3 has been mapped at the 
upstream boundary, resulting in a nucleosome positioned at —219. 
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nt external to the downstream boundary of Ni and may be sufficient to cause 
the Exoill to pause outside the core. A strong DNA sequence specific pause 
site corresponding to this run can be detected in Figure 3.12 migrating just 
above the 200nt marker. Assuming that each end is digested equally 
towards the nucleosome boundary, the centre or dyad of the nucleosome 
position Ni lies at —198bp from transcription start (Figure 3.13). 
The nucleosome positions calculated by Exolli digestion are summarised in 
Figure 3.13. Position Ni has been mapped at both boundaries and lies with 
its dyad at —198bp from the transcription start site. Nucleosome position N2 
has been mapped at only the upstream boundary. If one assumes that the 
core DNA is 146 bp, the mapped upstream end would position the dyad at 
—169bp. By the same argument, N3 would position at —219bp. 
The upstream boundary of N2 displays a tendency indicative of non core 
DNA associating with the nucleosome, as reflected by weak pause sites that 
are not strong enough to represent a nucleosome boundary (Figure 3.11). 
These interactions cover 20-30bp of DNA upstream of the nucleosome. This 
DNA separates the N2 nucleosome at —169bp from the Ni nucleosome at 
—198bp and may represent a link between the Ni and the N2 positions. A 
corresponding sequence with weak affinity for a nucleosome could exist at 
the downstream end of N2, explaining the lack of detection of a clear 
boundary here. 
Exonuclease III mapping has produced positions for Ni, N2 and N3. 
Mapping with a second technique should be able to reinforce these results. 
Currently either or both of Ni and N2 could be interpreted as the strong 
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positioned nucleosome A, mapped by monomer extension (Boa, 1999; 
Gencheva and Allan, 2005), as its position at -183 lies almost exactly between 
-169 and -198. 
3.5 Micrococcal Nuclease and Restriction Digest Mapping. 
Micrococcal nuclease (MNase) is a useful tool for the study of chromatin 
structure, as well as in the preparation of bulk chromatin. Reconstituted 
nucleosome positions were mapped by the method previously described 
(Meersseman et al., 1991; Yenidunya et al., 1994). 
In this approach core DNA is prepared from a reconstitute by MNase 
digestion. DNA protected by a nucleosome is not readily digested by MNase 
(Noll and Kornberg, 1977; Horz and Altenburger, 1981; Alexander et al., 
1961). This core DNA is digested with unique-cutting restriction enzymes, 
the unique pair of bands produced for each core particle isomer allows 
calculation of the position of the nucleosome boundaries with respect to the 
restriction site. Two unique restriction sites are required to absolutely map 
each core DNA with respect to its position on the gene. 
3.5.1 Production of Core Particle DNA. 
Fragment nAB was produced by PCR using primers nAF and nBR (Table 3.1) 
in a reaction including a32P dATP, resulting in a probe labelled uniformly 
throughout its length. 
Optimum conditions for digestion to core particle DNA were obtained for 
each reconstitution reaction by testing a small fraction of each at various time 
points. A typical MNase time course is shown in Figure 3.14. In this instance 
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Figure 3.14 MNase Time Course. 
Reconstituted DNA samples digested on ice for 20 minutes then at 21°C for 
0 (lane 2), 0.5 (lane 3), 1 (lane 4), 2 (lane 5), 3 (lane 6), 4 (lane 7), 5 (lane 8), 
and 6 minutes (lane 9). Undigested DNA is run in lane 1. 
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DNA was first digested on ice for 20 minutes. This was followed by 
digestion at room temperature (21°C) for 0, 0.5, 1, 2, 3, 4, 5 and 6 minutes. At 
this latter temperature MNase is able to trim to the core particle boundary by 
virtue of its exonuclease activity. The time point of 2 minutes digestion at 
room temperature was chosen for the large-scale core particle preparation 
(Figure 3.14, lane 5). Digestion for longer periods of time resulted in MNase 
beginning to invade into the nucleosome and loss of the protected core DNA. 
A mixture of nucleosome positions from a whole reconstitution reaction, 
rather than isolated individual positions was used in this experiment to 
maximise the available signal from weak nucleosome positions. The core 
DNA produced was 146bp when run on a denaturing gel (Figure 3.15 lane 1), 
and was mostly composed of a discrete fragment of this size. Thus the 
majority of bands produced by the restriction digests are products of 146bp 
core DNA. 
3.5.2 Nucleosome Mapping by Restriction Digestion of Core DNA 
Four unique-cutting restriction enzymes, spaced evenly along the probe, 
were chosen to be able to differentiate between the positions of Ni and N2, 
previously mapped by Exolli (Figure 3.13). In Figure 3.1513 it is seen that 
Avail should not cut core DNA protected by N2, and Smal should not cut 
core DNA from Ni. A test digest with each enzyme to be used, Avail, AccL 
Styl and Snial on the full-length (240bp) nAB fragment, showed the products 
separated on a denaturing gel gave up to 4 bands (Figure 3.15A). This is due 
to the fact that, apart from SrnaI, these enzymes do not leave blunt ends after 
cleavage. Avail, AccI, and StyI leave 3, 2 and 4nt, 5' overhangs respectively. 
The four bands are a result of the double stranded (ds) DNA being cut in 
two; each ds product runs as two separately labelled single strands on the 
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Figure 3.15 Restriction Test Digests. 
A. Restriction digest of the full-length fragment nAB separated on a 10% 
denaturing polyacrylamide gel. Two bands for each digest product can 
clearly be seen. m, markers were 1 k ladder from fermentas; U, undigested; 
Av, Avail; Ac, Accl; St, Sty! ; Sm, Smal. B Location of restriction sequences 
on nAB, with a schematic diagram depicting NI and N2 as mapped by Exoll. 
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denaturing gel. These products are slightly different sizes due to the 
overhangs produced by the restriction enzymes. This could have been 
eliminated by end labelling. This technique was not used in this instance as 
MNase digestion would remove the signal, an alternative could have been to 
label purified core DNA. 
Core particle DNA was digested with each restriction enzyme separately, 
and the products separated on a denaturing polyacrylamide gel (Figure 3.16). 
Although the band patterns formed are complex, the following examination 
indicates that patterns do emerge. 
The Smal digestion pattern (Figure 3.16, lane 5) is the simplest to interpret, 
containing no extra bands from overhangs to take into account. The location 
of Smal towards the end of the fragment (Figure 3.15) also means it does not 
cut in every nucleosome isomer and consequently there is a significant 
amount of non-digested DNA at 146bp in the Smal lane. The Smal digest 
produces a very strong band of 134nt. The Smal cleavage site itself is only 
50nt from the downstream end of the full-length probe (Figure 3.16B), so this 
band must indicate a core particle boundary 134nt upstream from the Smal 
site, i.e. at -257bp from the transcription start site. The corresponding 12nt 
fragment from Smal to the downstream boundary at -111 is not resolved on 
this gel. These boundaries correspond to a positioned nucleosome with a 
dyad at -184bp. This position equates to the original in vitro mapped 
position at -183bp (Boa, 1999), and lies between the Exolil mapped Ni 
position at -198 and N2 at -169. Bands in the AccI and StyI digests were also 
identified that correspond to a nucleosome at this position and are marked 
by red dots on the gel in Figure 3.16 and are listed in Table 3.2. The enzyme 
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Figure 3.16. Restriction Enzyme Digest of Core DNA. 
A. Products of restriction enzyme digestion of core DNA were separated on 
a 10% denaturing polyacrylamide gel. Lane 2 contains core protected DNA 
from an unfractionated reconstitute on nAB. The same DNA was digested 
with unique cutting restriction enzymes, Avail (lane 3), Accl (lane 4), Styl 
(lane 5) and Smal (lane 6). Pairs of bands corresponding to each 
nucleosome position are colour coded as described in the key. Markers are 
lObp ladder, band sizes in nt, calculated from the marker size are written in 
grey in order to be able to distinguish these from the position on the gene. 
Positions of the restriction enzyme sites on nAB are shown in B. Pairs of 
bands adding to 146bp, the length of the core protected DNA, have been 
identified (Table 3.1) and this data used to calculate nucleosome positions. 
The methodology used for calculation of the position of the nucleosome at 
—184 is displayed in B and for the —225 nucieosome position in C. 
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-184 N/A 44+102 88+58 134+12 
-213 30+ 116 73+73 117+29 N/A 
-225 42+104 85+61 129+17 N/A 
-234 95+51 94+52 138+8 N/A 
-176 N/A 36+110 80+66 126+20 
-169 N/A 29+117 73+73 119+27 
Full length 56+184 99+141 143+97 189+54 
Table 3.2 Pairs of Bands from the Restriction Digest of Core Protected 
DNA. 
Calculated nucleosome positions are colour coded to match Figure 3.16. 
Pairs of digest products observed for each enzyme are listed under the 
relevant enzyme. Where there is more than one pair of bands due to 
overhangs from restriction enzymes the pair from the sense strand adding to 
146nt is shown. N/A applies to nucleosome positions that are not cleaved by 
a particular restriction enzyme. 
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Avail does not cut in the core produced by this nucleosome, as a result there 
is a strong band at 146bp in the Avail lane indicating uncut core DNA. 
Other nucleosome positions were similarly identified by allocation of pairs of 
bands adding up to 146bp. Potential positions were calculated using one 
restriction enzyme and then cross referenced with a second and third to 
work out an unambiguous position. An example is shown in Figure 3.16C. 
The position of the nucleosome at -225 (marked by yellow dots in Figure 
3.16) was calculated initially from bands of 85 and 61nt in the AccI digest 
(Figure 3.16A, lane 3). The AccI data indicated either a nucleosome with 
boundaries at -274 and -128 (dyad at -201) or with boundaries at -298 and 
-152 (dyad at -225). StyI (lane 4) digestion of a nucleosome at -201 should 
yield fragmentsof 105 and 41 nt. There is no evidence for these fragments in 
the gel. StyI digestion of a nucleosome at -225 should yield fragments of 129 
and 17nt. A fragment of 129nt is detected, indicating that the -225bp 
nucleosome is probably a correct position (Figure 3.16C). The corresponding 
lThp fragment is not resolved on this gel. Avail (lane 2) digest products of 42 
and 104bp further confirm this (Table 3.2). The other nucleosome positions 
were assigned in a similar manner. All bands allocated to specific 
nucleosomes are marked by colour co-ordinated circles, and band sizes are 
recorded in Table 3.2. 
Bands resulting from restriction digest of full length DNA were also assigned 
to products. Fragments of predicted sizes (recorded in Table 3.2) were 
discovered in all digests, these are marked as open circles in Figure 3.16. 
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3.6 Summary of Nucleosome Positions. 
From the MNase / restriction mapping, nucleosomes positions were 
identified at -234, -225, -213, -184, -176 and -169bp from the transcription 
start site and by Exoill digestion at -219, -198 and -169bp from the 
transcription start site. The Exoill mapped nucleosomes can be linked to the 
isolated position isomer they were mapped from. Positions from restriction 
mapping must be linked to their corresponding isolated position isomer on 
the basis of the Exolli positions or their predicted migration through a gel. 
The strongest MNase / restriction mapped position at -184bp may 
correspond to the Ni Exolli position at -198bp, as this is the strongest 
binding position in both, although these positions are 14bp apart. 
The restriction mapped nucleosome position located at -169 mirrors the 
position for N2 derived from Exolli analysis. The restriction mapped 
position located at -176 is also close to this figure and these may represent 
two closely positioned nucleosome binding sites in N2. These two 
nucleosome positions are likely to be represented in the in vitro map by the 
nucleosome A peak at -184 (and shoulder positions within this Figure 3.2). 
The N3 nucleosome position isomer mapped by Exolli lies at -219. The 
nucleosome positions mapped by restriction digests at -234, -225 and at -213 
are therefore also likely to correspond to N3. These positions locate close to 
the upstream DNA end and thus are predicted to migrate as N3. The N3 
nucleosome positions are represented in the in vitro map (Figure 3.2) by 
nucleosome B at -224, which is close to the MNase mapped position at -225. 
The main in vitro peak is flanked by two shoulders, which may represent 
alternative nucleosome position isomers, these appear to be spaced lObp 
apart and could correspong to the MNase positions at -234 and -213bp. 
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3.6.1 Positioned Nucleosomes: Relevance to Stat5 Binding Sites. 
Any of the positions mapped for Ni and N2 place the two outer Stat5 
binding sites external to the nucleosome core (Figure 3.17) thus these both 
correspond to nucleosome position A. The nucleosomes at -213, -219, -225 
and -234bp are likely to migrate as the isolated isomer N3. All of these 
positions place only one Stat5 binding site outside of the core DNA, therefore 
these positions correspond to nucleosome B. Some of the nucleosome 
positions place the Stat5 binding sites very close to the nucleosome 
boundary. The Al binding site (Figure 3.17) is located between -279 and - 
271bp from transcription start. The upstream boundary of the nucleosome at 
-198 is at -272. This places the Al Stat5 binding site right on the boundary of 
this nucleosome position. The strong nucleosome at -184 places 14bp 
between the Al binding site and its boundary. 
At the downstream end of nAB, the StM Stat5 binding site (Figure 3.17) lies 
between -94 and -86bp from the transcription start site. The downstream 
boundary of the nucleosome at -169 is located -96 bp from the transcription 
start site. This is two bp away from the StM Stat5 recognition sequence. The 
strong nucleosome position at -184 places lThp between its boundary and 
the StM binding site. 
3.6.2 Discrepancies Between MNase and Exolil Maps. 
The in vitro mapped position at -183 was mapped using MNase digestion, 
this position corresponds closely with the -184 position which was mapped 
by MNase and restriction digest mapping in this study, but is out by 15 bp 
from the Ni position mapped by Exoill. It is unclear whether this difference 
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Figure 3.17 Summary of Mapped Nucleosome Positions. 
The original in vitro mapped positions (A and B) are shown at the top, 
numbers indicate the dyad axis of the nucleosome core with respect to the 
transcription start site. Each nucleosome core is predicted to cover 146bp of 
DNA. Ni positions are indicated by red borders, and N2 by blue borders. N3 
positions are coloured to match their corresponding bands in the MNase 
map. Exoill maps positions Ni at —198 and N2 at-169. Restriction digest 
mapping maps Ni at —185 and N2 at —1761-169. N3 positions are —234, -225 
and —213 bp from transcription start. Red circles mark positions of Stat5 
binding sites on the promoter. 
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can be accounted for by the different mechanisms of the two enzymes, both 
regards the DNA sequence specificity and method of DNA attack. 
Nucleosome positions on the beta globin gene have been mapped by both 
these methods (Kefalas et al., 1988; Yenidunya et al., 1994). The beta globin 
maps display a 3-4bp discrepancy between the positions mapped by MNase 
and Exoill. Nucleosome positions over the Saccharomyces cerevisiae 5S rRNA 
gene have also been mapped using Exoill, core restriction digests and 
DNaseI mapping. Nucleosome boundaries mapped by Exolli and core 
restriction varied by up to 8nt (Buttinelli et al., 1993). Sequence specificity 
may be partially responsible for this, MNase cuts preferentially at A and T 
residues flanked by a G or a C residue (Cuatrecasas et al., 1967; Horz and 
Altenburger, 1981) while Exolil has a tendency to pause at G residues 
(Linxweiler and Horz, 1982). 
The sequence of the proximal region of the BLG promoter shows several 
strings of two, three and even up to five G or C nucleotides. Most of the 
strong Exolil pause sites in the naked DNA lanes can be matched to runs of 
Gs. The (RsaI) N2 band corresponds to a run of three G residues in the DNA. 
However there is not a detectable lObp pattern following on from this point 
distinguishable from the contaminating Ni pattern. The N3 nucleosome at 
—292 mapped on (PvuII) coincides with a run of Cs. Exoill on (PvuII) maps 
the lower strand, where these Cs will be Gs. A sequence specific pause site is 
observed for this run of Cs. None of the other nucleosome boundaries 
correspond to a run of Gs on the digested strand indicating that all pause 
sites observed are due to positioned nucleosomes. 
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The two positions mapped at nucleosome A by ExoIll (-198 and —169) are 
spaced outside the MNase positions (-184 and —176). This may be significant 
taken together with the fact that the Exolil map of Ni covers slightly more 
DNA than the accepted 146bp. The sequence is GC rich (63% GC) which 
may affect the MNase digestion as this enzyme prefers to cut at AT, although 
the nucleosome core DNA produced was 146bp indicating that MNase 
digests right down to the nucleosome boundary. 
Taken together these data provide a reliable estimate of the actual positions 
nucleosomes sit on these fragments and demonstrate that Ni and N2 locate 
two Stat5 binding sites in linker DNA, and N3 locates only one Stat5 binding 
site in linker DNA (Figure 3.17). 
In summary, subtle sequence dependent effects within the 3-lactoglobulin 
promoter result in two clusters of preferred nucleosome positions. One 
positioned between A3 and StM Stat5 binding sites leaving both these sites 
within the nucleosome linker region. The second position places one of these 
binding sites within a nucleosome. This arrangement may be significant in 
the transcriptional activity of the gene. 
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4 ANALYSIS OF STAT5 BINDING TO THE BLG PROMOTER. 
The minimum 5' flanking region of the BLG promoter required for maximal 
expression is 406bp (Whitelaw et al., 1992). This is termed the proximal 
promoter. Further dissection of the promoter revealed three binding sites for 
a mammary specific factor, MPBF (Watson et al., 1991), which was later 
shown to be a member of the Stat family of transcription factors and is now 
known as Stat5 (Burdon et al., 1994a; Wakao et al., 1994). These binding sites 
are named Al, A3 and StM and lie at —278, —210 and —93bp from the 
transcription start site respectively. Of these, the proximal site (StM) has the 
greatest affinity for Stat5. StM contains the full consensus sequence for Stat5 
binding 1TC(N)3GAA whereas Al and A3 both have single nucleotide 
changes from the consensus (Figure 4.1). A conserved binding site for Stat5 
is present in the region around —90 bp from the transcription start site of the 
promoter of many milk protein genes, mutation of which abolished the 
hormone responsiveness of the promoters (Schmitt-Ney et al., 1992; Burdon 
et al., 1994b; Soulier et al., 1999; Schmitt-Ney et al., 1991; Demmer et al., 
1995). The proximal promoter has also been shown to be responsible for the 
tissue specific expression of many milk protein genes (Lee et al., 1989; 
Whitelaw et al., 1992). 
4.1 Stat5 Bandshifts. 
The binding of Stat5 to these and similar sequences has been previously 
studied using the electrophoretic mobility shift assay (EMSA, or bandshift 
assay) (Watson et al., 1991; Schmitt-Ney et al., 1991; Burdon et al., 1994a; 
Burdon et al., 1994b; Soldaini et al., 2000). Recent work on the chromatin 
structure of the BLG promoter in vivo (Boa, 1999) has shown different 
nucleosome positions in tissues where BLG is active and inactive, which may 
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influence the ability of Stat5 to bind to the promoter (Chapter 3.1.1). This has 
led to our renewed interest in Stat5 binding to the BLG promoter. 
In order to study further the interactions of Stat5 with the BLG promoter, 
bandshifts of oligonucleotides encompassing individual Stat5 binding sites 
from the BLG promoter by Stat5 from a mammary nuclear extract have been 
reproduced. The same bandshift interactions were also carried out on a 
larger fragment of the BLG promoter, nAB, which contains all three Stat5 
binding sites see (3.2.1). Even though only one of the Stat5 binding sites on 
nAB fully obeys the recognised consensus, all three binding sites should be 
able to associate with Stat5. The binding of purified recombinant Stat5 
(rStat5) to these probes is also studied in this chapter. Use of rStat5 facilitates 
comparison of the two forms of Stat5, Stat5A and Stat5B, and also the effects 
of the tetramerisation mutant W37A. 
4.2 Stat5 Binding Sites Produce a Shift in Mammary Nuclear Extracts. 
Previous bandshifts with Stat5 on the BLG and other milk protein promoters 
have used short oligonucleotide probes specific to individual binding sites 
with protein from nuclear extracts made from lactating mammary gland. 
These experiments were repeated to characterise the behaviour of Stat5 in the 
bandshift system described (2.8.3) before moving on to bandshifts with the 
longer probe nAB. 
4.2.1 Nuclear Extract Bandshifts using Oligonucleotide Probes. 
Oligonucleotide probes of the proximal Stat5 binding sites, StM and asl 
produce a specific shift in reactions with mouse, rabbit and ovine mammary 
gland nuclear extracts (Figure 4.2) and (Burdon et al., 1994a; Watson et al., 
1991; Jolivet et al., 1996; Wakao et al., 1992; Pierre et al., 1994). Sequences 
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causing this shift pattern have been shown to be prolactin responsive in CHO 
and COS 7 cell lines (both with co-transfection of prolactin receptor) and in 
the mouse mammary cell line HC11 (Wakao et al., 1994; Soulier et al., 1999; 
Schmitt-Ney et al., 1991; Demmer et al., 1995; Burdon et al., 1994a; Burdon et 
al., 1994b). The presence of the proximal binding sites, specifically StM, is 
required for the prolactin responsiveness of the BLG promoter (Burdon et al., 
1994a; Burdon et al., 1994b; Demmer et al., 1995). 
Complimentary oligonucleotide pairs for Stat5 binding sites were designed 
for use in bandshift experiments. Stat5 binding sequences used are: StM, Al 
and A3 from the BLG promoter and asl, the proximal StatS binding site of 
the rabbit aSl-casein promoter; another strong Stat5 binding sequence, the 
affinity of which has been well characterised in bandshift experiments (Pierre 
et al., 1994). Point mutations designed to disrupt the consensus and 
predicted to prevent Stat5 binding were introduced to produce a second set 
(StMm, Aim, A3m). Sequences of the oligonucleotide probes that were used 
in bandshifts are shown in Figure 4.1. 
Bandshift reactions with these oligonucleotide probes show two bands, of 
which the faster migrating (marked by the solid arrow) is stronger (Figure 
4.2.). A similar pattern can be seen in many of the published Stat5-nuclear 
extract bandshifts (Meyer et al., 1997; Burdon et al., 1994a; Watson et al., 
1991; Soldaini et al., 2000; Millot et al., 2001) and has been explained by the 
binding of multiple Stat5 dimers as a dimer-dimer complex, referred to as 
tetramerisation. This interaction usually involves cooperative binding to two 
weak Stat5 binding sites by interactions of the N-terminus of Stat proteins, 
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StM 	 GGGATTCCGGGAACCGCGTG 
StMm 	CAAGT GGGATCCCGGGATCCGCGTGGCTG 
Al 	 GAAGTGTTCCTGGCACTGGCAGCC 
Aim GACCCCGGAAGTGTACCTGGCACTGGCAG 
A3 	 GGGGTCTACCAGGAACCGTcTAGGC 
A3m CTTCTGGGGTCTACCATGGTACCGTCTAGGCCC 
asi 	 GAGAATTCTTAGAATTTAAA 
Figure 4.1 Sequences of Oligonucleotide Probes used in Bandshift 
Reactions. 
Stat5 consensus binding sites are highlighted in bold and the mutations 
introduced to disrupt the consensus are underlined. The sense strand is 
shown here, the antisense is the exact reverse compliment. Each mutation is 
designed to introduce a restriction enzyme site as well as to destroy the Stat5 
binding site. StMm contains both a Smal (CCCGGG) and a BamHl 
(GGATCC) site. Aim contains a Rsal (GTAC) site and A3m both an Ncol 
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Figure 4.2 Bandshift Reactions with Oligonucleotide Probe. 
A. Bandshifts with the asi oligonucleotide probe and nuclear extracts from 
rabbit liver, lactating rabbit mammary gland or mid lactating mouse mammary 
gland as indicated. Two bands are consistently seen with mammary but not 
with liver nuclear extracts, the faster migrating of which is the stronger. 
There is also a non-specific band marked by * The same pattern is seen in 
Stat5 bandshifts with the StM probe in B. Cold competitor studies were 
carried out with the three Stat5 binding sites from the BLG promoter at 
indicated molar excesses. All are bandshifts with the StM oligonucleotide 
probe and mouse mammary nuclear extracts. Competition of Stat5 binding 
to StM with mutated binding sites and with the long probe nAB is studied in 
C. This demonstrates that the mutant probes do not bind Stat5. Lanes with 
no competitor are marked by a dash. Arrows mark shifted bands, as 
described in the key. The two halves of part C are from different gels, a non 
competed lane is included for each. 
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but can also occur on single Stat5 binding sites (Soldaini et al., 2000; Meyer et 
al., 1997). Tetramerisation can be blocked by mutation of tryptophan 37 to 
alanine (W37A). Both shifted oligonucleotide bands observed are competed 
equally by cold competitor. The secondary band could also be due to either 
other factors binding or differently phosphorylated forms of Stat5. This 
could also explain the differences in intensity of the secondary band in the 
shifts in Figure 4.2. The oligonucleotide probes were purified as double 
stranded so binding to contaminating single stranded probe cannot explain 
the two bands. 
The asi probe is bandshifted by mouse and rabbit lactating mammary gland. 
Liver nuclear extract, which is traditionally used as a negative control for 
BLG expression also displays a weak bandshift activity with this probe 
(Figure 4.2a), the liver shift was also observed by (Burdon et al., 1994b). This 
result is not unexpected as active Stat5 is not confined to the mammary 
gland. It and other Stat species that will also bind to these probes are also 
found in many other tissues. The mammary gland shift is much stronger 
than that seen with liver, both reactions contain an identical amount of 
protein. A third band is also seen with the rabbit mammary, and the liver 
extract. This band is occasionally seen in the published Stat5 nuclear extract 
bandshifts, although no other binding sites are detected in the probe. No 
other shifted bands are observed with the oligonucleotide probes, so parts B 
and C of Figure 4.2 show only the two shifted bands. 
Figures 4.2 B and C show bandshifts of the StM probe from the BLG 
promoter by mid lactating mouse mammary gland nuclear extract. The 
affinity of the various binding sites is tested by cold competitor studies, 
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where a known excess of unlabelled probe is added to the reaction after 
addition of the labelled probe. This technique is commonly used to compare 
the affinity of binding sites for proteins. Addition of a 20-fold molar excess 
of an unlabelled StM oligonucleotide completely competed the binding of 
Stat5 to the labelled probe and no shift is seen. When the cold competitor 
used is Al and A3, although competition is clearly occurring, complete 
competition is not seen even at 200-fold excess (Figure 4.2 B), reflecting the 
different affinity Stat5 has for these compared to the consensus StM or aSi 
binding sites. Competition with a 100 to 200-fold excess of each mutated 
Stat5 binding site (Figure 4.2 C) shows no difference from non-competed, 
demonstrating that the mutations created abolish Stat5 binding. The longer 
probe nAB also completely competes binding of Stat5 to StM at 200-fold 
excess. Lower concentrations of competitor were not tested. 
4.2.2 Nuclear Extract Bandshifts using 240bp nAB Fragment. 
Bandshift experiments with the same nuclear extract were repeated using the 
larger fragment of the promoter, nAB, which has been shown to bind to Stat5 
by cold competitor studies (section 4.2.1). This probe contains three binding 
sites for Stat5, so may associate directly with up to three Stat5 dimers. 
Bandshifts with this probe and the same nuclear extracts used in 
oligonucleotide bandshifts show a smear between the free probe and the top 
of the gel rather than the individual discrete bands that are seen with the 
oligonucleotide probe (compare Figures 4.2A, and 4.3). This smear pattern is 
most likely due to the binding of multiple factors to the longer probe. There 
are consensus binding sites present for many transcription factors in the 
sequence of nAB including: NF-1, SP1, NF-kappaB, GR, YY1 and C/EBP 
alpha (Figure 1.8). There is no reproducible difference detected between the 




Figure 4.3 Nuclear Extract Bandshifts of nAB. 
5tg nuclear extract from indicated sources was incubated with 5' end 
labelled nAB at room temperature and separated on a 5% polyacrylamide gel 
in TBE. An arrow at the bottom left indicates the free probe. The three 
nuclear extracts marked by * below the probe are the same as those used in 
Figure 4.2 A. 
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liver extracts that can be attributed to Stat5. For these reasons, Stat5 from a 
nuclear extract source will not be suitable for further studies on the 
interactions of Stat5 with the nAB probe and an alternative source must be 
found 
4.3 Production of Recombinant Stat5. 
To study further Stat5 binding to the BLG promoter, it is essential to be able 
to produce clear reproducible bandshifts using the nAB probe. The most 
straightforward method to eliminate binding of other transcription factors is 
to use purified Stat5. Previous attempts to purify Stat5 from tissue have 
produced an amount just greater than 0.01mg with a specific activity of 
3,000,000u/mg (one unit being defined as the amount which causes the 
retardation of lfmol labelled DNA probe in a bandshift assay,) from 800g of 
rat lactating mammary gland (Wakao et al., 1992); or less than 0.01mg (with a 
specific activity of >15,000,000 units per mg,) from 6kg of ovine lactating 
mammary tissue (Wakao et al., 1994). These purifications involved multiple 
stages of separation using Bio rex 70, DNA-sepharose and a specific DNA 
affinity column. 
Other groups have used a baculovirus expression system (BEVS), to produce 
recombinant Stat proteins, including Stat5 containing a 6-His tag engineered 
into the N-terminus for ease of purification (John et al., 1999). Use of 
recombinant Stat5 also allows the introduction of mutations into the StatS 
molecule, such as the tetramerisation mutant W37A, and separate analysis of 
the two forms of Stat5, Stat5a and Stat5b. 
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4.3.1 Baculovirus Expression System. 
Bandshifts have previously been carried out using Stat5 produced in a 
baculovirus expression system (BEVS), so this approach was also chosen to 
produce recombinant Stat5 for use in these studies. Use of the BEVS has 
many advantages over other methods of producing recombinant protein. 
Proteins produced by over-expression in bacterial systems are often not 
correctly folded or post-translationally modified. Insect cells however 
process and modify proteins in a similar manner to mammalian cells (Smith 
et al., 1983; Miyamoto et al., 1985). It has been reported that Stat proteins 
produced in the BEVS are phosphorylated on the conserved tyrosine that is 
normally only modified in vivo in the activated form of Stat (section 4.3.6 and 
(Soldaini et al., 2000; John et al., 1999)). Phosphorylation on this tyrosine is 
essential for Stat DNA binding activity. This phenomenon eliminates the 
need to activate Stat5 in vitro before it will bind DNA in a bandshift reaction. 
A recombinant Stat5 baculovirus was produced by cloning Stat5 into an 
altered virus genome under the control of the polyhedrin promoter. The 
polyhedrin promoter in a wild type virus would normally drive expression 
of polyhedrin, the viral coat protein, and as such it is a strong promoter 
(Smith et al., 1983; Pennock et al., 1984). High yields of recombinant protein 
are produced under the correct conditions. Typical yields are much higher 
than expression in a mammalian culture system could produce, and are 
capable of being greater than 50% of total cell protein (Miyamoto et al., 1985; 
Maeda et al., 1985). Host protein synthesis is shut down during infection so 
most of the cell's resources are directed towards the production of viral 
proteins. 
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4.3.2 Cloning Stat5 into pFastBac Vectors. 
Human Stat5 was cloned into a baculovirus expression vector using the Bac-
to-Bac kit from Invitrogen. Stat5a (pHuStat5a-6HisBacPAK8), Stat5b 
(pHuStat5b-6HisVL1392), Stat5aW37A (pCi-Stat5aW37A) and Stat5bW37A 
(pCi-Stat5bW37A) DNA sequences were a gift from W J Leonard. pFastBacl 
and pFastBacHl vectors are from Invitrogen. Wild type Stat5a and 5b were 
cloned into pFastBacl, and Stat5aW37A and 5bW37A were cloned into 
pFastBacHT as described below. Wild type Stat5a and 5b contain a 6-His tag 
engineered after the third amino acid; this is used to purify the recombinant 
protein. 
Stat5a cDNA (accession number u43185, (Schindler et al., 1995; John et al., 
1999)) was removed from pHuStat5a-6HisBacPAK8 as a Sad - Smal fragment 
and cloned into the Multiple cloning site (MCS) of pFastbacl (that had 
previously been linearised with NcoI, the ends blunted with 14 polymerase, 
then digested with Sad) to produce pFastbaclStat5ax. However this method 
inadvertently introduced a second ATG site between the polyhedrin 
promoter of pFastbacl and the Stat5 transcription start site ATG codon, 
which was not in frame with the protein (Figure 4.4A, the extra ATG is 
shown in grey). In order to correct this, a site directed mutagenesis PCR was 
carried out to introduce a BssHII restriction site between the two ATG start 
codons. This amplified a fragment of 400bp, which includes a unique NdeI 
restriction site internal to the Stat5a gene. There are now two BssHII sites, 
flanking the extra ATG. This PCR product was cloned into pGEM—T 
(Promega) to give pGEM-T5ax. Digestion to completion with BssHII and 
NdeI results in a 330bp fragment, encompassing the correct transcription start 
(Figure 4.4B). A short fragment containing the extra ATG, was discarded. 
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Figure 4.4. Strategy for Removal of the Extra ATG in pFastbaclStat5ax 
Schematic diagram describing the method used to remove the extra ATG 
from pFastbactStat5ax. A. A site directed mutagenesis PCR was carried out 
to insert a BssHll recognition site between the two ATG sites. The product 
was cloned into pGEM-T B. An Ndel/BssHll digest removes a fragment 
containing only the correct ATG and the beginning of the gene. This is 
cloned into the original plasmid opened with Ndel/BssHll to replace the 
sequence containing the incorrect ATG, C. resulting in Stat5 cloned correctly 
into pFastbacl. 
N = Ndel, B = BssHll. 
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been digested with BssI-ITI and NdeI and purified to remove the incorrect 
ATG sequence (pFastbacl5aNB, Figure 4.4C) to produce pFastbaclStat5a. 
The correct sequence was verified by sequencing. 
Stat5b (accession number u47686 (Lin et al., 1996)) was removed from 
pHuStat5b-6HisVL1392 as an EagI / XbaI fragment and cloned into 
pFastbaclopened with NotI / XbaI. The correct insertion was verified by 
restriction enzyme analysis and sequencing. 
The Stat5aW37A and Stat5bW37A DNA sequences do not contain an internal 
6-His tag. In order to purify them they were cloned into a vector, 
pFastbacHT, which is designed to add a 6-His tag to the N terminus of the 
protein. This 6-His tag can be removed by AcTEV protease digestion of a 7 
amino acid recognition site situated between the tag and Stat5. Three vectors 
HTA, HTB and HTC are available, each has the 6-His tag in a different 
reading frame. Stat5aW37A was cloned into pFastbacHTB that had been 
opened with NcoI and NotI. NcoI was chosen as its position at the start of the 
gene brought it as close as possible to the 6-His tag in the pFastHT vector, 
minimising the inserted amino acids at the N terminus to two (after removal 
of the tag). NcoI cuts three times internal to the Stat5a coding sequence so 
Stat5aW37A was cloned into pFastHTB by three separate steps. 
The cloning of Stat5aW37A from pCi-Stat5aW37A into pFastHT is outlined 
in Figure 4.5. The Stat5aW37A gene was digested into three fragments by a 
combination of EcoRI, NcoI and NotI digests (Figure 4.5A and B). EcoRJ was 
used to separate two of the NcoI sites. The first step was to clone the central 
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Figure 4.5 Cloning Stat5W37A into pFastbacHT. 
Schematic diagram of the method used to clone Stat5aW37A into pFastHTB. 
The restriction enzyme sites in pCi—Stat5aW37A are shown in A. Restriction 
digest products of 5aW37A are shown in B (grey boxes indicating fragments 
1 2 and 3). The three cloning stages into pFastHTB are shown in C, D and 
E. Cloning of Stat5bW37A into pFastHT was by a similar method not 
detailed here. 
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part of the gene (fragment 2), from NcoI to EcoRI into pFastHTB to create 
pFastHTB-AW2 (Figure 4.5C). The second step was to clone the most 5' 
125bp of Stat5aW37A (fragment 1) as an NcoI-NcoI fragment into pFastHTB-
AW2 to give pFastHTB-AW12 (Figure 4.51)) this product was verified by 
sequencing, as the insertion was too small to be sure of the correct 
orientation and copy number by restriction analysis. Finally, in the third 
step, the 3' end of the gene (fragment 3) was inserted as an EcoRI to NotI 
fragment into pFastHTB-AW12 to give pFastHTB-AW123 (Figure 
3.5E).Stat5b was cloned into pFastHT by a similar method, but as Stat5b 
contains only two NcoI recognition sites there was one less step. Effectively 
the two cloning steps were as steps one and three from the Stat5a cloning. 
The final products were verified by restriction analysis and sequencing. 
4.3.3 Production of Virus. 
Recombinant baculovirus was produced using the Bac-to-Bac baculovirus 
expression system from Invitrogen. In this system the recombinant viral 
DNA is produced in E.coli DH1OBac cells, rather than in insect cells as with 
the traditional BEVS. It also makes use of blue white screening, which saves 
time and effort and eliminates the need for repeated rounds of virus 
purification to obtain a pure recombinant virus as only the correct 
recombinant DNA is introduced into insect cells. 
The pFastbac vectors contain two Tn7 transposon attachment elements that 
flank the MCS, and a gene encoding resistance to gentamycin. pFastbac 
vectors were transformed into DH1OBac competent cells, which contain a 
baculovirus shuttle vector (bacmid) and a helper vector. The bacmid 
includes a mini-attTn7 target site and a kanamycin resistance gene. The 
helper vector encodes for tetracycline resistance and Tn7 transposase. The 
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transposase inserts the Tn7 target sequence from a pFast vector, including 
any sequences that were cloned into the MCS, into the Tn7 attachment site on 
the bacmid by a transposition reaction. The Stat5 gene, cloned into the MCS 
of pFastBacl, and gentamycin resistance are now found as recombinant virus 
DNA in the bacmid. Insertion of the Tn7 sites disrupts the LacZa gene 
allowing blue white screening for recombinant bacmid DNA. Growth in the 
presence of the three antibiotics, tetracycline, kanamycin and gentamicin also 
selects for colonies that have successfully integrated. To screen for correct 
insertion, minipreps of the high molecular weight DNA were amplified by a 
PCR reaction with M13 primers. These amplify the DNA sequence between 
the Tn7 attachment sights. Primer sequences are: 
M13F GTTTTCCCAGTCACGAC 
M13R CAGGAAACAGCTATGAC 
An empty bacmid results in a product of 300bp, and Stat5a cloned into 
pFastbacl generates a product of 5.5kb. This is in agreement with the 
inserted Stat5a DNA length of 3.2kb plus 2.3kb from the pFastbac vector. 
Figure 4.6 shows a typical experiment. Lane 5 is the 300bp product from an 
empty bacmid vector, and lane 2 is the 2.3kb product from an insertion of an 
empty pFastbacl vector. Lanes 4 and 6 may be an incorrect Stat5 insertion 
and lanes 7 and 8 are the products from a correctly inserted Stat5a 
recombinant baculovirus. 
Approximately ing of each StatS recombinant baculovirus DNA was 
transfected into mid-log SF9 cells using Cellfectin reagent (Invitrogen). After 
72 hours, the cells start to produce virus. The medium was collected and 
clarified before being used to infect fresh mid log cells to amplify the stock. 









Figure 4.6. Products of M13 PCR Reaction. 
Verification of the correct insertion of Stat5 genes into the bacmid was 
carried out by a PCR reaction. Recombinant bacmid DNA preps were 
amplified using M13-Forward and M13-Reverse primers. The PCR on an 
empty bacmid (lane 5) gives a product of 300bp. Lane 2 contains the 
product from an empty pFastbacl insertion and lane 3 from a pFastHTCAT 
control insertion. Stat5a recombinant bacmid DNA reactions are lanes 4 and 
6 to 8. Of these lanes 7 and 8 are the expected size of 5.5kb. Lane 1 is 1 k 
ladder. 
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4.3.4 Virus Titer. 
Virus titers of the P2 virus stocks were calculated in plaque forming units 
(pfu) per ml using the BacPAK Baculovirus Rapid Titer Kit (Clontech). P2 
stocks were typically in the range 0.3 to 3 x10 8 pfu/ml in a volume of 2m1, a 
second amplification step to obtain a larger volume of stock was termed P3. 
Every recombinant baculovirus produced will behave slightly differently as 
regards progression of the infection and maximum production of 
recombinant protein. The multiple of infection (MOl) and time of harvesting 
employed can be varied to maximise the yield. Previous studies expressing 
Stat proteins in a baculovirus system (Schindler et al., 1995; John et al., 1999) 
have used MOIs of 5 pfu per cell and harvested cells at between 66 and 72 
hours post infection. This was taken as a starting point in the determination 
of the optimal conditions for production of Stat5 in this baculovirus 
expression system. 
4.4 Analysis of Protein Expression. 
Test baculovirus expression studies were carried out to determine the 
optimal MOl with which to infect SF9 cells, and the best time point to harvest 
the cells in order to maximise Stat5 yield. 
1x106  SF9 cells per well of a 12 well plate were infected at MOIs of 1, 2, 5, 10 
and 20 pfu/ml, and harvested at either 24, 48, 66, 72 or 96 hours post 
infection. Equal amounts of whole cell extracts, were separated on NuPage 
protein gels, and Western blotted with an anti-Stat5 antibody that recognises 
both Stat5a and Sb (Zymed 33-5900) to determine the total yield of StatS. The 
lower half of the membrane was probed with an anti-SF9 cell line antibody 
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(Biodesign K47012R) as a loading control; this antibody picks up many bands 
but one discrete band migrating at about 37kDA was used to normalise 
Western blots to any differences in protein concentration. 
At low MOIs (of one or two) Stat5 is only detected after 72 hours (data not 
shown). No Stat5 was detected at 24 hours at any MOl. By 48 hours Stat5 
begins to be detected at higher MOIs. 
These results show that, contrary to previous studies, maximal levels of Stat5 
protein were produced at 96 hours post infection, and with a relatively high 
MOl of 20 pfu/cell (Figure 4.7A, middle panel and 4.7B light blue bars). 
However, it is not just the yield of Stat5 that is important. As I intend to 
utilise the intrinsic phosphorylating activity of SF9 cells to produce 
phosphorylated, and therefore active, Stat5 the level of this also must be 
assessed. 
4.4.1 Phosphorylation Status. 
Recombinant Stat protein produced in a baculovirus expression system has 
been reported to have DNA binding activity and to be phosphorylated on the 
conserved tyrosine residue (Y694 in Stat5a, Y699 in Stat5b) (Lin et al., 1996; 
Soldaini et al., 2000) that is modified on activation in the JAK/Stat pathway, 
without the need for additional stimulus. A mechanism native to the SF9 cell 
line must be causing this phosphorylation, a Stat family protein has been 
found in insect cells (Yan et al., 1996; Hou et al., 1996) indicating the existence 
of pathways capable of phosphorylating Stat proteins. 
In order to characterise the intrinsic phosphorylating behaviour of the SF9 
cells, the blots described in section 4.3.5 and Figure 4.7 were stripped and re- 
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Figure 4.7 Stat5b Expression Tests. 
1X1 06 SF9 cells were infected with Stat5b at indicated MOls and the total 
protein harvested at the indicated times. Aliquots were separated on 
NuPage protein gels and transferred to nitrocellulose membrane. 
Membranes were probed with antibodies against pan-Stat5 (central panel) 
and pan-phospho-Stat5 (top panel). The western blots are shown in part A. 
Density of signal at each time point was normalised to the protein loading. 
The total amount of Stat5 plus the ratio of phosphorylated Stat5 over total 
Stat5 for each sample (MOl time of harvest)are shown in the graph in part 
B. 
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probed with an anti-phospho-tyrosine-694 Stat5a/b antibody (Zymed 33-
6000) to determine the optimal conditions for maximum yield of the 
phosphorylated protein 
The levels of phosphorylated Stat5 showed a different pattern to total Stat5 
(Figure 4.7 compare the top and middle panels). When this data was 
analysed it was revealed that the proportion of phosphorylated, and 
therefore active, Stat5 that is produced changes with time (Figure 4.7B). 
Although more Stat5 is produced after 96 hours, the level of phosphorylated 
Stat5 remains more constant meaning less of the Stat5 produced will be 
capable of binding DNA in a bandshift reaction. It may be that proteins 
involved in the phosphorylating activity are down-regulated with the rest of 
the host proteins during the course of the infection, or that the rate of 
production of Stat5 may be greater than the rate at which it can be 
phosphorylated. 
The relative amounts of phosphorylated Stat5 over total Stat5 are shown in 
Figure 4.73 (blue bars). When this is compared to the relative levels of total 
Stat5 (light blue bars) the time point chosen as having the greatest proportion 
of phosphorylated Stat5 is 72 hours post infection, with a MOl of 10 pfu/cell. 
These were the conditions used for the large scale production of Stat5. The 
time point of 96 hours postinfection at a MOl of 10 was not chosen, although 
it appears to contain a high proportion of phosphorylated Stat5, as 72h with a 
MOl of 10 actually produces a higher level of phosphorylated protein. 
4.4.2 Nickel Column Purification 
The Stat5 described in this chapter has been engineered to contain a 6-His tag 
at the amino terminus. Proteins tagged in this way can be easily isolated 
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using nickel (Ni2 ) affinity chromatography. Amino acids, particularly 
histidine and cysteine have affinity for divalent cations such as nickel, zinc 
and cobalt (Porath et al., 1975). Nickel is generally considered the best metal 
to use, and sufficient purification was achieved with this that it was thought 
unnecessary to try to optimise the system with an alternative metal. The run 
of six histidine residues in the 6-His tag has a higher affinity for Ni 2 than 
most proteins; this property is made use of to purify Stat5 from the total 
protein. Imidazole, as an electron donor, competes with histidine and other 
amino acids for interactions with the metal ions (Porath, 1992). Ni 2 charged 
HiTrap Chelating HP columns (Amersham Biosciences) were used to purify 
rStat5 from whole cell extracts of baculovirus infected SF9 cells. Cell extracts 
were loaded in a binding buffer containing sufficient imidazole 
concentration to efficiently compete the binding of as much of the total 
protein as possible, while allowing all the tagged rStat5 to remain bound. 
The elution buffer was chosen with an imidazole concentration sufficient to 
ensure that all tagged rStat5 eluted in one step. 
Optimum irnidazole concentrations were selected in test purifications. A 
whole cell extract of SF9 cells infected with a 6-His tagged Stat5a baculovirus 
in phosphate buffer with 10mM imidazole was loaded onto a lml column. 
Five ml aliquots of phosphate buffer containing increasing imidazole 
concentrations were added between washes of phosphate buffer with 10mM 
imidazole. The eluates were collected and separated on a protein gel. The 
imidazole concentration immediately before Stat5 is first eluted is the 
optimal binding buffer. Stat5 first appears with elution at 40mM imidazole, 
(data not shown) so the binding buffer used was 30mM imidazole. Stat5 was 
















Figure 4.8. Purified rStat5. 
Coomassie stained 12% BisTris NuPAGE gels showing the purification of 6-
His Stat5 on a nickel charged column. A is Stat5a and B. is Stat5b. m are 
Precision Protein Standards (Bio-Rad), wc is whole cell extract, ft is the 
column flowthrough, w are the wash steps and e represents the elution steps 
(all at 300mM imidazole). The whole cell, flowthrough etc is shown for both 
W37A mutants (between the two marker lanes) and only the elution steps for 
the WTStat5 (to the right of the central marker lane). Stat5a WT and W37A 
and Stat5b W37A were eluted in e2 and Stat5b WT was eluted in e3. 
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Stat5 purified under these conditions is >95% pure (Figure 4.8). The rStat5 
band is clearly seen in the whole cell lane at about 90kda, and is not present 
in either the flow through or the washes. There is also a second band at 
approximately 60kda present in the whole cell that is reduced in the 
flowthrough and in the first wash step but this band is not enriched in the 
purification steps. Stat5 can be observed eluting usually in the second or 
third fraction. Typical yields of rStat5 were between 3 and 6.3mg rStat5 per 
10 SF9 cells. 
4.4.3 Cleavage of 6-His Tag. 
The 6-His tag on the Stat5 W37A mutants was designed to be removed by 
AcTEV protease. A seven amino acid recognition site (Gln-Asn-Leu-Tyr-
Phe-Gln-Gly) is inserted between the 6-His tag and the StatS transcription 
start by the pFastHTB vector. The AcTEV used (from Invitrogen) also 
contains a 6-His tag so it can be removed from the sample after cleavage. 
Cleavage of the 6-His tag can be followed by staining the gel with I nVisionTM 
His gel stain from Invitrogen. This stains proteins containing a poly histidine 
tag, causing them to fluoresce when excited by UV light. 
Test digests of Stat5aW37A and Stat5bW37A with the AcTEV protease 
(Figure 4.9) show that in these gels StatS migrates as a group of bands, in 
contrast to Figure 4.8 where only a single band is seen. The fastest migrating 
band appears to be the most resistant to AcTEV digestion, as only this and 
one other band remains in the Stat5bW37A digest after digestion for one 
hour, no other bands are seen in the Stat5aW37A digest at this time point. 
The slower migrating bands that disappear almost immediately after AcTEV 
cleavage are also not observed in the Coomassie stain of Stat5bW37A 
suggesting that total degradation of these species has occurred rather than 
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Figure 4.9 AcTEV Digests of Stat5 W37A. 
rStat5a W37A (left hand panels) and rStat5b W37A (right hand panels) was 
digested for the indicated time periods with AcTEV to remove the 6-His tag, 
then separated on NuPAGE gels under reducing conditions. Gels were 
stained with InVision His tag gel stain to display 6-His tagged proteins (upper 
panels) then coomassie stained to display the total protein. 
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removal of the 6-His tag. In fact the total protein stain mirrors the gradual 
disappearance in the 6-His stain of the fast band that is resistant to 
degradation. In the Stat5aW37A digests the 6-His tagged bands disappear 
faster than they do in Stat5bW37A, only a trace is seen after 4 hours whereas 
for Stat5b a band is still present after 7 hours. 
In both digests, bands are seen at 80kda and below with the Coomassie stain 
that do not stain for the His tag, indicating cleavage of the 6-His tags. A 
band at 60kDa appears at one hour of AcTEV digestion of Stat5aW37A, and 
is also observed at later stages of digestion of Stat5bW37A. These bands are 
too small to be full length Stat5. Bands of between 20 and 30 kda appear in 
digested samples with the 6-His stained gel but are not seen with the 
Coomassie stain, these may represent the cleaved part of Stat5 (perhaps the 
other part of the 80kda band) or the AcTEV. Both of these contain a 6-His 
tag. Similar patterns were seen under other digestion conditions (data not 
shown). It appears that AcTEV digestion degrades Stat5 and that removal of 
the 6-His tag from the Stat5W37A is not a viable option. A search in the Stat5 
sequence for a motif resembling the AcTEV recognition site did not pull up 
any possible cleavage sites. Stat5bW37A in general appears to be more 
resistant to degradation than Stat5aW37A. 
4.5 Bandshifts using rStat5. 
The 6-His tagged rStat5 described in section 4.3 was used in bandshifts of 
both the oligonucleotide probe StM and the 240bp probe nAB. Binding 
patterns for each rStat5 on each probe are described in the following sections. 
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4.5.1 Recombinant Stat5 Bandshifts of StM 
The probe StM should only be able to associate directly with one Stat5 dimer, 
as it contains only a single binding site for Stat5. Bandshifts using this probe 
with rStat5 show multiple bands (Figure 4.10 compare lane 2 (nuclear 
extract) with lanes 3 - 6 (rStat5)). It has been suggested that this may be due 
to the binding of either alternatively phosphorylated forms of Stat5 or 
truncated (perhaps degraded) Stat5. Phosphorylated Stat5 has been known 
to migrate at a different level from non-phosphorylated (Vinkemeier et al., 
1996). Alternatively it must be noted that these recombinant Stat5 proteins 
contain a 6-His tag at their N-terminus (plus other sequences for W37A) 
which may be a factor in the migration of DNA bound complexes. 
Previously, bandshifts with nuclear extracts have shown a pair of bands 
specific to Stat5 (Figure 4.2). The slower migrating secondary band, labelled 
S in Figure 4.2, might not show in the nuclear extract shift in Figure 4.10, as it 
is generally much weaker than the primary band. In fact with different 
nuclear extracts the relative intensity of these bands vary enormously. The 
whole gel including the free probe is shown in Figure 4.10 and no non-
specific bands are seen. 
Stat5 produced in the baculovirus system is phosphorylated by an unknown 
mechanism on the conserved tyrosine that is required for dimerisation and 
the DNA binding activity of the molecule. This indiscriminate 
phosphorylation suggests that the protein may also be inappropriately 
modified on other residues. The phosphorylation status of proteins 
including Stats is known to affect their migration through polyacrylamide 
gels (Shuai et al., 1992), and although rStat5 appears to migrate as a discrete 
band through a non-reducing NuPAGE protein gel (Figure 4.8), in a gel run 
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Figure 4.10 rStat5 Bandshifts of Oligonucleotide Probes. 
Bandshifts of the oligonucleotide probe StM with recombinant Stat5aW37A, 
wild type rStat5a, wild type rStat5b, rStat5bW37A or with a mouse mammary 
nuclear extract. The first lane is the StM probe without any protein. An arrow 
at the bottom of the gel marks the migration of the free probe. 
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under reducing conditions Stat5 migrates as a collection of bands (Figure 
4.9). Alternatively-phosphorylated forms of Stat5 may behave differently in 
a native polyacrylamide gel, such as those used for bandshifts. It is possible 
that alternative phosphorylation is the source of the multiple Stat5 bandshifts 
observed. 
The rStat5 purified in Figure 4.8 migrates as a discrete band, but preparations 
that have been stored for long periods of time occasionally do show 
degradation products when separated on protein gels (data not shown). As 
the extra bands observed in bandshifts are seen to migrate more slowly than 
the primary Stat5 bandshift it is unlikely that degraded Stat5 binding is the 
source of the multiple bands. Two bands were also observed in bandshifts 
with nuclear extracts. These migrate at the same speed as the rStat5 bands 
although the relative intensity varies between individual extracts and rStat5 
preparations (Figure 4.10 and Figure 4.2). 
Recombinant Stat5 carrying the W37A mutation shows a similar bandshift 
pattern of the oligonucleotide probes as their wild type counterparts. This 
sugests that the multiple bands are not due to the previously characterised 
tetramerisation interactions. The possibility still exists that Stat5 interacts 
with other Stat5 molecules through an uncharacterised mechanism. 
Previous tetramerisation interactions (John et al., 1999; Vinkemeier et al., 
1996; Soldaini et al., 2000), required that binding sites for Stat5 be spaced 
between 6 and 10 bp apart in order to facilitate tetramerisation interactions. 
The three binding sites on nAB are spaced much farther apart than this with 
68bp between Al and A3 and llThp between A3 and StM. Therefore it is 
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unlikely that tetramerisation interactions are involved in Stat5 binding to the 
naked probe nAB, although half Stat5 consensus sites (UC or GAA) are 
present near to both the Al and the A3 binding sites. These are spaced 11 
and 12 bp from their counterpart in the defined binding site, this spacing is 
still compatible with the formation of higher order Stat5 structures. Also on 
certain sequences Stat5 preferentially forms tetramers rather than dimers 
(Soldaini et al., 2000). 
As there are three binding sites present, up to three Stat5 dimers should be 
able to interact with nAB separately. The StM binding site is a strong site 
and will bind Stat5 preferentially compared to the weaker Al or A3 binding 
sites. Because Stat5 bandshift products on even the short probe StM give rise 
to multiple bands, it is impossible to say with any certainty how many Stat5 
binding sites are occupied solely by the migration through the gel. 
4.5.2 Recombinant Stat5 Bandshifts on nAB. 
Stat5 bandshifts on the nAB probe show a similar pattern to those on the 
shorter oligonucleotide probe StM (Figure 4.11), although they appear to 
migrate at a slightly slower rate. This is likely to be due to the extra 
retardation effects of the longer DNA sequence. There is a slight difference 
in migration between the two rStat5a species, wild type (A) and W37A (AW) 
and the two rStat5b species, B and BW. Stat5a migrates at a slightly slower 
rate than Stat5b, but Stat5a is also slightly larger than Stat5b (787 amino acids 
as opposed to 794 amino acids). The third slow migrating band seen 
previously with the oligonucleotide bandshifts is stronger in shifts with 
Stat5a than it is in shifts with rStat5b. As the Stat5 will eventually be used to 
shift nucleosome associated probes, two lanes from a gel run under the 
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Figure 4.11 rStat5 Bandshifts of nAB and StM. 
Bandshifts of the oligonucleotide probe StM and of probe nAB by rStat5 as 
indicated. The last two lanes are from a different gel, which was run under 
the conditions used for reconstitution gels rather than those of the other Stat5 
bandshift gels to highlight the difference in migration seen between gels. 
Arrows to the right of the gel mark the migration of the free probes nAB 
(upper arrow) and StM (lower arrow). 
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4.11 (last two lanes) to compare migration behaviour. When bandshifts of 
the probe nAB are run under the same conditions as the reconstituted 
nucleosomes, a different migration pattern is observed (Figure 4.12 and 4.11). 
For the Stat5 bandshifts described above, 5' end-labelled nAB was incubated 
with lj.tg rStat5 and separated on a 6% 1 X TBE polyacrylamide gel run in 
0.25 X TBE buffer at 200V constant for three hours at room temperature. 
Reconstituted nucleosomes are separated on a 5% 1 X TBE polyacrylamide 
gel in 1 X TBE buffer, at 60V constant overnight (16 hours) at +4°C. This 
DNA is labelled by addition of [cx 32P] dCTP into the PCR reaction that 
produces nAB. Under these conditions the three Stat5 bandshift products do 
not resolve as well and the difference in migration between Stat5a and 
Stat5aW37A appears to be more pronounced (Figure 4.12). Any of the 
changes in the way the gels are run could influence the resolution. 
4.6 Stat5 Binding Sites on the BLG Promoter. 
Stat5 binding sites in nAB have been mutated by site directed mutagenesis 
both individually and in various combinations to the same sequences used in 
the mutate oligonucleotide probes (Figure 4.1). There are a total of eight 
different possible combinations of binding sites (Figure 4.13). Using these 
mutated nAB probes the migration of StatS bandshifts with varying numbers 
of StatS binding sites was studied. It was found that, similar to the histone 
core, the position of a bound Stat5 dimer on the DNA fragment affected the 
migration through the gel. In Figure 4.12 only one Stat5 dimer can bind to 
each of A1S (lane 2) and A3S (lane 3) but the A3S complex migrates faster 
than the A1S complex. On the A1S probe, Stat5 can only bind at the centrally 
positioned A3 binding site (Figure 4.13) while on the A3S probe, binding can 
only occur at the Al position, which is situated towards the end of the 
fragment. It would appear that as with a nucleosome reconstitution, a 
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Figure 4.12 Bandshifts of nAB. 
Bandshifts of variations of the probe nAB with rStat5 as indicated below were 
separated on a 5% polyacrylamide gel in 1 x TBE overnight at 60V constant, 
these are the conditions used for nucleosome bandshifts, but these shifts are 
of naked probes. Lanes two and three contain probe what was labelled with 
32p from a different activity date, so although the amount of DNA added to 
each reaction is equal, the specific activity is relatively greater in these two 
lanes. The intensity of signal in lane three has been adjusted to be able to 
compare band migration in this gel. Lanes 1-4 contain WT Stat5a, lane 5 
contains Stat5a W37A, lane 6 Stat5bW37A and lane 7 no protein. Lane I is 
a shift of the SAA version of the fragment, Lane 2 is Al S, lane 3 is A3S and 
lanes 4-7 are WT. 
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Figure 4.13 Combinations of Stat5 Binding Sites. 
Representation of nAB showing the eight possible combinations of Stat5 
binding sites. Red circles represent wild type binding sites for Stat5, while 
open circles represent mutated sites. The probes are named for the mutated 
binding sites in each. 
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centrally positioned Stat5 migrates through a native polyacrylamide gel at a 
slower rate than an end positioned Stat5. The effect does not appear to be as 
pronounced with Stat5 as with a nucleosome core. This may reflect the way 
the two protein complexes bind DNA, in particular the angle of DNA entry 
and exit. Stat dimers appear to simply bind with only a minor 
conformational change in the DNA, while in a nucleosome core the DNA is 
bent round the protein complex. (Becker et al., 1998; Chen et al., 1998; 
Richmond and Davey, 2003; Luger et al., 1997). 
Unexpectedly we are unable to determine the number of Stat5 molecules 
bound to the probe by the presence of a faster migrating band in shifts of 
nAB containing only one intact binding site compared to the WT with three 
Stat5 biding sites (Figure 4.12, compare shifts of wild type (lane 4) and A35 
nAB (lane 3)). This will also explain why there is little difference between 
binding of WT and W37A Stat5. nAB is not predicted to facilitate a 
tetramerisation interaction by the spacing of the Stat5 sites. My hypothesis is 
that as the StM site is a much stronger binding site, Stat5 binds preferentially 
at this site and the binding observed is just to this one site. The majority of 
the probe remains unbound. This free probe contains a large reservoir of 
StM binding sites, which Stat5 will always preferentially bind to before Al or 
A3. In Figure 4.2, Al and A3 did not completely compete Stat5 binding to 
StM at even 200X excess indicating that Stat5 affinity for StM is at least 200 
fold greater than for either of the weaker sites. This theory was tested in a 
titration experiment where the amount of probe to rStat5added was reduced 
to a 1:1 ratio. However the Stat5 shifted probe band reduced in intensity in 
line with the free probe and no extra bands could be detected (data not 
shown). 
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The relative strength of the StM, Al and A3 binding sites is also indicated in 
Figure 4.12. In this figure the SAA and WT probes are labelled using 32P  with 
a lower specific activity than the other fragments, lanes have been adjusted 
accordingly. The WT nAB in lane 4 contains all three Stat5 binding sites, and 
lanes 2 and 3 contain only one weak site. The total amount of signal present 
is much reduced in lane 4 compared to lane 2 (A1S), but the intensity of the 
shifted band is about equal indicating WT binds more Stat5 than A1S does. 
Similarly the total signal (after adjustment) in lane 3 (A3S) is greater than in 
lane 4, but the shifted band is only slightly more intense. These results could 
also be explained by the multiple binding sites present on nAB, but given the 
known greater affinity of Stat5 for StM it is likely to be due to StM binding 
only (Figure 4.2 and (Burdon et al., 1994b)). The total signal in lane 3 (A3S) is 
less than in lane 2, but the shifted band is more intense, suggesting that the 
Al binding site is stronger than the A3, but not as strong as StM. 
As expected, there is very little or no Stat5 binding to the SAA probe (Figure 
4.12 lane 1), as this has all three Stat5 binding sites mutated. All three 
mutations have been shown individually not to bind Stat5 in Figure 4.2. 
4.7 Summary of rStat5 Binding. 
The above experiments show that recombinant Stat5 produced in the 
baculovirus expression system behaves in a similar manner to Stat5 from a 
nuclear extract in bandshift experiments. Under the correct conditions, 
sufficient levels of phosphorylation were found to use the recombinant 
protein in bandshift reactions without further action to phosphorylate Stat5. 
rStat5 binds to nAB producing a distinct reproducible bandshift. Bandshifts 
with the rStat5aW37A mutants and rStat5b appear to run faster, indicating a 
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smaller complex, than shifts with the WT rStat5a on the long probe. This 
may indicate a failure of the rStat5aW37A mutants and Stat5b to make Stat5-
Stat5 (dimer-dimer) interactions. Stat5b may not have the same tendency as 
Stat5a to tetramerise (John et al., 1999). Recent reports suggest that Stat 
proteins can interact with each other without the requirement for activation 
(Schroeder et al., 2004; Ota et al., 2004). There are also implications that the 
W37A mutation is not vital in making tetramerisation interactions and any 
affect it has is simply due to a destabilisation of the N-terminus of the protein 
(Chen et al., 2002). This is discussed further in Chapter 6. 
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5 STAT5A BINDING TO A CHROMATIN TEMPLATE. 
The binding of both Stat5 and the histone octamer to a fragment of the BLG 
promoter, nAB, has been characterised in Chapters 3 and 4. To investigate 
Stat5a binding to nucleosomes, isolated positioning isomers were 
bandshifted by Stat5a. Relatively few studies have studied the interactions 
of transcription factors with chromatin in this way; a brief review of some of 
those that have is included below (Section 5.1). The lack of such studies is 
surprising when you consider that all interactions of transcription factors, 
and the DNA replication and transcription complexes with eukaryotic DNA 
must occur within a chromatin context. 
5.1 Transcription Factor Interactions with Chromatin. 
The organisation of DNA into chromatin has an intrinsic negative effect on 
gene expression, as the association of DNA with nucleosomes must 
adversely affect the binding of transcription factors. Nucleosome positions 
have been mapped both in vivo and in vitro over the promoter regions of 
many genes. Well studied genes include the chicken 13 globin gene (Kefalas 
et al., 1988; Yenidunya et al., 1994), the mouse mammary tumour virus long 
terminal repeat (MMTV LTR) (Richard-Foy and Hager, 1987), the yeast 
PH05 locus (Lohr, 1997) for review and Ovine BLG (Boa, 1999; Gencheva 
and Allan, 2005). The 5S RNA gene has been extensively studied as its 
repeats contain strong nucleosome positioning signals (Gottesfeld, 1987; 
Meersseman et al., 1991; Flaus et al., 1996). These maps can indicate which 
transcription factor binding sites are covered by nucleosomes and which are 
situated in linker DNA. For example nucleosome positions on the 5S RNA 
gene can affect the binding of TFIIIA (Rhodes, 1985; Panetta et al., 1998). As 
such these maps are useful sources of information regarding how positioned 
nucleosomes may affect gene regulation at this fundamental level. 
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In reality, the activation of genes is more complicated and involves a 
complex interaction of transcription factors with each other and the 
chromatin template. First, transcription factors may or may not be able to 
associate with nucleosomal DNA. Bound factors may recruit other factors 
resuling in the modification of both these and histones. Large multi-protein 
assemblies such as the chromatin remodelling complexes may be recruited, 
resulting in nucleosome movement or displacement. Changes in the 
chromatin structure over regulatory regions can be seen with the activation 
or silencing of many genes, manifested by the appearance of DNaseI 
hypersensitive sites. All these processes also must occur in the context of the 
30nm fibre, as well as within other higher order chromatin structures (Horn 
and Peterson, 2002; Adkins et al., 2004). 
Several studies have now looked further at the interactions of transcription 
factors with nucleosomal DNA. The nucleosome structure over the MMTV 
LTR has been studied in relation to binding of the glucocorticoid receptor 
(GR). Changes in the DNaseI digestion patterns through a positioned 
nucleosome on the MMTV LTR in response to GR were observed (Richard-
Foy and Hager, 1987; Perimarm and Wrange, 1988). More recent studies 
include the binding of HNF3 and the estrogen receptor (ER) to the 
vitellogenin promoter. Using DNaseI digestion and bandshifts of a 
reconstituted chromatin probe it was shown that HNF3 binds to nucleosome 
associated DNA at the periphery of a nucleosome (Robyr et al., 2000). Again 
on the vitellogenin promoter, estrogen receptor a (ERa) was shown to be 
more efficient than ER3 in the estrogen-stimulated activation of the Xenopus 
vitellogenin A2 estrogen response element (ERE) on a chromatin template, 
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using an in vitro transcription system with a HeLa nuclear extract (Cheung et 
al., 2003). 
The Xenopus 5S RNA gene contains strong nucleosome positioning 
sequences. The oocyte and somatic versions of the gene are differentially 
activated by the same factors, in a manner regulated by specific nucleosome 
positioning. TFIIIA will preferentially bind in the nucleosome positions 
found in the somatic gene, but only if the 3' end of its binding sequence is 
located outside the nucleosome. Nucleosomes on the oocyte gene position 
more over the TFIIIA binding sequence and preferentially bind the linker 
histone Hi (Rhodes, 1985; Panetta et al., 1998). This binding invoves 
displacement of -20bp of DNA from the edges of the nucleosome (Vitolo et 
al., 2004). 
NFl binds to the MMTV LTR after hormone induction of the CR in vivo, and 
appears to do so on DNA associated with a nucleosome. However NFl will 
not bind to nucleosomal DNA in vitro, but will bind to DNA associated with 
an H3/H4 tetramer, representing a nucleosome remodelling event. Both 
active CR and progesterone receptor will bind to nucleosomal DNA on the 
MMTV LTR and binding of these appears to be responsible for a nucleosome 
change that allows NFl to bind. This may involve recruitment of the 
SWI/SNF complex (Piña et al., 1990; Cordingley et al., 1987; Eisfeld et al., 
1997; Ostland Farrants et al., 1997; Spangenberg et al., 1998). These 
interactions may be relevant to this project as MMTV is a mammary specific 
promoter and there are binding sites for both NFl and CR on the BLC 
promoter. 
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The activating potential of Stati within a chromatin template has been 
studied using an in vitro transcription system. This showed the C terminal 
domain to be essential for transcription in a chromatin context, and that this 
required the recruitment of the transactivator CBP/p300. The binding of 
Stati to the chromatin template, but not necessarily to nucleosome associated 
DNA, was demonstrated by DNaseI protection (Zakharova et al., 2003). 
The majority of these studies only show that transcription factors can bind 
within chromatin, not how they interact with individual positioned 
nucleosomes. Authors are reluctant to commit as to whether or not their 
transcription factor binds to DNA in a nucleosome. In this chapter, the 
binding of Stat5a to sites incorporated in the previously characterised 
nucleosome positioning isomers on the BLG promoter is investigated, and a 
potential role of nucleosomes in potentiating higher order Stat5a-Stat5a 
interactions questioned. 
5.2 Stat5a Binding to a Reconstituted Chromatin Template. 
There are three sets of nucleosome positions on the fragment of the BLG 
promoter (nAB) that are available for analysis; characterisation of these was 
described in Chapter 3. All three positions cover the central Stat5 binding 
site, A3. The strongest two nucleosome position, Ni and N2 cover only A3 
(Figure 5.1). The N2 position also borders the most downstream Stat5a 
binding site (StM) (Figure 5.1). The third nucleosome position, N3, is a 
combination of end-positioned nucleosomes and sequence directed 
nucleosome positions that sit over both the A3 site and the most upstream 
Stat5 binding site, Al (Figure 3.16 and Figure 5.1). With this knowledge 
nucleosomes were reconstituted onto variations of nAB that contain 
combinations of the various Stat5 binding site mutations (Figure 4.13) to find 
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Figure 5.1 Relation of Nucleosome Position Isomers to Stat5 Binding 
Sites. 
Positions of nucleosome position isomers on nAB, determined in Chapter 3, 
are represented by arrows. The positions are represented as groups that 
migrate as Ni, N2 or N3. The relative strength of each position is 
represented by the thickness of the arrow. Stat5 binding sites Al, A3 and 
StM are represented by red circles. See Figure 3.16 for the precise 
nucleosome positions. 
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out whether or not Stat5a can bind to DNA associated with a nucleosome, 
and if so which Stat5a binding sites are available for binding on each 
nucleosome position. 
5.2.1 Reconstitution onto nAB Probes. 
Nucleosomes were reconstituted onto the WT, A1A3, SAA, A1S, A3S, and A3 
versions of nAB (See Figure 4.13 for naming of nAB mutations), and the 
individual positioning isomers isolated (Figure 5.2). Some of the 
reconstitutes contain three bands (marked by solid arrows) as was observed 
previously for WT nAB (Figure 3.5). Others contain an extra band (NX 
marked by an open arrow in Figure 5.2) that migrates between the N2 and 
the N3 positions. The reconstitutes containing NX resemble the reconstitute 
in Figure 3.8, lane 5 and the NX band is also similar to that formed during 
Exoill digestion of N2 (Figure 3.10 lane 7). The gel in Figure 5.2 was run 
shortly after the isolated positions were separated, there is no certainty that 
the isomers remain in these positions. Redistribution can and does occur 
after longer periods of storage, as observed in nucleosome isomer bands in 
Figures 5.5 through 5.10. However the majority of the signal remains in the 
correct position. 
5.2.2 NX and the A3m Mutation. 
The N2 band in the reconstitute on WT nAB accounts for 29.6% of the total 
signal. In the reconstitute on A1A3, which contains the extra band, the N2 
band and the NX band together account for 29.5% of the total signal (17.3% 
and 12.2% respectively in N2 and NX). The similarity of the signal 
distribution between N2 and N2/NX suggests that NX is formed by a 
movement from the N2 nucleosome. The proportion of signal in the Ni and 
N3 bands remains unchanged. 
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Figure 5.2. Nucleosome Positioning Isomers from Reconstitutions onto 
nAB. 
Nucleosomes were reconstituted onto variations of the probe nAB containing 
various combinations of mutated or wild type Stat5 binding sites. 
Nucleosome positioning isomers were isolated for each (Lanes 1-4 are 
nucleosomes reconstituted onto A1A3; Lanes 5-8 on WT; Lanes 9-12 on 
SAA; Lanes 13-16 on All S; Lanes 17-20 on A3S and Lanes 21-24 are on A3. 
Solid arrows at the right hand side mark the three main nucleosome positions 
Ni, N2 and N3. An open arrow marks a fourth position present only in 
reconstitutes on probes that contain the A3 mutation. Bands were separated 
on 5% non-denaturing polyacrylamide gels run in TBE. 
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The NX band is present only in reconstitutes formed on an nAB probe that 
contains the mutated A3 Stat5a binding site (i.e. A3S, A3, SAA and A1A3) 
and is not seen in reconstitutions where A3 is wild type (i.e. WT and A1S). 
Thus it appears likely that the A3m mutation is causing a change in the 
nucleosome positions on nAB. The Aim and StMm mutations do not visibly 
affect the nucleosome positions. The migration of the nucleosome position 
isomers Ni and N3 appears unchanged by the A3m mutation. 
Mutation of the A3 Stat5 binding site to A3m involved mutation of an A to a 
T residue at —204 bp from the transcription start site and also an insertion of a 
T at —206 (Figure 4.1). Of the three Stat5 binding site mutations designed, 
only the A3 mutation contains an insertion. The Al and StM mutations 
contain only straightforward nucleotide exchanges. It is possible that it is 
this insertion that is causing the observed change in nucleosome migration. 
It has been suggested that the 20-30bp either side of the dyad are crucial to 
nucleosome positioning (Figure 5.3) and (FitzGerald and Simpson, 1985). 
The mutated A3m site is in this region for the N2 mapped nucleosomes 
although it is closer to the dyad axis in the Ni mapped nucleosome. It may 
be that the insertion of an extra base pair in the A3m mutation is sufficient to 
cross a threshold in the statistical likelihood that the NX position will exist. 
The migration pattern with the A3m mutation is similar to that of the (RsaI) 
reconstitution (compare Figure 5.2 lanes 4, 12, 20 and 24 to Figure 3.8 lane 5) 
suggesting a tendency of this fragment to position a nucleosome at NX, but 
that this is masked by the stronger N2 binding site. This may provide an 
explanation why quite minor changes in each are sufficient to cause an 
entirely different nucleosome migration, as also discussed in Section (3.4.1). 
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Figure 5.3 Selected Features of DNA Binding Within a Nucleosome. 
A. The central 30 bp either side of the nucleosome dyad is bound by the 
(H3H4)2 tetramer, this sequence is also responsible for directing nucleosome 
position. The outer DNA sequences are bound by 1-12A and 1-1213. The 
central 1 00b is 1000 times less accessible than free DNA, whereas end 
sequences are 50 times less accessible (Linxweiler and Horz, 1984). B. 
Relation of Stat5 binding sites on core DNA to the 1-131-14 bound DNA, the 
three Stat5 binding sites are represented by different coloured circles. 
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A similar situation arises in a comparison of the sequences of the caprine and 
ovine BLG promoters. These contain subtle differences, which result in an 
altered nucleosome structure. The main in vitro mapped nucleosome in 
caprine is shifted by lObp downstream placing its dyad at —174bp with 
respect to the transcription start site. The two promoter regions are very well 
conserved, but there is a substitution of two C residues in the ovine sequence 
to two T residues in the caprine sequence at 19 and 9 bp from the dyads 
respectively. There are nine other AlT to C/G mutations within the nAB 
region and one instance of a G residue in the ovine sequence that is not 
present in the caprine sequence (see appendices). 
5.3 Stat5a Binding to a Whole Reconstitution. 
Initial Stat5a bandshifts were carried out on unfractionated reconstitutes to 
demonstrate that Stat5a can bind to a reconstituted chromatin probe. Both 
WT Stat5a and Stat5a W37A bound to a reconstituted chromatin probe, as 
manifested by a broad band migrating more slowly than the isolated 
nucleosome positioning isomers (Figure 5.4A, lanes 2, 3, 5 and 6). 
5.3.1 Migration of Stat5a Shifted Complexes. 
A percentage of the shifted nucleosome band observed will be due Stat5a 
binding to naked nAB, as the nucleosome associated DNA was not separated 
from the free DNA. However the Stat5a shifted reconstitute band migrates 
more slowly than the Stat5a shifted naked DNA band does (Figure 5.4A 
compare lanes 1 and 2). This indicates a complex is formed of DNA bound 
to at least one Stat5a dimer plus a nucleosome, as opposed to Stat5a binding 
to naked DNA after the displacement of a nucleosome. Stat5a probably 
binds to the reconstituted fragment as well as to the naked DNA fragment 
judging by the relative disappearance of the naked DNA and nucleosome 
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Figure 5.4 Stat5 Bandshifts of Reconstituted Probes. 
A. Reconstituted nAB (lanes 2-7), and naked DNA (lane 1) were bandshifted 
by the addition of recombinant Stat5a and separated on 5% non-denaturing 
polyacrylamide gels. Shifts of the WT and AIA3 nAB probes by both 
WTStat5a and Stat5aW37A are indicated above the gel. Populations of 
various shifted bands are marked by brackets either side of the gel. B. 
Signal trace following the migration of bands in lanes 4-7 from the gel in A 
after normalisation to lane loading (produced using AIDA software). The 
average signal intensity in each lane was plotted against the distance 
migrated in mm. The chart in C. represents the proportion of the signal that 
remains in each nucleosome position after Stat5 binding (lanes 5 and 6) 
expressed as a percentage of the signal in that nucleosome position before 
the addition of Stat5 (lanes 4 and 7) determined using Quantity One analysis 
of a phosphorimage. This indicates the extent each nucleosome positioning 
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Figure 5.4 continued. 
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bands. This is not unexpected as all three nucleosome positions place the 
strongest Stat5 binding site (StM) external to the core DNA. 
The shifted nucleosome band is very diffuse. As with the naked DNA shifts, 
no difference could be detected between the complex produced from shifts of 
either the WT or the A1A3 reconstitutes (Figure 5.4 lanes 5 and 6). Also there 
was no difference observed between the migration of complexes formed by 
the binding of WT Stat5a or Stat5aW37A. This is not unexpected as the 
shifted band is a complex structure, and little is known of the reasons why 
nucleosome position isomers migrate according to their position on DNA in 
non-denaturing polyacrylamide gels (Pennings, 1997). Also, the migration of 
Stat5a bandshifts of naked DNA are themselves not fully understood, 
involving also a certain amount of DA bending. Thus, the rate of migration 
of a complex formed by binding of StatS to a positioned nucleosome cannot 
be predicted and in any case will not be simple. The possibility also exists 
that StatS binding may result in repositioning of a nucleosome. 
The graph in Figure 5.4B from left to right follows the trace of the signal 
intensity from top to bottom of lanes 4 through 7 of Figure 5.4A. In order to 
calculate which nucleosome positions Stat5a is binding to, the proportion of 
signal in each nucleosome position isomer was calculated as a percentage of 
the total signal in the lane. This was calculated for the reconstitutes on A1A3 
and on WT both with and without addition of Stat5. The graph in Figure 
5.4C shows the proportion of the signal in each nucleosome position in the 
Stat5 bound lanes, expressed as a percentage of the signal in that nucleosome 
position in the non-Stat5 lanes. These data indicate that Stat5 binds to all 
three nucleosome positions. 
169 
The proportion of signal remaining after the addition of Stat5a is lowest in 
the N2 and the NX positions, indicating that these nucleosomes bind Stat5a 
well. The proportion of the signal remaining is greatest in the N3 position 
and intermediate in Ni. The conclusion drawn from this data was that 
Stat5a preferentially binds to N2/NX, more weakly to Ni and lastly to N3. 
This can also be seen by eye (Figure 5.4A). No major differences were 
detected between binding to the A1A3 probe or the WT probe. This is likely 
to be because the strongest Stat5a binding site, StM, is external to all of the 
positioned nucleosomes (Figure 5.1). Binding to the StM site probably 
accounts for the majority of the Stat5a binding detected. 
The only factor influencing the binding of Stat5a to each positioned 
nucleosome on the A1A3 probe, which contains only the StM Stat5 binding 
site, is the proximity of this binding site to the nucleosome boundary. The 
order of Stat5a binding affinity is N2>N1>N3, likewise the proximity of StM 
to the nucleosome boundary is N2<Ni<N3 with StM placed closest to the 
nucleosome in N2 and furthest from it in N3 (Figure 5.1). To investigate 
further the binding of Stat5a to each nucleosome position, Stat5a bandshifts 
were carried out on isolated positioning isomers. 
5.4 Stat5a Binding to Isolated Nucleosome Positions. 
Nucleosome positioning isomers isolated from reconstitutes on the variations 
of nAB (Figure 5.2) were used as probes in Stat5a bandshifts. Stat5a is shown 
to bind to all three nucleosome position isomers (Figure 5.5) on both the 
A1A3 and WT versions of nAB. A more detailed study of binding is carried 
out in Figures 5.6, 5.7 and 5.8. One limitation of the experiments described 
below is that, unless otherwise stated, each was conducted only once. 
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Nevertheless the results were consistent between several experiments 
lending weight to the conclusions drawn. 
5.4.1 N ucleosome Redistribution. 
It is also apparent that the nucleosome positions on the unbound 
reconstituted probe do not remain static, and that although the majority of 
the signal remains in the correct band, nucleosomes do redistribute to all 
three (or four in the case of A1A3) positions. For example, compare the 
migration of isolated nucleosome positioning isomers in Figure 5.2 with 
Figure 5.5. N3 is the most likely to remain at the correct position; this also is 
the case for untreated nucleosome positioning isomers (Section 3.2.4) and 
may reflect a tendency of nucleosomes to move towards an end position. 
The redistribution observed is not due to the addition of Stat5a as the two 
outer lanes (1 and 14) in Figure 5.5 do not contain Stat5a, but yet display the 
same pattern of redistribution. Nucleosome redistribution is most likely due 
to spontaneous nucleosome movement brought about by the conditions the 
nucleosomes were stored under. 
The percentage of the signal in each nucleosome position was calculated 
from a phosphorimage using Quantity One software for the two outer lanes 
containing the non-Stat5-shifted Ni or N2 positions (Figure 5.5 lanes 1 and 
14). The total signal in all the nucleosome bands in each lane was taken as 
100 and the proportion of signal in a defined area around each position 
calculated as a percentage of this. However because of the irregular shape of 
some bands, resulting in band overlapping, it may have been better to 
calculate the signal using lane scan integration. In the Ni isomer without 
Stat5a (Figure 5.5 lane 14) 77.3% of the signal remains in the Ni position and 
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Figure 5.5. Stat5 Binding to Isolated Nucleosome Positions. 
Isolated nucleosome positioning isomers Ni, N2 and N3 were shifted by 
addition of either WTStat5a or Stat5aW37A and separated on non-denaturing 
polyacrylamide gels. Shifted probes are indicated at the top of the gel, and 
the Stat5a species added are indicated at the bottom. Block arrows on the 
left mark the migration of Ni (red) N2 (blue) and N3 (black) for shifted (open 
arrows) and non shifted (filled arrows) nucleosome positioning isomers. Stick 
arrows to the right of the gel mark the migration of the secondary (open 
arrowhead) and primary (closed arrowhead) bandshifts for nucleosome 
position Ni. The percentage of signal in each nucleosome positioning 
isomer for the isolated positions Ni and N2*  in the Stat5a shifted and non-
shifted lanes was calculated by quantifying the signal in a set outline around 
each band using Quantity One software, results are shown in Table 5.1. The 
strengths of the Stat5a shifted bands were not quantified. 
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NI N2 N3 
WT NI - Stat5a 77.3% 18.5% 4.2% 
WT NI + Stat5a 75.4% 18.1% 6.5% 
WT N2 - Stat5a 16.6% 70.9 12.5% 
WT N2 + Stat5a 31.1% 55.2 13.7% 
Table 5.1. Distribution of Signal in Isolated Nucleosome Positions 
The distribution of the signal calculated from a phosphor image using 
Quantity One Software in each nucleosome position for each isolated 
position in figure 5.5 is indicated, described as a percentage of the total 
signal in the nucleosome-shifted bands. This shows the extent of 
redistribution that has occurred between the positions. The 'correct' 
nucleosome position for each isolate is highlighted in bold. 
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in the N2 lane without Stat5a (Figure 5.5 lane 1) 70.9% of the signal remains 
in the N2 position (Table 5.1). The same analysis was carried out on the 
nucleosome distribution in the Stat5a shifted lanes. The proportion of signal 
in the Ni position in the Ni isomer lane after addition of Stat5a (Figure 5.5 
Lanes 10 and 12) fell to 75.4% (from 77.3% in lane 14). The percentage of N2 
contamination in the Ni isomer lanes remained constant on Stat5a addition 
(Table 5.1), suggesting the majority of the observed shift is of the Ni position. 
In the N2 isomer lanes the percentage of the signal in N2 fell to 55.2% (from 
70.9% in lane 1 without Stat5a) on addition of Stat5a (Figure 5.5 lanes 6 and 
8). The percentage of the total signal in N3 for both the Ni and N2 isomers 
remained fairly constant regardless of Stat5a addition. The complete data is 
shown in Table 5.1. These data suggest that in the N2 bandshifts it is the N2 
isomer that is shifted by Stat5a, but in the Ni shifts both Ni and N2 are 
shifted by binding of Stat5a. This would suggest that Stat5a binds to N2 
better than it does to Ni. The data from the two WT probes and the two 
A1A3 probes agreed, although only the data from WT lanes are shown in this 
analysis as the two outside lanes are on WT. 
The migration of each Stat5a shifted nucleosome position is related to the 
migration of the isolated nucleosome position that was used as the probe. In 
Figure 5.5 the Ni Stat5a shift (open red arrow to the left of the gel) migrates 
more slowly than the N2 Stat5a shift (open blue arrow), which in turn 
migrates more slowly than the N3 Stat5a shift (open black arrow); just as 
their respective nucleosome positioning isomers do (filled red, blue, or black 
arrows). This suggests that the Stat5a shift observed is due to binding to the 
designated probe. The three Stat5a shifted nucleosome positions are not 
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separated to the same extent as the individual nucleosome positioning 
isomers are. This may be due simply to their increased size, the resolving 
ability of the gel, or to the position of bound Stat5a. The main difference is 
that the N3 position migrates much closer to the Ni and N2 positions in the 
Stat5a shifted nucleosomes than it does in the non-Stat5-shifted nucleosomes. 
The N3 nucleosome position is situated at the upstream end of the fragment, 
and the StM binding site at the downstream end. Stat5 binding to StM may 
even out the differences in the migration caused by the conformation of the 
DNA tails exiting the nucleosome resulting in a faster relative mobility of N3. 
The different migration of the three Stat5-shifted nucleosome positioning 
isomers accounts for the diffuse migration of the Stat5a shifted 
unfractionated reconstitutes in Figure 5.2, which are a combination of shifts 
from all the nucleosome positions. Much tighter bands are observed for the 
shifts of the isolated positioning isomers. 
The migration of nucleosomes through non-denaturing polyacrylamide gels 
is governed by a combination of the mass and charge of the complex, but also 
by conformational factors. The free DNA tails exiting the nucleosome cause 
nucleosomes to migrate differentially according to their position on the 
fragment. Consequently a centrally positioned nucleosome will migrate at a 
slower rate than an end positioned nucleosome. Addition of glycerol to the 
gel mix removes this conformational factor, and nucleosomes migrate solely 
according to their mass and charge (Pennings, 1997; Pennings et al., 1992). 
Conceivably, the migration of the Stat5 shifted nucleosome bands could be 
simplified by the addition of glycerol to the gel used to separate the shifted 
complexes. This would remove the conformation effect of the nucleosome 
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position, and each nucleosome bound to nAB would migrate at the same rate 
regardless of its position. This could be useful in further studies using 
bandshifts of nucleosomes and may make it possible to detect multiple Stat5a 
dimers bound to the probe. However, as the position of the nucleosome on 
the DNA is central to these studies of Stat5a binding, bandshifts were carried 
out on non-denaturing polyacrylamide gels that did not contain glycerol to 
be able to verify that nucleosomes remain positioned at the expected sites as 
indicated by their migration through the gel. 
5.4.2 Stat5a Binding to Nucleosome Positioning Isomers on WI and 
AIA3 Probes. 
A comparison of the binding of WTStat5a and Stat5a W37A to each isolated 
nucleosome position on both wild type and A1A3 nAB was carried out to 
look for binding of multiple Stat5a dimers (Figure 5.5). The shifts with WT 
Stat5a have a weak secondary band above the primary bandshift, which is 
not apparent in the shifts with Stat5aW37A. This band also appears in shifts 
of the A1A3 nucleosome, although A1A3 contains only one binding site for 
Stat5a. It is likely that this secondary band is, as with shifts of naked nAB, 
not due to DNA binding induced tetramerisation but simply to other 
undescribed Stat5 interactions. On the naked DNA probe the Stat5aW37A 
mutant binds equally as well as the WT Stat5a does as regards both the 
primary and the secondary band, but in the nucleosome shifts Stat5W37A 
does not appear to produce the secondary band. The secondary band 
appears stronger in Ni shifts than for any of the other nucleosome positions, 
but Ni primary bandshifts are also much stronger than any other, with the 
exception perhaps of the WT N2 Stat5a shifts, so the intensity of the 
secondary band may simply be a reflection of the signal available. 
Comparison of the signal in the secondary and primary Stat5a shifted bands 
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was complicated by the fact that the secondary bands are little above the 
background signal from the primary shift, which is extremely variable 
between lanes. 
5.4.3 Analysis of Primary and Secondary Stat5a Bandshifts of WT and 
W37A Stat5a. 
To investigate further the possibility of multiple Stat5a dimers binding to the 
WT and A1A3 probes, bandshifts of each isolated nucleosome position by 
WT Stat5a and Stat5a W37A were carried out on gels with better resolution. 
These samples were loaded on 5% polyacrylamide gels in 1 X TBE as 
previous, but the wells were wider, and the running buffer was diluted to 
0.25 X TBE. This change in running conditions resulted in a tighter migration 
of the shifted bands. These results show that, as was observed in Figure 5.5 
for each isolated nucleosome position, Ni (Figure 5.6), N2 (Figure 5.7) and 
N3 (Figure 5.8) WT Stat5a produces a secondary band that is not obvious in 
Stat5a W37A shifts of the same probe. Stat5a W37A shifts also appear to 
migrate at a marginally more rapid rate than WT Stat5a shifts. A Stat5a shift 
of nucleosome positions Ni and N2 on the triple Stat5 mutation of nAB, 
SAA, is included as a control to demonstrate that the shifts are due to Stat5a 
interactions with the probe and not with the nucleosomes. No shift is 
observed of either of these SAA probes or of a whole reconstitution onto 
SAA (data not shown). 
The proportion of signal in each band, primary or secondary, expressed as a 
percentage of the total shifted bands is shown below each shift lane in 
Figures 5.6, 5.7 and 5.8. For each nucleosome position the proportion of 
signal in the primary and secondary band is the same regardless of the DNA 
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Figure 5.6 Bandshifts of Nucleosome Position NI. 
The isolated nucleosome position Ni from reconstitutes onto either the WT, 
Al A3 (AA) or SAA versions of nAB was bandshifted by addition of 1ig of 
either WT Stat5a or Stat5a W37A. Complexes were separated on a 5% non-
denaturing polyacrylamide gel in 0.25 X TBE at 60V constant overnight at 
4°C. Analysis of the proportion of signal in the primary and secondary 
bands, expressed as a percentage of the total shifted band is shown 
underneath each shifted lane, including SAA to demonstrate that the weaker 
the shift the closer each value is to 50%. The signal is very weak so this 
quantification may be unreliable The Stat5a that was used to shift each 
nucleosorne is indicated above the gel and arrows to the right of the gel mark 
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Figure 5.7 Bandshifts of Nucleosome Position N2. 
The isolated nucleosome position N2 from reconstitutes onto either WT or 
Al A3 (AA) versions of nAB was bandshifted by addition of 1 lag of either WI 
Stat5a or Stat5aW37A, and complexes were separated on a 5% non-
denaturing polyacrylamide gel in 0.25 X IBE at 60V constant overnight at 
4°C. Analysis of the proportion of signal in the primary and secondary 
bands, expressed as a percentage of the total shifted band is shown 
underneath each shifted lane. The signal is very weak so this signal may be 
unreliable. The Stat5a that was used to shift each nucleosome is indicated 
above the gel and arrows to the right of the gel mark the secondary (open 
arrow) and the primary (closed arrow) bandshifts. 
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Figure 5.8 Bandshifts of Nucleosome Position N3. 
The isolated nucleosome position N3 from reconstitutes onto either WT, 
AIA3 (AA) or SAA versions of nAB was bandshifted by addition of 1 P of 
either WT Stat5a or Stat5aW37A. Complexes were separated on a 5% non-
denaturing polyacrylamide gel in 0.25 X TBE at 60V constant overnight at 
4°C. Analysis of the proportion of signal in the primary and secondary 
bands, expressed as a percentage of the total shifted band is shown 
underneath each shifted lane, including SAA. The signal was very weak so 
this quantification is unreliable. The Stat5a that was used to shift each 
nucleosome is indicated above the gel and arrows to the right of the gel mark 
the secondary (open arrow) and the primary (closed arrow) bandshifts. 
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For example both A1A3 and WT nAB in the Ni nucleosome position contain 
15% of the shifted counts in the secondary band when shifted by WT Stat5a, 
but only 4-6% when shifted by Stat5aW37A (Figure 5.6). This is 
approximately 3 times more in the secondary band in shifts by WT Stat5a 
than in shifts by Stat5aW37A. The N2 position has a similar ratio with 20% 
of the counts shifted by WT Stat5a migrating in the secondary band and 3-
11% with Stat5aW37A shifts (Figure 5.7). This is 2.7 times more in WT 
compared to W37A Stat5a shifts. The N3 probe also follows the same pattern 
with about 30% in the secondary band in WT Stat5a shifts and about 21% in 
Stat5aW37A shifts (or 1.4 times difference between WT and W37A). The 
higher values in the N3 shift are likely to be caused by the fact that the N3 
probe contains by far the lowest signal, and the signal in the shifted bands is 
little above background. As demonstrated by quantification of shifted bands 
in the SAA lanes in Figures 5.6 and 5.8, there is no Stat5a shifted signal and 
the signal is at background level, so the ratio becomes close to 50:50. The 
Stat5 shifted signal is weak in all three figures so the above quantification is 
unreliable, but nevertheless gives an indication of the signal distribution. 
These experiments demonstrate that there is a link between the appearance 
of the secondary shifted band and the use of either WT Stat5a or 
Stat5aW37A, and that this is approximately 2 times more pronounced in the 
Ni and N2 nucleosome positions than the N3 position (WTIW37A ratios of 3 
and 2.7 compared to 1.4 in Ni, N2 and N3 respectively). 
However these data are from only one set of gels, and although they agree 
with each other, the results may not be representative. The bandshifts in 
Figures 5.5, 5.6, 5.7 and 5.8 all show the secondary band is present in WT 
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Stat5a shifts but not in Stat5aW37A shifts, lending weight to the conclusion 
that there may be a difference between WT Stat5a and Stat5a W37A. More 
work must be carried out to determine if the increased appearance of the 
secondary band in shifts of the N3 position compared to the Ni and the N2 
positions is real, and also to provide further insight into the observed 
difference between WT and Stat5aW37A. 
These experiments have also demonstrated that Stat5a can bind to a 
reconstituted nucleosome for all three nucleosome positions on the WT and 
AiA3 probes. All three nucleosome positions place the strongest binding 
site, StM, external to the nucleosome and this site is present in both the WT 
and the A1A3 probes. To investigate binding of Stat5a to other sites in a 
nucleosomal context, mutations of nAB which abolish the StM and other 
Stat5 binding sites individually were employed (Figures 5.9 and 5.10). 
5.5 Stat5a Binding to Sites Covered by a Nucleosome. 
There is currently no evidence in the literature to suggest whether or not 
Stat5a, or any Stat family protein can bind to sites situated within a 
nucleosome. Statl will bind to chromatin, but the question remains open as 
to whether or not this occurs within DNA that is associated with a 
nucleosome (Zakharova et al., 2003). 
5.5.1 Stat5a will not Bind to A3 Within a Nucleosome. 
The A1S version of nAB contains only the central (A3) Stat5a binding site, 
StM and Al having been mutated (Figure 4.13). The A3 binding site is 
covered by the nucleosome in every nucleosome position mapped on the 
nAB fragment (Figures 5.1, 5.3 and 3.17). When a nucleosome from a 
reconstitute on A1S is bandshifted by addition of WT Stat5a, nucleosome 
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positions Ni and N2 are not shifted (Figure 5.9 lanes 2 and 5). The same is 
true for nucleosome position N3, as an unfractionated reconstitute onto A1S 
also does not bind Stat5a (Figure 5.10 lane 2). As Stat5a will bind to naked 
A1S (Figure 4.12 lane 2) it must be the presence of the nucleosome that 
precludes binding of Stat5a to AiS. This data indicates that Stat5a does not 
bind to the A3 binding site when it is located within a nucleosome. The 
minimum distance of the A3 binding site from a nucleosome boundary is 
40bp, this is calculated from the upstream boundary of the N2 position at 
-169bp from the transcription start site. The A3 StatS binding site covers the 
sequence from -211 to -201 and the upstream boundary of the nucleosome is 
at -242bp from the transcription start site. A binding site 40bp from the 
nucleosome boundary is located fairly centrally within the nucleosome. It is 
possible that a binding site located closer to the nucleosome boundary may 
allow Stat5a to bind. 
5.5.2 Binding of Stat5a to Al Within Nucleosome Associated DNA. 
To investigate Stat5 binding to sites closer to the nucleosome boundary, 
similar experiments were carried out for the Al Stat5a binding site as for the 
A3 site, using the A3S version of nAB. This has both the A3 and the StM 
Stat5 binding sites mutated (Figure 4.13). The Al binding site is located 
outside the nucleosome in positions Ni and N2, but internal to the 
nucleosome in position N3 (Figures 3.17 and 5.1), although the location of 
Stat5 binding sites in the alternative band NX are unknown. Unexpectedly, 
given that previously Stat5a has been shown not to bind to DNA associated 
with a nucleosome (Section 5.5.1), Stat5a will bind to an A3S reconstituted 
probe for all three nucleosome positions including N3 (Figure 5.10). This 
suggests that the position of a Stat5 binding site with respect to the 
nucleosome boundary and dyad are important in Stat5a binding. The Al 
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Figure 5.9 Stat5a Binding to Sites in Nucleosomal DNA. 
WT Stat5a bandshifts were carried out on nucleosome isomers Ni and N2 
on variations of nAB containing Stat5 binding site mutations indicated above 
lanes, along with a representation of the binding sites. Red circles represent 
WT binding sites, and black crosses represent mutated binding sites. The 
two AIA3 bandshifts are of a probe labelled with a lower specific activity than 
the other shifts, the apparent intensity of these lanes has been increased 
during Quantity One analysis although all lanes are from the same gel. Plus 
or minus signs about the gel indicate the presence or absence of WT Stat5a 
in each lane. 
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binding site is a maximum of 26bp from the boundary of the N3 nucleosome 
(calculated from the isomer at -234bp from the transcription start site) and a 
minimum of 15bp (from the isomer at -213bp). The Al binding site is a 
weaker site than the A3 binding site (Burdon et al., 1994b) indicating that the 
difference in Stat5a binding observed is not due to binding site strength. 
Thus Stat5 cannot bind to a site 40bp from a nucleosome boundary, but it can 
bind to a site 15bp from the boundary. 
The N3 nucleosome position is composed of a collection of positioned 
nucleosomes at -234, -225, -219 and -213. An end positioned nucleosome 
can be at either end of the fragment, thus it is possible that a fraction of the 
Al binding sites are available through this way for binding in the N3 
position, for example, if an end-positioned nucleosome was positioned at the 
downstream end of nAB. Alternatively, contaminating bands from the Ni 
and N2 positions in the N3 isolation may be responsible for this bandshift. 
There is no lane containing non Stat5a shifted position N3 on A3S to observe 
which band is being shifted, however a comparison of the proportion of 
signal in each nucleosome positioning band in N3 isolations from the other 
experiments shows that the percentage in position N3 on other versions of 
nAB is approximately 66.7% for a Stat5a bound lane. In lane 5 of Figure 5.10 
the percentage of the signal in the N3 position is 73.5%. This is a 6.8 
percentage-point difference. These values are different enough to suggest 
that Stat5a may not be binding to the N3 position, but rather to other 
contaminating bands in the isolation resulting in the higher proportion of 
signal in the N3 position, however this may also reflect a slightly different 
nucleosome distribution on A3S. In Figure 5.2 the N3 position on A3S is 
more prominent than in any other reconstitute on nAB. Binding to N3 
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Figure 5.10 Stat5a Binding to Sites at the Nucleosome Boundary. 
WT Stat5a bandshifts were carried out on isolated nucleosome positions Ni, 
N2 and N3 and on unfractionated reconstitutes (R) on probes containing 
various Stat5 binding site mutations. The names of the mutated fragments, 
as described in Figure 4.13 are shown above the gel with a representation of 
the binding sites. Red circles represent WT StatS binding sites, and black 
crosses represent mutated binding sites. Plus or minus signs above the gel 
indicate the presence or absence of WT Stat5a in each lane. The isolated 
nucleosome position isomer that was used for each shift is also shown above 
each lane. Arrows to the right of the gel mark the secondary (open arrow) 
and primary (closed arrow) shifted bands. 
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cannot be ruled out as the MS N3 band migrates at the same level as the A3 
N3 band rather than the N2 or Ni bands (Figure 5.10 compare lane 5 to lane 
6 and to lane 4 or 7) suggesting that binding is to N3. The possibility still 
exists that Stat5a can bind to sites in DNA at the boundary of a nucleosome. 
Taken together the results in section 5.5 indicate that the position of a Stat5a 
binding site relative to a reconstituted nucleosome affects the binding of 
Stat5 to that site. Therefore it follows that the positions of nucleosomes over 
gene promoters must have a major role in the regulation of Stat5a responsive 
genes such as BLG. 
5.6 Restriction Enzyme Access to Nucleosomal Binding Sites. 
The mapped nucleosome positions indicate that the Al binding site is 
covered by the nucleosome in the N3 nucleosome position. Stat5a access to 
Al in the N3 position was questioned in 5.5.2 and the issue of access to this 
site remains unresolved. To investigate access to the Al binding site in the 
N3 nucleosome position, restriction digests were carried out on DNA in all 
three nucleosome positions for comparison. The Al mutation was designed 
to create an RsaI cleavage site (Figure 4.1), an enzyme which does not cut 
elsewhere in the nAB sequence. Digests of a probe containing the Al 
mutation with RsaI will show restriction enzyme access to DNA specifically 
at the Al site. RsaI digests of reconstitutions onto the A1S probe show that 
there is partial access of RsaI to the Al site on the N3 position (Figure 5.11 
lane 5) this is consistent with Stat5a being able to bind at this site. No DNA 
sequence in a nucleosome is completely protected, and access depends on the 
proximity of the sequence to the nucleosome boundary (Anderson et al., 
2002). Sequences within a nucleosome can be protected by up to 1000 times 
compared to DNA, whereas for sequences near the nucleosome boundary 
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this falls to 50 times (Linxweiler and Horz, 1984) this is illustrated in (Figure 
5.3). This can occur while the nucleosome remains positioned, probably by 
spontaneous partial unwinding of the DNA. It is likely that as the Al Stat5a 
binding site is positioned near to the periphery of the N3 nucleosome, it 
allows Stat5a binding. The A3 Stat5a binding site, which is positioned more 
central to the nucleosome core does not allow Stat5a binding. 
5.6.1 Non-Nucleosomal DNA Interactions with the N2 Positioned 
N ucleosome. 
Interestingly, the RsaI restriction enzyme accessibility assay also reports that 
there is no access to the Al binding site in the N2 nucleosome position. In 
fact the Al site on the N2 nucleosome binds Stat5a well (Figure 5.10, lane 4). 
A repeat of the digest gave the same result. The N2 position, as mapped in 
Chapter 3 should place the Al binding site external to the nucleosome core 
(Figures 3.17 and 5.1). Its position at -169 and -176 places the nucleosome 
boundary at a minimum of 22bp from the closest edge of the Al Stat5a 
binding site. At this distance one would predict that the presence of a 
nucleosome should not inhibit restriction enzyme digestion although the 
behaviour of individual restriction endonucleases within a chromatin 
environment has not been studied. Exonuclease III digestion of the N2 
position from the upstream end during nucleosome mapping revealed a 
collection of nucleosome specific pause sites up to 30bp external to the 
recognised nucleosome boundary (Figure 3.11). These pauses do not initiate 
a characteristic lObp pattern and are only present at low concentrations of 
Exolli and thus do not represent a true nucleosome boundary. The extra 
pauses were explained by interactions of non-nucleosomal DNA (i.e. DNA 
external to the 146bp in the histone core) lying on the surface of the 
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Figure 5.11 Restriction Enzyme Accessibility of Nucleosome 
Positioning Isomers. 
Isolated nucleosome positioning isomers (NI, N2 and N3) and naked DNA 
(d) were digested by either Rsal (Al S) or Hinf I (WT), and the resulting 
products separated on an 8% polyacrylamide gel in i X TBE, run at 200V 
constant for 3 hours (A). Digests were carried out in 0.1 X supplied buffers, 
to maintain low salt concentrations. Each contained MgCl2 at 1mM. Solid 
arrows mark the predicted digest products, and open arrows mark the 
unexplained bands. Predicted fragment lengths are indicated on a 
representation of nAB showing the Stat5 binding sites as red circles (B). 
nucleosome. It is entirely possible that this interaction also accounts for the 
inability of RsaI to digest at the Al Stat5a binding site in the N2 position 
Isomer, although both the Exolli and RsaI experiments were carried on nAB 
that contained the wild type A3 binding site, and do not contain an 
identifiably NX position. 
5.6.2 Hinfl Digests. 
Because of these unexpected results, restriction digests were also carried out 
with a second enzyme, Hinfl. Digestion sites and expected fragment sizes for 
this enzyme are illustrated in Figure 5.11B and relation of the cleavage sites 
to nucleosome positions in Figure 5.12. Hinfl cuts twice in nAB, at -248 and 
at -97bp. The -248 site is 30bp internal to the RsaI Al site and the -97bp site 
is in the StM Stat5a binding site. Hinfl digestion did not result in digestion to 
completion of any of the isolated nucleosome positions. This was expected 
as the two sites are 151 bp apart leaving room for one nucleosome with a 
dyad at -172 +/- 3bp. There is no corresponding nucleosome position on the 
nAB sequence although several are close. Each nucleosome position should 
therefore have at least one site where digestion is hindered by the presence of 
a nucleosome. 
Of the three positions, DNA from the Nl position is digested most 
completely, with no uncut DNA detected. Products of 24 and 216 bp show 
that in Ni the downstream (-97bp) Hinfl site is available for digestion, and a 
band of 63bp indicates that the upstream (-248) Hinfl site also is available. 
The absence of a band of 177bp and a strong band at 155bp indicates that 
there is little single digestion at only the -248bp site, cleavage is either at the 
-97 alone or at both the -97 and the -248 sites. The strong Nl nucleosome 
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Figure 5.12 Restriction Sites in Relation to Mapped Nucleosome 
Positions. 
This schematic diagram shows the cleavage sites of Rsal and Hinf I in 
relation to the sequences protected by nucleosomes. The extra sequence 
interactions detected in N2 are marked by dashed lines. 
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nucleosome overlaps the same by 23bp (Figure 5.12). This cleavage pattern 
may represent a double digest of the more centrally placed —184 nucleosome 
and a single digest of the —198 nucleosome which places the upstream Hinfl 
cleavage site further within the nucleosome. A seventh unexplained band 
migrating about 50bp is present in both the Ni lane and the DNA lane, there 
is no corresponding Hinfl or similar restriction site present in the nAB 
sequence and the enzyme is not reported to have any star activity. The 
source of this band must be something in the sequence (perhaps introduced 
by a PCR mutation) that is covered by the nucleosome in positions N2 and 
N3 but not Ni. A faint band migrating at approximately iObp suggests that 
the 50bp band may be a cleavage product of the 63bp band. 
The N2 position contains a significant proportion of DNA that is not digested 
at either Hinfl site demonstrated by a band of 240bp. But bands of 216, 177, 
153, 63 and 24bp are all seen, indicating that all sites are partially accessible 
and that in a proportion of the nucleosomes both sites are cut (Figure 5.11). 
This reflects the multiple nucleosomes in each isolated position. The 
nucleosome at —169bp sits almost exactly between the two sites, just 
overlapping the —97 Hinfl site (Figure 5.12). The —176 nucleosome also sits 
between the two Hinfl sites (Figure 5.12), overlapping the —248 Hinfl 
recognition site by one bp. These positions would suggest that Hinfl should 
digest N2 more efficiently than Ni. The only explanation for the under-
cutting of sites with the N2 nucleosome position compared to the Ni is the 
previously described interactions of non-nucleosomal DNA with the N2 
positioned nucleosome, blocking access to sites in this stretch of DNA. 
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The issue of the total failure of RsaI to cut the N2 position, while the more 
central Hinfl site at -248 is partially cut (as demonstrated by the appearance 
of the 63bp band) remains unresolved. If the unexplained band is a digestion 
product of the 63bp Hinfl band, then Hinfl must also cut at the upstream end 
of this fragment, but not in N2. A possible explanations for the peculiar 
digestion of N2 is that it is caused by an end-positioned nucleosome. The N2 
position cannot be an end position as the -279 RsaI site is 35bp from the end 
of the fragment. It is unlikely that a nucleosome would be associated with 
this stretch of DNA, but not with the -248 Hinfl site 63bp from the end as this 
would mean less than one turn of DNA was wrapped round the nucleosome. 
An end positioned nucleosome is also predicted to migrate at the fastest rate 
(Pennings, 1997). The N2 position migrates more slowly than N3, suggesting 
that N3 is the end positioned nucleosome. Another, more likely explanation 
is that the nucleosome/DNA interactions external to the core DNA are 
involved, blocking access to sites in this sequence. Finally, there could be a 
higher order structure in the DNA sequence that does not allow RsaI to cut, 
but this would be expected to be present in digests other than of the N2 
nucleosome position. 
The N3 nucleosome position digest contains neither a 24bp band nor a 
corresponding 216bp band, therefore is not cut at -97 by Hinfl. A fraction of 
the N3 DNA is cut at -248, but a significant proportion of probe is uncut. 
This suggests a nucleosome that is able to cover the -97 Hinfl site, but still 
protecting the -248 Hinfl site. This is hard to explain by the binding of a 
single nucleosome. The -97 Hinfl site is positioned over the StM Stat5 
binding site, suggesting that StM may be covered by the nucleosome in the 
N3 position. The probe A1A3, which contains only this site, is still shifted in 
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the N3 nucleosome position (Figures 5.7 and 5.8). If as the restriction data 
suggest an end positioned nucleosome sits at the downstream end of the 
probe this shows that for StM at. least Stat5 can bind to DNA near the edge of 
a positioned nucleosome. 
The restriction enzyme accessibility data backs up the hypothesis that there is 
partial although unpredictable access to DNA at sites close to the boundary 
of a positioned nucleosome on nAB. The A3 binding site that does not allow 
Stat5a binding is positioned more toward the nucleosome dyad than the Al 
binding site is, Al may still allow Stat5a binding although it is in nucleosome 
associated DNA. The position of the Stat5a binding site on the nucleosome 
may be crucial to whether or not Stat5a will bind to a weaker binding site. 
5.7 Do Stat5a Dimers make Higher Order Interactions on nAB. 
My hypothesis is that the wrapping of DNA round a positioned nucleosome 
in the Ni position brings together the strong StM and the weaker Al Stat5a 
binding sites, potentially facilitating DNA bound Stat5a-Stat5a dimer-dimer 
interactions, otherwise referred to as tetramerisation. If Stat5a dimers 
interact with each other as a tetramer on a nucleosome associated nAB probe 
their synergistic interaction should exhibit a more stable Stat5a binding to the 
Al site, and hence more stable total Stat5a binding to the probe (John et al., 
1999; Vinkemeier et al., 1996; Vinkemeier et al., 1998). Usually consensus and 
nonconsensus binding sites must be placed close to each other in cis on the 
DNA sequence to facilitate tetramerisation. Organisation of DNA into a 
nucleosome could have the same result, bringing two Stat5 binding sites 
close enough to allow tetramerisation. 
194 
5.7.1 NI Competitor Studies with A3. 
The relative strength of both WT Stat5a and Stat5aW37A binding to the Ni 
nucleosome position on a WT probe was assessed using competition studies 
with an unlabelled double stranded oligonucleotide to the A3 binding site as 
competitor. The A3 site was chosen as it binds Stat5a weakly, and thus 
should be able to reveal more subtle changes in the binding affinities of the 
two Stat5a species to the nucleosomal probe. Bandshift reactions were 
carried out as previously described, with the exception that the final 
incubation at room temperature was for 10 minutes before addition of the 
competitor and incubation for a further 10 minutes at room temperature 
before the reaction was loaded onto a polyacrylamide gel in TBE. 
The two competitor concentrations of 20- and 200-fold molar excess (relative 
to the labelled probe) were chosen to give a maximal range of competition. 
A3 almost completely competes Stat5 binding to the StM oligonucleotide 
probe at 200-fold excess, and as expected a significant amount of signal 
remains at 20-fold excess (Figure 4.2.B). 
The primary and secondary shifted bands are seen for both WT Stat5a and 
for Stat5aW37A shifts in non-competed lanes, Figure 5.13. The secondary 
band is totally competed in W37A shifts with a 20-fold excess of the A3 
oligonucleotide, but in WT Stat5a shifts it is still visible at 20-fold. The 
percentage remaining signal after competition in the combined primary and 
secondary shifted bands was calculated as a percentage of the signal in the 
non-competed lane, after normalisation to the total signal in each lane 
(Quantity One analysis of a phosphorimage). These values are listed below 
each lane in Figure 5.13A. The data suggests that WI Stat5a may have a 
subtly higher affinity for the Ni probe than Stat5aW37A does, but the values 
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Figure 5.13 A3 Competition on the NI Position at 20 and 200-fold Molar 
Excess. 
The strength of binding of WT Stat5a and Stat5aW37A to the Ni nucleosome 
position was studied using competition by the weak Stat5 binding site A3. An 
image of the gel is shown in A, and a graphical representation of the results 
after analysis of a phosphorimage in B. Arrows mark the secondary and 
primary shifted bands. The percentage remaining signal in the shifted band 
and the lane number are marked on the gel. Above the gel the Stat5a used 
to shift in each lane and the fold molar excess of competitor (relative to the 
labelled probe) are indicated. 
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are probably not different enough to indicate a real difference. These results 
are also shown as a graph in Figure 5.13B. 
5.7.2 NI and N3 Competitor Studies with A3. 
The competition experiment was repeated on nucleosome positions Ni and 
N3 on a WT probe. N3, unlike Ni, is predicted to cover a second Stat5a 
binding site that is potentially involved in tetramerisation. From the 
nucleosome mapping this is predicted to be Al, although the restriction 
enzyme analysis experiments suggest that there is access to this site, and that 
it may be the StM site that is covered by the N3 nucleosome. Stat5a does 
bind to StM in the N3 nucleosome position (Figures 5.5 and 5.8), and 
probably also to Al as demonstrated in Figure 5.10. The N2 position was not 
used because of its unexplained behaviour; any results could not be 
interpreted in the context of nucleosome position. A lower competitor range 
was chosen for this experiment to examine any more subtle changes in Stat5a 
affinity for nAB. Results of competitor experiments with 10 and 20-fold 
molar excess of unlabelled A3 are shown in Figure 5.14. 
For both the nucileosome positions Ni and N3, there is no difference between 
the addition of 10 or 20-fold molar excess competitor on shifts with WT 
Stat5a (Figure 5.14). In position Ni, 70% of the shifted signal remains after 
competition at a 10-fold and 67% remains after competition at a 20-fold 
excess for ten minutes. 52% and 55% signal remain in Position N3. On the 
other hand competitions of Stat5aW37A shifts on position Ni demonstrate a 
1.7 fold difference between 10 and 20-fold excess competitor (72% remaining 
signal for 10-fold and 34% for 20-fold excess). The same difference for N3 is 
2.1 fold (24% and 14% remaining). These results again suggest that WT 
Stat5a may have a higher affinity in general for a nucleosomal probe than 
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Figure 5.14 A3 Competition of Stat5a Binding to NI and N3 at 10 and 20-
Fold Molar Excess. 
The strength of binding of WT Stat5a and Stat5aW37A to the NI and N3 
nucleosome positions was studied using competition by the weak Stat5 
binding site A3 at a lower fold excess competitor to probe more subtle 
differences. An image of the gel is shown in A, and a graphical 
representation of the results after analysis of a phosphorimage in B. Arrows 
mark the secondary and primary shifted bands. The signal remaining in the 
shifted bands expressed as a percentage of the uncompeted shifted signal 
for the appropriate Stat5a nucleosome position is marked below the gel. 
Above the gel the Stat5a used to shift in each lane, the fold molar excess of 
competitor (relative to the labelled probe in each reaction) and the shifted 
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Stat5aW37A does. WT Stat5a shows no difference between a 10 or a 20-fold 
competitor, perhaps reflecting a plateau in the stability of the Stat5a complex, 
which is overcome at a higher fold competitor such as the 200-fold excess in 
Figure 5.13. It is possible this is mediated by the tetramerisation interaction 
as this is not observed with the W37A mutant. These results are shown in 
graphical form in Figure 5.14.B. As Stat5a can bind to both the Al and StM 
sites in both nucleosome positions, these subtle differences in the position of 
the nucleosome may not be important. However a nucleosome that places 
the Stat5 binding site more centrally, as for the A3, would be predicted to be 
more likely to have an effect. 
When the relative affinities of Stat5a for the N3 and the Ni nucleosome 
positions were compared, a surprising result emerged. N3 positions in 
general appeared to have a greater resistance to competition by A3 than Ni 
positions did. For WT Stat5a, N3/N1 ratios for 10 and 20-fold molar excess 
are 1.35 and 1.22 respectively, and for Stat5a W37A they are 3.00 and 2.43 
respectively. It may be that the arrangement of DNA on the N3 nucleosome 
is more favourable to Stat5 binding than the Ni, as the StM binding site is 
further from the nucleosome. The N3 shifted bands are very weak making 
any quantification unreliable, so no solid conclusions can be drawn from this. 
The angle of the DNA exiting the nucleosome or the rotational setting, i.e. 
whether or not the DNA sequence is orientated correctly to allow 
interactions would both influence Stat5a binding interactions. The rotational 
setting will particularly influence binding to Al and A3 (see section 6.2.1). 
DNaseI experiments to determine the rotational setting on these nucleosomes 
are in progress. The difference between the affinities of WT Stat5a and 
Stat5aW37A for N3 is similar to those for Ni but the N3 position has a 
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slightly higher difference of 2.1 compared to 1.7 fold for the Ni. This theory 
requires further testing, as it backs up the results in Figure 5.8, which 
suggested that nAB might shift at the secondary shift level more in the N3 
position than in Ni or N2. 
5.8 Chapter Conclusions. 
The work in this chapter has shown that Stat5a will bind to a reconstituted 
chromatin probe, and to each individual nucleosome position isolated from 
this. Stat5a binds to the position isomers in order N2/NX>Ni>N3. Binding 
to individual Stat5 binding sites inside nucleosome associated DNA is also 
described. Stat5a will not bind to the A3 binding site, which is situated in the 
middle of a nucleosome. The question of whether or not Stat5a can bind to 
the Al Stat5 binding site at the periphery of a bound nucleosome has not 
been fully answered, but restriction analysis suggests that partial access is 
available to this site when it is near the edge of a nucleosome. There is no 
restriction enzyme access to the StM site in position N3, indicating that it 
may be covered by an end positioned nucleosome, yet Stat5a will bind to this 
site. The position of a binding site within nucleosomal DNA appears to have 
a major role in whether or not Stat5a will bind. Alternatively, as the StM 
binding site is much stronger that the A3 and the Al, binding to this site may 
be a reflection of the affinity Stat5a has for the sequence. This could be 
investigated further by substituting the A3 site for an StM site, assuming that 
this does not cause further changes in nucleosome positioning. 
This chapter also described the anomalous migration of the N2 nucleosome 
position as a secondary band, termed NX. It is likely that this is a result of a 
change in the stability of the N2 band that causes an already present 
structural abnormality in this nucleosome (the restriction of access to the 
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upstream sequences) to alter the migration of N2//NX through a non-
denaturing polyacrylamide gel; perhaps by altering the likelihood that a 
nucleosome positions to the N2 or the NX site. Alternatively N2 and NX 
could position at the same location and the extra contacts in NX may cause a 
different migration. 
Finally Stat5a dimer-dimer, or tetramerisation interactions were studied. A 
difference is detected between the affinity of WT Stat5a (which can make 
tetramerisation interactions) and Stat5aW37A (which cannot) for 
nucleosomal probes especially at low molar excess of a weak competitor. 
Further study must be carried out to characterise this further. 
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6 DISCUSSION. 
It is clear that the chromatin structure over the BLG gene plays a major role 
in its regulation, most likely by regulating the accessibility for transcription 
factors such as Stat5. In this thesis I have demonstrated that recombinant 
Stat5a will bind to reconstituted nucleosomes in vitro, and that it will do so 
on Stat5 binding sites that are located within the outer 25bp of core protected 
DNA. Stat5a will not bind to sites internally located by 40bp or more from 
the nucleosome boundary. This information forms the basis for resolving the 
precise role of a positioned nucleosome on the BLG promoter. 
6.1 Stat5 Binding to DNA. 
The binding of both recombinant Stat5, produced in a baculovirus expression 
system, and Stat5 from a nuclear extract to binding sites in the 240bp 
fragment of the BLG promoter (nAB) and to oligonucleotide probes 
corresponding to the individual Stat5 binding sites has been studied in 
Chapter 4. Both sets of shifts exhibited multiple shifted bands (Figures 4.2 
and 4.10). Multiple bands were present also in shifts using Stat5 containing 
the W37A mutation, which has been reported previously to block the 
formation of Stat5 dimer-dimer interactions, known as tetramerisation (John 
et al., 1999; Vinkemeier et al., 1998), indicating that the multiple shifted 
bands observed in probes shifted by recombinant StatS are not due to 
tetramerisation interactions (but see section 6.1.1). The pattern of bands 
observed in shifts by recombinant Stat5 and Stat5 from a mammary gland 
nuclear extract are different, the most rapidly migrating shifted band 
migrates at the same level in both but there are three bands in rStat5 shifts, 
and only two in nuclear extract shifts. 
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An explanation for the appearance of multiple shifted bands is that a 
percentage of the Stat5 population is post translationally modified. Stat 
proteins are reported to be phosphorylated on residues other than the 
conserved tyrosine essential for activation of the protein (Beuvink et al., 2000; 
Park et al., 2001; Ridderstrale and Groop, 2001; Yamashita et al., 2001). Both 
Stat5a and Stat5b have been reported to be phosphorylated on serine 
residues (S725 and S779 in mouse Stat5a) (Yamashita et al., 2001). 
The recombinant Stat5 produced in the baculovirus expression system was 
found to be phosphorylated on the conserved tyrosine (Y694 in Stat5a) and 
was able to bind DNA without the need to co infect cells with a JAK 
encoding baculovirus. This indiscriminate phosphorylation may also result 
in the inappropriate modification of other residues, which could affect the 
migration of the shifted complex through a polyacrylamide gel. Altering the 
conditions used to separate the shifted complexes resulted in the migration 
of shifted complexes as a discrete band (Figure 4.12). 
6.1.1 Tetramerisation. 
Recent work has suggested that the previously characterised N-terminal 
interactions involved in tetramerisation are not correct. The actual 
tetramerisation interface does not involve W37, but rather hydrophobic 
interactions between E29 and L78 and also between L15 and L77 (this 
numbering relates to Stat4) (Chen et al., 2002). These residues are all at least 
semi-conserved between Stats 1, 4, 5a and 5b (Figure 6.1). However the 
W37A mutant has been shown to prevent tetramerisation occurring, and 







Stat5a 	 MAGWIQAQQL DALRQMQVLYGQHFVRHYL IES PWDAIDLDNPQDRAQATQL 
Stat5b MAVWIQAQQLQ§EALHQMQALYGQHFI;VRHYLSMIESIAWDSVDLDNPQENIKATQL 
Stat4 	 MSQNQVQQLEIKFLEQVDQFYDDNFPMEIRHLL IS DWEAASNNE----TMATIL 
Stat5a 	 LEGLVQELQKKAE"QVGEDGILLKIKLGHYATQLQKTYDRCPLELVRCIRHILYNEQRLV 
Stat5b LEGLVQELQKKAEHQVGED LKIKLGHYATQLQNTYDRCPMELVRCIRHILYNEQRLV 
Stat4 	 LQNLLIQLDEQLIVSKEKNLLLIHNLKRIRKVLQGKFHGNPMHVAVVISNCLREERRIL 
Figure 6.1 Interactions at the N-terminal Domains of Stats. 
A. Alignments of Stats 4, 5a and 5b were carried out using ClustaiW. 
Residues thought to be involved in tetramerisation are highlighted. Residues 
not fully conserved in Stat5 are in coloured font instead of highlighted. B. 
Top two images are the original model for Stat tetramerisation (Vinkemeier et 
al., 1998), the bottom two images are the revised model (Chen et al., 2002). 
The views are from different angles. Residues are highlighted in A blue for 
the Vinkemeier model and Yellow for the Chen model. The Structures in part 
B were taken from (Chen et al., 2002) and the numbering relates to Stat4. 
the mutation still functions, probably by destabilising the N-terminal 
domain. The residues proposed to make the tetramerisation interactions are 
conserved between Stat5a and Stat5b, so these cannot explain why Stat5b 
does not make tetramerisation interactions as efficiently as Stat5a does. An 
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alignment of Stat5a and Stat5b reveals that most of the differences occur at 
the N- and C-terminal domains (see appendices). Residues within these 
areas are likely to be involved in tetramerisation and other protein-protein 
interactions, and may hold the key to the different activation profiles of the 
two proteins. 
No role for tetramerisation has been either proven or disproved by the work 
discussed in this thesis, but several avenues of investigation remain open. 
Most significantly competition analysis has not been carried out on naked 
DNA to compare the binding strengths of the two Stat5a species to this, or on 
the N2 nucleosome position, which was shown to bind Stat5a better than the 
other nucleosome positions. It may also be useful to repeat the whole 
experiment using the newly identified set of N-terminal tetramerisation 
interactions (Chen et al., 2002). 
6.2 Nucleosome Positioning on the BLG Promoter. 
Nucleosomes position at precise locations on nAB, a fragment of the 
proximal BLG promoter. These migrate as three discrete bands when a 
reconstitute is separated by non-denaturing polyacrylamide gel 
electrophoresis (Ni, N2 and N3 in Figure 3.5). Nucleosome position isomers 
that migrate as the Ni band are located most closely to the centre of nAB, 
with nucleosome dyads positioned at -184 and -198 bp from the 
transcription start site. The N2 positioning isomer is composed of 
nucleosomes positioned at -169 and -176 and the N3 position is a 
combination of end positioned nucleosomes and sequence directed 
nucleosomes at -234, -225, -219 and -213 bp (Figure 3.17). These groups of 
positioned nucleosomes were isolated and the binding of Stat5a to each 
group studied. Results demonstrated that Stat5a will bind to all three 
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nucleosome isomers at sites external to, or near to, the nucleosome boundary, 
but will not bind to sites located more centrally on the nucleosome. 
6.2.1 Rotational Positioning on nAB. 
The nucleosome positioning isomers on nAB do not appear to be rotationally 
related, as their positions on nAB do not exhibit a lObp periodicity (Figure 
6.2). However digestion with Exoill results in a characteristic lObp 
periodicity of the nucleosome specific Exolli pause sites detected in the Ni 
and N2 isolates (Figures 3.11 and 3.12). This arrangement suggests that 
rotationally related nucleosomes do exist within each group of nucleosome 
position isomers. The pauses in Ni also align with those in N2, indicating 
that these groups of positions are rotationally related to each other (Figure 
3.11). It is unclear why when there is evidence for the presence of 
rotationally positioned nucleosomes, the mapped positions do not agree with 
this. 
Further analysis of the data suggests an explanation for this, the three 
positions mapped by Exoill are located with dyads at —219, —198 and —169 nt 
from the transcription start site. These positions are separated by 19 and 
31bp and thus are rotationally related with an approximate lObp periodicity 
(Figure 6.2). The DNA protected by the nucleosome from Exoill digest was 
calculated to be 149 bp, this is slightly larger than the accepted 146bp, 
indicating a small potential error in these maps. The nucleosomes mapped 
by core particle restriction digests are located with dyads mapping at —234, 
—225, —213,-184, —176 and —169nt from the transcription start site (Figures 
3.16 and 6.2). With the exception of the nucleosome position at —169, which 
was detected only weakly, these nucleosome positions are also related with 
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an approximate lObp periodicity, but this is out by 5bp from the periodicity 
detected by Exolil digestion (Figure 6.2). 
This difference in the periodicity is likely to be a reflection of the different 
mapping techniques used to calculate these positions. Nucleosome positions 
mapped over the beta globin gene displayed a similar discrepancy between 
the Exoill mapped position, which detected a nucleosome with boundaries at 
-207 and -60 nt from the transcription start site (Kefalas et al., 1988), and a 
core DNA restriction mapped position with nucleosome boundaries at -204 
Exoill Mapped 
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-234 -225 -213 -184 -176 
Restriction 
Mapped 
Figure 6.2 Rotational Setting of Mapped Nucleosome Positions. 
The rotational setting of the nucleosome positions mapped on nAB is 
indicated in this schematic diagram. ExoIll mapped locations of the 
nucleosome dyad are indicated above the line, and restriction mapped dyad 
locations below the line. The Exolil lObp periodicity is marked by black 
triangles at -179, -169 etc and the restriction I Obp periodicity by white 
triangles at -234, -224 etc. 
and -56 (Yenidunya et al., 1994). A similar discrepancy was observed with 
these two mapping techniques on the 5S rRNA gene (Buttinelli et al., 1993). 
This may be a general feature of Exolli and core restriction mapping, and 
may reflect the degree of access each enzyme requires at the nucleosome 
boundary or the relation of cleavage sites to binding sites. A similar 
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comparison of the access of DNaseI and Exolli to a positioned nucleosome 
showed that Exoill consistently cut further into the nucleosome core than 
DNaseI (Pmnell, 1983). These two enzymes also produced slightly different 
positions for nucleosome boundaries on the 5S rRNA gene (Meersseman et 
al., 1991; Simpson and Stafford, 1983; Penriings et al., 1991). MNase has also 
been demonstrated to produce core particles with slightly recessed 5' ends 
(Cousins et al., 2004). The similar discrepancy of 4bp between the Exolil and 
restriction digest mapping techniques in the beta globin map, along with the 
accepted errors in mapping, is sufficient to explain the alternative periodicity 
that results from the two mapping techniques on nAB, indicating that as 
suggested by the lObp periodicity detected in the Exoill digest, all the 
positions are rotationally related. A DNaseI digest of the unfractionated 
reconstitute would confirm if this is the case. Not enough is known about 
the mechanisms of Exolli digestion within a nucleosome to be able to use this 
to determine the rotational setting of nAB on these nucleosomes, but a 
DNaseI digest may be more informative. Furthermore a DNaseI protection 
assay may also be able to detect Stat5 binding to each of the three binding 
sites on a positioned nucleosome. 
The orientation of a Stat5 binding site against the nucleosome may be a factor 
in Stat5 recognition of a binding site that is located in a nucleosome, 
particularly as regards the Al and the A3 Stat5 binding sites, both of which 
are only half consensus sites. The TTC of Al and the GAA of A3 are 
separated by 76 bp, thus placing them at opposite sides of the DNA helix. 
The A3 site did not allow Stat5a binding, but the Al binding site did. This 
may be due to the orientation of each binding site on the nucleosome or 
alternatively it may be due to reduced accessibility at sites further from a 
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nucleosome boundary. The function of rotationally positioned nucleosomes 
on nAB could be to ensure that binding sites for transcription factors such as 
Stat5, which may be located within the nucleosome, remain in a position that 
allows them to be recognised and bound. Different rotationally positioned 
nucleosomes may therefore favour binding to either the Al or the A3 binding 
sites. 
6.2.2 Mapping Nucleosome Dyads. 
A degree of ambiguity remains as to exactly where on nAB nucleosomes are 
positioned. The strength of the interaction of DNA with the nucleosome 
boundary clearly varies between nucleosomes, for example N2 makes strong 
interactions at the upstream nucleosome boundary that are detected in Exolil 
digests (Figure 3.11). Such differences affect the detection of nucleosome 
boundaries by nucleases, as the more tightly DNA is bound to the 
nucleosome the less likely the DNA will be made available to a nuclease 
(Figure 6.3). 
A technique has been developed where nucleosome positions can be mapped 
by site-directed cleavage by hydroxyl radicals engineered into the 
nucleosome core near to the dyad axis (Flaus et al., 1996). Repeating the 
nucleosome map on nAB using this technique would allow nucleosome 
positions to be mapped absolutely with respect to the dyad axis rather than 
to nucleosome boundaries. Nucleosome positions on nAB have been 
mapped accurately using the Exolil and core restriction techniques described 
in Chapter 3. These maps also provide additional useful information about 
the nucleosome boundary that would not be evident from a hydroxyl radical 
map. A combination of these techniques would allow nucleosome positions 
on nAB to be mapped beyond doubt. 
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Figure 6.3 Mapping Nucleosome Boundaries. 
The potential downside of nucleosome mapping techniques that use 
detection of nucleosome boundaries are highlighted in Figure 6.3. A weak 
interaction between the histone core and DNA, indicated at the downstream 
boundary of the nucleosome in this schematic diagram, may cause the 
nucleosome boundary to be detected further in to the core than it actually is 
(an open arrow marks the false boundary, and a closed arrow the true 
boundary). Conversely, an interaction of DNA external to the nucleosome 
with the histone core, depicted at the upstream boundary of the nucleosome 
in this diagram, may cause the nucleosome boundary to be detected further 
out from the core than it actually is. Again an open arrow marks the false 
boundary and a closed arrow the true boundary. This diagram depicts a 
single nucleosome, the dyad of which does not move, a technique that maps 
from the nucleosome dyad (lightning bolt) would not be affected by these 
boundary effects. 
6.2.3 Implications for In Vivo. 
The question of which of these nucleosome positions, if any, is present over 
the active gene promoter in vivo has yet to be addressed. The original in vivo 
map showed that an array of strongly positioned nucleosomes ends just 
upstream of the proximal promoter region studied in this thesis (Figure 3.1 
and Boa, 1999). 
Protected DNA bands are still detected in the in vivo nucleosome map of the 
proximal BLG promoter region (incorporating nAB) in mammary tissue 
(Figure 3.1), which suggests that a nucleosome remains at this location. This 
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may reflect the proportion of cells in the mammary gland that are not 
expressing BLG, or alternatively it may reflect the presence of a different, 
perhaps remodelled, nucleosome structure that does not protect the DNA 
from digestion to the same extent. One proposed mechanism for the action 
of nucleosome remodelling complexes, such as SWI/SNF, is the removal of 
H2A and H2B leaving only the (H3H4)2 tetramer bound to DNA (Workman 
and Kingston, 1998; Bruno et al., 2003). NFl, which acts synergistically with 
both Stat5 and CR for maximal expression of WAP, has been shown to be 
able to bind to such a structure but not to a complete nucleosome octamer, 
this interaction is mediated by CR binding to the nucleosome 
(Mukhopadhyay et al., 2001; Spangenberg et al., 1998). There are binding 
sites for CR, NF-1 and Stat5 in the proximal BLC promoter (Figure 1.8 and 
Figure 6.4). A similar mechanism may take place on the BLC promoter, 
whereby the binding of CR and also Stat5 results in a change in the 
chromatin structure facilitating the initiation of transcription from the 
promoter. 
It is a feature of active genes that nucleosomes appear to be displaced from 
the immediate promoter, usually after binding of transcription factors that 
can recognise their binding sites within the nucleosome (Cosma, 2002; Boeger 
et al., 2003; Lee et al., 2004). If this is the case on BLC, the role of a positioned 
nucleosome on the proximal promoter would be confined to initiating the 
formation of the transcription complex. 
6.2.4 A Poised Chromatin Structure? 
The in vivo map determined the chromatin structure over both the active BLC 
gene, in lactating mammary gland, and the chromatin structure in liver, a 
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Figure 6.4 Transcription Factor Binding Sites on nAB. 
Schematic diagram showing selected transcription factor binding sites on 
fragment nAB of the BLG promoter. The box above the sequence contains 
the key to which shape represents each factor. Figure 1.8 shows the 
sequences of each transcription factor binding site. 
observed over the BLG gene, HSIV and HSV, are present up to the onset of 
milk protein production in mammary tissue and disappear with the 
upregulation of milk protein gene expression (Whitelaw and Webster, 1998). 
These are not present in liver suggesting that non-lactating mammary tissue 
may contain a different chromatin structure again from that observed in 
either the transcribed or the repressed genes (Figure 6.5). 
The function of such a poised chromatin structure could be to maintain the 
BLG promoter in a mammary specific chromatin state that is ready to be 
activated during late pregnancy and lactation. Mammary gland specificity is 
conferred by the 406bp proximal promoter region of BLG in transgenic mice, 
although the specific mechanism of this is unknown (Webster et al., 1995). It 
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is possible that a specific chromatin structure over the proximal promoter, 
developed during mammary gland development, is responsible for the 
mammary specificity of BLG and results in a specific Stat5 binding pattern. 
This could explain why all three Stat5 binding sites are essential for 
maximum gene activity in mammary cells, but not in CHO cells (Demmer et 
al., 1995; Burdon et al., 1994b). 
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Figure 6.5 In vivo Chromatin Structures over BLG. 
A schematic diagram of how the chromatin structure over the BLG promoter 
may look. The repressed structure is that seen in liver, a tissue that never 
expresses BLG. The poised structure may contain a positioned nucleosome 
over the proximal promoter such as those detected in the in vitro map, this 
nucleosome is removed in the active promoter, and the nucleosomes 
throughout the gene are disrupted. 
A poised chromatin state may involve the positioning of a nucleosome at a 
specific location over the proximal promoter. For this reason it would be 
interesting to study the chromatin structure over the BLG promoter in 
mammary gland at other developmental stages, for example in virgin or 
involuting mammary gland. It would also be helpful to carry out this 
mapping with a higher resolution technique such as ligation mediated PCR 
(LM PCR) which would enable the nucleosome position in vivo to be mapped 
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to the base pair. Nucleosome positions observed in vitro do not necessarily 
occur in vivo as other factors, such as proteins bound to DNA, may influence 
nucleosome position. 
Further studies of the in vivo structure during mammary gland development 
could determine which of the Stat5 activation models proposed below are 
relevant. Chromatin immunoprecipitation (ChIP) could be utilised to detect 
the timepoint when Stat5 is first detected bound to the BLG promoter and the 
chromatin structure compared with this. Another Stat family member, Stat3, 
is involved in mammary gland involution and can also bind to the Stat5 
binding sites present in nAB. The appearance of Stat3 could also be 
monitored by the same methods. The transcription factor ying yang 1 (YY1), 
a mammalian polycomb group protein, and a second unidentified factor 
have been demonstrated to repress the -casein promoter. Binding of Stat5 
to the promoter overcomes YY1 mediated repression (Lee and Oka, 1992; 
Meier and Groner, 1994). A binding site for YY1 is present in the proximal 
BLG promoter region. YY1 may also have a role in regulation of the BLG 
gene. 
6.2.5 A Role for the Extracellular Matrix? 
The mouse mammary epithelial cell line, HC11, will not express transfected 
BLG and other milk proteins at high levels unless the cells are fully 
confluent, and have formed a basal membrane structure (Figure 6.6). This 
resulted in the theory that the extracellular matrix conveys a signal that 
maximises milk protein expression by controlling Stat5 activation levels 
(Zoubiane et al., 2003). CR also has been shown to have a role in maintaining 
differentiated mammary epithelial cells (Murtagh et al., 2004). 
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The formation of a basal matrix is another physical manifestation of 
mammary cell differentiation, this structure is essential in formation of 
lactationally competent cells (Roskelley et al., 1994; Streulli and Edwards, 
1998). Milk protein promoters are not induced by a cocktail of 
dexamethasone, insulin and prolactin (DIIIP) in dividing HC11 cells, cells 
must be confluent and have produced a basal membrane structure (Figure 
6.6). The development of the basal membrane structure in HC11 cells may 
mirror the differentiation process of mammary cells in late pregnancy in vivo. 
The HC11 cell line was derived from a mid pregnant mouse (Danielson et al., 
1984) and does not express BLG as well as mice containing an identical 
transgene, this is also reflected in the strength of the HSIII (B. Whitelaw, 
personal communication). This could reflect that the transfected BLG is not 
incorporated into the optimal chromatin structure as it has not undergone 
development. 
6.2.6 Nuclear Arrangement of Milk Protein Genes 
The WAP gene is flanked by two highly expressing genes and its mammary 
specificity is probably at least partially controlled by a potential nuclear 
matrix attachment region (MAR) which has been detected in rabbit and 
mouse WAP at —8kb from the transcription start site (Millot et al., 2003). 
These sites may represent a chromatin boundary. 
There is also a MAR in the 3' flanking sequences of BLG, that appears to 
affect the basal level of BLG expression (Whitelaw et al., 2000). Although a 
shorter sequence that does not include this is also capable of directing 
position independent expression in transgenic mice but not to act as a locus 
control region (Whitelaw et al., 1992; James et al., 2000). MARs can anchor 
DNA sequences to the nuclear matrix, one role of this could be to localise 
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groups of genes, such as the milk proteins, to a common region of the 
nucleus. It is unknown how the locations of milk protein genes relate to each 
other within the nucleus, and this would be an interesting question to 
answer. 
6.3 Stat5 Actions. 
The hypothesis of this project is that a positioned nucleosome on the BLG 
promoter could regulate Stat5 binding to binding sites in the promoter, thus 
influencing BLG gene activity. It was proposed that this could occur by two 
separate mechanisms. Either by a nucleosome position arrangement that 
facilitated the Stat5 tetramerisation interaction (Figures 1.9 and 6.7), or by 
alternative nucleosome positions that either allowed or did not allow Stat5 to 
bind (Figures 1.9 and 6.7). All three Stat5 binding sites have been shown to 
be required for full BLG activity in the mouse mammary epithelial cell line 
(HC11) and in mice transgenic for BLG although even after mutation of all 
three Stat5 binding sites (SAA) a minimal and non-inducible expression still 
occurred (Burdon et al., 1994b; Burdon et al., 1994a), suggesting that 
hormone induced BLG expression is mediated by Stat5 action, but that other 
factors control the basal mammary specific expression. This leaky basal 
expression level may reflect the poised state of the promoter. 
6.3.1 A Role for Stat5 Tetramerisation in the Regulation of BLG? 
The winding of DNA round a nucleosome could bring binding sites for Stat5 
close enough to allow two bound Stat5 dimers to be able to facilitate 
tetramerisation interactions through their N-terminal domains. A 
nucleosome positioned more centrally between the two outer Stat5 binding 
sites, such as the strong nucleosome position detected at —184bp (Figure 
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Figure 6.6. HCII Differentiation Model. 
A Schematic diagram showing how the chromatin structure in 
undifferentiated (A) dividing mammary epithelial cells in culture (top) may 
maintain the BLG gene in a repressed chromatin structure (grey oval, 
bottom). When cells reach confluence they differentiate and form a basal 
membrane structure (purple) (B) resulting in a change in the chromatin 
structure (open oval) that allows transcription factor binding (represented 
here by filled red circles) after treatment of cells with the lactogenic 
hormones. The subsequent activation of milk protein genes (yellow circles) 
may coincide with removal of the nucleosome (C). 
equidistant from the nucleosome (Figure 1.9, A and Q. In this model Stat5 
probably binds to the full consensus site StM first, this facilitates recruitment 
of a second dimer to the Al and perhaps eventually also to the A3 binding 
site. A3 is located near to the dyad axis of the nucleosome and therefore also 
close to the other two Stat5 binding sites. The Al and A3 sites are separated 
by 76bp, which places them together when both are in a nucleosome, such an 
organisation in a "supergroove" may allow two Stat5 dimers bound to these 
sites to interact (Edayathumangalam et al., 2004). Although Stat5 cannot 
bind to the A3 site in vitro, the nucleosome is almost certainly not present 
when the gene is in an active state and the A3 site will therefore be available 
for binding. The path of the DNA exiting the nucileosome is unknown so 
these interactions cannot be accurately modelled. 
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The ability of Stat5a to tetramerise on the BLG promoter was investigated by 
the addition of purified recombinant Stat5a to nucleosomes reconstituted on 
nAB. Complexes formed were then competed with varying amounts of a 
specific cold competitor DNA, an oligonucleotide to the A3 binding site. 
Two Stat5 dimers bound as a tetramer should form a more stable complex 
than two independently bound dimers. The mutant Stat5a W37A, which 
cannot make tetramerisation interactions but is able to bind as a dimer, was 
used as a control for individual dimer binding affinity. If tetramerisation 
interactions occur, WT Stat5a binding should be more stable than Stat5a 
W37A binding. 
No significant stabilisation of WT Stat5a complexes compared to Stat5a 
W37A complexes was detected on either the Ni or the N3 nucleosome 
positions at high levels of competitor (Figure 5.13). However at this 200-fold 
molar excess competitor a Stat5 dimer bound to StM is almost completely 
competed (Figure 4.2). A slight stabilisation was detected for WT Stat5a over 
Stat5aW37A containing complexes for both the nucleosome position isomers 
Ni and N3 using competition with a lower range of competitors. A 20-fold 
but not a 10-fold molar excess of the unlabelled A3 binding site 
oligonucleotide produced this difference (Figure 5.14). However the 
difference was not observed with the same 20-fold molar excess of the Stat5 
binding site oligonucleotide A3 (Figure 5.13). To be certain if tetramerisation 
is occurring this experiment must be repeated. It may be that the level of 
binding stabilisation conferred by tetramerisation on a nucleosome is very 
subtle and that a 20-fold molar excess competition is close to the point where 
the affinity of Stat5 dimers and tetramers for the probe differs. Slight 
variations from this or the time competition is carried out for may result in 
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all or both being competed. Thus it has not been proven that neither the Ni 
or the N3 arrangement are able to facilitate a Stat5 tetramerisation interaction 
nor that they cannot. The N2 position isomer has not been tested in this 
assay (see Section 6.2.5). 
6.3.2 Recruitment of Stat5. 
A second mechanism by which the nucleosome position could affect gene 
regulation of BLG also involves recruitment of Stat5 but does not take into 
account stabilisation of binding to weaker sites by tetramerisation. This 
model assumes that Stat5 will bind preferentially to binding sites located 
outwith the nucleosome. Although Stat5 has been shown to bind to sites in a 
nucleosome, other transcription factors that also do so have been shown to 
bind to free DNA with a higher affinity (Ruh et al., 2004; Li and Wrange, 
1993). It can be predicted that Stat5 will bind with a similar behaviour 
although this remains to be tested. 
The strongest Stat5 binding site, StM, is placed furthest from the nucleosome 
in the N3 nucleosome position. Ni also places StM a significant distance 
outside the nucleosome boundary (Figures 5.1 and 6.7). SP1 and GR binding 
sites are also situated external to the nuclesomë in N3, and lie just internal in 
the Ni arrangement (Figure 6.7). These transcription factors can bind to 
DNA arranged in a nucleosome and GR has been implicated in the 
disruption of a positioned nucleosome (Li and Wrange, 1993; Li et al., 1994; 
Perlmann and Wrange, 1988; Fletcher et al., 2000) and Chapter 5 of this 
thesis. Binding of Stat5 to StM may result in recruitment of CBP/p300 and 
GR and eventually in removal of the nucleosome so Stat5 can bind to the 
other two binding sites. This model could occur in any of the mapped 
nucleosome positions. 
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6.3.3 Alleviation of Repression. 
Stat5 may also be able to bind equally as well to the BLG promoter in other 
cell types and at other promoters. Expression of -casein has been linked to 
alleviation of repression, it may be that non mammary cell types contain 
negative regulators of Stat5 such as SOCS or the C-terminal truncated 
dominant negative version of Stat5 that prevent activation of the gene. A 
specific interaction with the prolactin receptor when the correct cocktail of 
lactation hormones is present in the cell may create a specifically modified 
Stat5 that mediates formation of a mammary specific complex over the 
promoter. 
Stat5 is constitutively phosphorylated on serine 779 in mammary tissue 
(Beuvink et al., 2000). This modification appears to prevent Stat5 binding to 
DNA and reduces the expression level of a reporter gene driven by the f-
casein promoter but is overcome by co-stimulation of cells with 
dexamethasone (a GR agonist) and prolactin. The mechanism of phospho-
serine inhibition is unknown. The function of this modification could be to 
repress milk production during late pregnancy and mammary gland 
development, when the poised chromatin structure may have developed, 
until a cooperative interaction with CR overcomes the phospho-serine 
inhibition. By this mechanism, although high levels of Stat5 are present from 
late pregnancy, milk protein genes are not activated until parturition 
(Yamashita et al., 2001). 
6.3.4 Does Stat5 Position Nucleosomes. 
If there is not a positioned nucleosome in the active gene, there is still a 
strong positioning signal present in the DNA, such that the nucleosome must 
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be actively removed and prevented from binding here. The in vitro map of 
nucleosome positions over the BLG gene matched the in vivo map in liver, 
suggesting that this is the default state of the gene (Boa, 1999). The above 
models (Figure 6.7) provide a mechanism by which Stat5 binding facilitates 
disruption of this nucleosome. An alternative model proposes that Stat5 
binding resuts in the poised chromatin structure. 
Stat5 is required for mammary gland development. At some point during 
this development I have proposed that a chromatin structure over the BLG 
promoter is formed that renders the gene in a poised state, ready to be 
activated. This has yet to be tested by looking at the chromatin structure in 
vivo over the promoter, but HSIV and V suggest a different chromatin 
structure is present over the non expressed BLG gene in mammary gland 
compared to that observed in a tissue that BLG is never expressed in. These 
hypersensitive sites lie in the transcribed region of the gene, not over the 
proximal promoter where a Stat5 dependent chromatin structure is predicted 
to take place, however a chromatin structure could be nucleated at the 
proximal promoter and spread along the gene in a similar way to 
heterochromatin spreading or spread to the proximal promoter from a 
different nucleation point. 
One argument against Stat5 creating a poised chromatin structure, is that no 
displacement of nucleosomes was detected after Stat5 binding, however it is 
likely that if this occurs it is mediated by interactions with other proteins 
recruited to the promoter by Stat5, for example CR. Bandshifts with lactating 
mammary nuclear extracts or extracts from cultured cells which can be 
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Figure 6.7 Transcription Factors Binding to Nucleosomes. 
Schematic diagrams depicting transcription factors binding to nAB in 
nucleosorne positions N3 and N1/N2. Transcription factors are represented 
by the same shapes as in Figure 6.4. In the N3 position, Stat5 is recruited to 
the StM binding site and GR can also bind, Stat5 may not be able to bind to 
the Al and A3 binding sites. VYI may also be able to bind in N3. In N1/N2 
Stat5 can bind to both StM and Al which may potentially allow 
tetra merisation. SPI and GR binding may induce nucleosome displacement 
and allow NFl binding. 
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other factors in nucleosome movement. 
6.3.5 Functional Significance of Tetramerisation. 
Work is in progress to compare the effects of organisation of the BLG 
promoter into chromatin on expression level of the gene. The BLG promoter 
is either transiently or stably transfected into CHO-K3 cells. Transient 
transfections will be organised into a form of chromatin structure, but stable 
integrants may have a more organised chromatin structure formed over 
them, which may be organised into an appropriate structure by the signals in 
the DNA. This approach however does not mimic mammary gland 
differentiation. If any difference is observed between the stably and 
transiently transfected cells then this experiment could be taken a stage 
further. The effects of overexpression of the tetramerisation mutant and WT 
Stat5a and 5b will be compared in both types of transfected cell with and 
without D/I/P stimulation (Neil et al., 2004). 
6.4 The N21 NX Positions. 
The N2 position isomer exhibits an interesting behaviour. N2 displays a 
tendency to migrate as the isomer NX. It does so with minor changes in the 
lengths of tail DNA that lie external to the nucleosome (Figures 3.6 and 3.8). 
This led to the conclusion that the NX position may already exist within the 
N2 band, as a different position that migrates through a non-denaturing 
polyacrylamide gel at the same rate as N2. An isomer migrating in the NX 
band also appears when the A3 Stat5 binding site is mutated to A3m, by 
exchange of an A to a T and insertion of a T (Figures 5.2 and Figure 4.1). It is 
unlikely that this single insertion would be sufficient to significantly alter the 
migration of a positioned nucleosome but it may alter the nucleosome 
position. The change lies within 30 bp of the dyad axis, this is the DNA that 
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makes contact with the (H3H4)2 tetramer, which is responsible for 
positioning the nucleosome. It is possible that this ibp insertion is sufficient 
to cause an entirely new nucleosome position on nAB. Groups searching for 
the signal in the DNA that drives nucleosomes positioning in vitro could in 
the future exploit single base changes like this. 
Another feature of the N2 isomer is that approximately 30bp of DNA 
upstream of the nucleosome core interacts with the nucleosome. This 
interaction is sufficient to cause a non sequence-specific pause in an Exoill 
digest that does not remain at higher Exolil concentrations suggesting that it 
is not a true nucleosome pause site (Figure 3.11). The Ni site lies upstream 
of the N2 site and the DNA interacting with the nucleosome is the sequence 
that separates the two position isomers. This interaction may represent a link 
between N2 and Ni. Alternatively, the extra DNA covered by this structure 
places the two outer Stat5 binding sites exactly at the nucleosome boundary. 
The centre of this extended nucleosome would lie at —184. The significance 
of this arrangement is not yet clear. 
In the restriction enzyme accessibility assays of the nucleosome position 
isomers in Chapter 5, N2 also exhibited a strange behaviour. A RsaI site 
lying 22bp upstream of the nucleosome boundary was not cleaved by RsaI, 
but Hinfl cleaved at a site 30bp towards the nucleosome dyad (Figure 5.11), 
this Hinfl site is within the N2 nucleosome (Figure 5.12). Hinfl cuts within 
Ni at both sites better than it does N2, this may reflect a stronger interaction 
of the DNA with the nucleosome core in N2 than in Ni, perhaps facilitated 
by the extra DNA associated with the nucleosome. This may reflect a 
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property of the N2 nucleosome in vitro where transcription factor access is 
impeded. 
In Stat5a bandshifts of unfractionated reconstitutes, Stat5 preferentially 
bound to the N2 nucleosome position isomer over either the Ni or the N3 
isomers (Figure 5.2). The additional 30bp associated with the nucleosome 
brings both the Stat5 binding sites together right at the boundary of the 
nucleosome associated DNA. Stat5 has been demonstrated to be able to bind 
to DNA at the periphery of a nucleosome, it is therefore likely that both these 
Stat5 binding sites can be bound in this extended nucleosome, as long as 
binding of one does not impede the binding of the other. As the N2 isomer 
also exhibits a tendency to reposition to the isomer NX, and thus the location 
of this nucleosome on nAB could not be established beyond doubt, 
competition assays to determine the affinity of WT and W37A Stat5a for 
these positions were not carried out. Given a more accurate location of N2 
and NX, perhaps by hydroxyl radical mapping, it would be of interest to 
study the relative affinity of N2 and NX in the competition assay. 
6.5 Which Stat5 Sites are Bound In Viva. 
Binding to all three Stat5 binding sites is essential for full gene activity in 
mammary epithelial cells. Conventional chromatin immunoprecipitation is 
unable to differentiate between the three binding sites, as all would be cross 
linked in one large complex by the nucleosome. A technique such as 
incorporation of a DNA cleavage or crosslinking reagent into the Stat5 
molecule may be able to determine exactly which Stat5 binding sites are 
occupied, and at which stage of mammary gland development. An 
alternative strategy could be to carry out an in vivo footprint of the region, 
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involving digest of the genomic DNA, perhaps with Exolil or DNaseI and 
making use of LM-PCR to detect protected areas over the Stat5 binding sites. 
6.6 Complex Regulation of BLG. 
Work in this thesis has shown that Stat5 can bind to sites at the boundary of a 
a nucleosome, but not to sites further than 40bp from the boundary. 
Nucleosome position isomers have been mapped and a specific feature of the 
N2 nucleosome isomer described. A role of Stat5 tetramerisation in the 
binding of Stat5a to DNA within a nucleosome was investigated, although 
this study was not conclusive. 
From these results I have proposed several models for the mammary specific 
activation of the BLG gene. Many of these will be relevant to other milk 
proteins. The nature of the mammary specific signal for BLG expression is 
yet to be discovered and many avenues of investigation remain open. 
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Appendices 
Alignment of Stat5a and Stat5b using CLUSTAL W (1.74). The conserved 
tyrosine involved in activation of the protein is highlighted in red. 
Stat5a 	 MAGWIQAQQLQGDALRQMQVLYGQHFPIEVR}iYLAQWIESQPWDAI DLDNPQDRAQATQL 
Stat5b MAVWIQAQQLQGEALHQMQALYGQHFPIEVRHYLSQWIESQAWDSVDLDNPQENIKATQL 
Stat5a 	 LEGLVQELQKKAEHQVGEDGFLLKIKLGHYATQLQKTYDRCPLELVRCIRHILYNEQRLV 
Stat5b LEGLVQELQKKAEHQVGEDGFLLKIKLGHYATQLQNTYDRCPMELVRCIRHILYNEQRLV 
Stat5a 	 REANNCSSPAGILVDAMSQKHLQINQTFEELRLVTQDTENELKKLQQTQEYFIIQYQESL 
Stat5b REANNGSSPAGSLADAMSQKHLQINQTFEELRLVTQDTENELKKLQQTQEYFI IQYQESL 
***** ***** 
Stat 5a 	 RIQAQFAQLAQLS PQERLSRETALQQKQVSLEAWLQREAQTLQQYRVELAEKHQKTLQLL 
Stat5b RIQAQFGPLAQLS PQERLSRETALQQKQVSLEAWLQREAQTLQQYRVELAEKHQKTLQLL 
Stat5a 	 RKQQTI ILDDELIQWKRRQQLAGNGGPPEGSLDVLQSWCEKLAEI IWQNRQQIRRAEHLC 
Stat5b RKQQTIILDDELIQWKRRQQLAGNGGPPEGSLDVLQSWCEKLAEIIWQNRQQIRRAEHLC 
************************************************************ 
Stat5a 	 QQLPIPGPVEEMLAEVNATITDIISALVTSTFIIEKQPPQVLKTQTKFAATVRLLVGGKL 
Stat5b QQLPIPGPVEEMLAEVNATITDIISALVTSTFIIEKQFFQVLKTQTKFAATVRLLVGGKL 
************************************************************ 
Stat5a 	 NVHMNPFQVKATIISEQQAKSLLKNENTRNECSGEILNNCCVMEYHQATGTLSAHFRNMS 
Stat5b NVFIMNPPQVKATIISEQQAKSLLKNENTRNDYSGEILNNCCVMEYHQATGTLSAHFRNMS 
Stat 5a 	 LKRIKRADRRGAESVTEEKFTVLFESQFSVGSNELVFQVKTLSLPVVVIVHGSQDHNATA 
Stat5b LKRIKRSDRRGAESVTEEKFTILFESQFSVGGNELVFQVKTLSLPVVVIVHGSQDNNATA 
S tat5a 	 TVLWDNAFAEPGRVPFAVPDKVLWPQLCEALNMKFKAEVQSNRGLTKENLVFLAQKLFNN 
Stat5b TVLWDNAFAEPGRVPFAVPDXVLWPQLCEALNMKFKAEVQSNRGLTKENLVFLAQKLFNN 
Stat 5a 	 SSSHLEDYSGLSVSWSQFNRENLPGWNYTFWQWFDGVMEVLKKHHKPHWNDGAI LGFVNK 
Stat5b SSSHLEDYSGLSVSWSQFNRENLFGRNYTFWQWFDGVMEVLKKHLKPHWNDGAILGFVNK 
************************* ****************** *************** 
Stat5a 	 QQAHDLLINKPDGTFLLRFSDSE IGGITIAWKFDSPERNLWNLKPFTTRDFS IRSLADRL 
Stat5b QQAHDLLINKPDGTFLLRFSDSEIGGITIAWKFDSQERNFWNLMPFTTRDFS IRSLADRL 
Stat5a 	 GDLSYLIYVFPDRPKDEVFSKYYTPV ----- LAKAVDIVKPQIKQWPEFVNASADAGG 
Stat 5b GDLNYLIYVFPDRPKDEVYSKYYTPVPCESATAKAVDGVKPQ IKQVVPEFVNASADAGG 
*****************•******* 	**************************** 
Stat5a 	 SSATYMDQAPSPAVCPQAPYNMYPQNPDHVLDQDGEFDLDETMDVARHVEELLRRPMDSL 
Stat 5b GSATYMDQAPS PAVCPQAHYNMYPQNPDSVLDTDGDFDLEDTMDVARRVEELLGRPMD- - 
Stat5a 	 DSRLSPPAGLFTSARGSLS 
Stat5b -SQWIPHAQS 
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Alignment of the Caprine and Ovine proximal promoter sequences using 
CLUSTAL W (1.74). The insertion is highlighted in yellow. The dyad axis 
mapped in vitro by (Boa, 1999) for each sequence is highlighted in pink. 
Caprine 	------------------- TTGGAGGAGCTGGTGCCCAAGGCAGAGGCCACCCTCCAGGA 
Ovine ------------------- TTGGAGGAGCTGGTGCCCAAGGCAGAGGCCACCCTCCAGGA 
Caprine 	 CACACCTGTCCCCAGTGCTGGCTCTGACCTGCCCTTGTCTAAGAGGCTGACCCCGGAAGT 
Ovine CACACCTGTCCCCAGTGCTGGCTCTCAGCTGTCCTTGTCTAAGAGGCTGACCCCGGAAGT 
************************* * *** **************************** 
Caprine 	 GTTCCTGGCACTGGCAGCCAGCCTG-ACCCAGAGTCCAGACACCCACCTGTGCCCCCACT 
Ovine GTTCCTGGCACTGGCAGCCAGCCTGGACCCAGAGTCCAGACACCCACCTGTGCCCCCGCT 
************************* ******************************* ** 
Caprine 	 TCTGGGGTCTACCAGGAACCGTCTAGGCCCAGAGGGGGACTTCTGCTTGGCCCCGGATG 
Ovine TCTGGGGTCTACCAGGAACCGTCTAGGCCCAGAGGGEGACTTCCTGCTTGGCCTTGGATG 
***************************************************** ***** 
Caprine 	 GAAGAAGGCCTCCTATTGTCCTCGTAGAGGAAGCCACCCCGGGGCCCGGGGATGAGCCAA 
Ovine GAAGAAGGCCTCCTATTGTCCTCGTAGAGGAAGCCACCCCGGGGCCTGAGGATGAGCCAA 
********************************************** * *********** 
Caprine 	 GTAGGATTCCGGGAACCTCGTGGCTGGGGGCCCGGCCCGGGCTGGCTGGCTGGCACGCCT 
Ovine GTGGGATTCCGGGAACCGCGTGGCTGGGGTACCAGCCCGGGCTGGCTGGCCTGCATGCCT 
** ************** *********** ** **************** *** **** 
Capr me 	 CCTGTATAAGGCCCCGAGCCCGCTGTCTCAGCCCTCCACTCCCTGCAGAGCTCAGAAGCA 
Ovine CCTGTATAAGGCCCCAAGCCTGCTGTCTCAGCCCTCCACTCCCTGCAGAGCTCAGAAGCA 
*************** **** *************************************** 
Caprine 	 CGACCCCAGCTGCAGCCATGAAGTGCCTCCTGCTTGCCCTGGGCCT 
Ovine CGACCCCAGCTGCAGCCATGAAGTGCCTCCTGCTTGCCCTGGGCCT 
********************************************** 
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